activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177496	CHEMBL803640	Inhibition of Ribosomal S6 kinase 3	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	60.0	CHEMBL2345	Homo sapiens	Activity	%	60.0
	177496	CHEMBL803640	Inhibition of Ribosomal S6 kinase 3	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	60.0	CHEMBL2345	Homo sapiens	Activity	%	60.0
	178809	CHEMBL803641	Inhibition of Ribosomal S6 kinase 3	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	33.0	CHEMBL2345	Homo sapiens	Activity	%	33.0
	178821	CHEMBL803642	Inhibition of Ribosomal S6 kinase 3	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	IC50	nM	2000.0	CHEMBL2345	Homo sapiens	IC50	uM	2.0
	182556	CHEMBL803640	Inhibition of Ribosomal S6 kinase 3	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	24.0	CHEMBL2345	Homo sapiens	Activity	%	24.0
	182570	CHEMBL803642	Inhibition of Ribosomal S6 kinase 3	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	IC50	nM	640.0	CHEMBL2345	Homo sapiens	IC50	uM	0.64
	554894	CHEMBL800991	Inhibition of RSK-2 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	9.0	CHEMBL2345	Homo sapiens	Inhibition	%	9.0
	559738	CHEMBL800992	Inhibition of RSK-2 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	Inhibition	%	0.0
	572981	CHEMBL800992	Inhibition of RSK-2 in presence of 10 uM ATP	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	11.0	CHEMBL2345	Homo sapiens	Inhibition	%	11.0
	586372	CHEMBL800991	Inhibition of RSK-2 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	Inhibition	%	0.0
	915771	CHEMBL803643	Inhibition of Ribosomal S6 kinase 3 at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	21.0	CHEMBL2345	Homo sapiens	Activity	%	21.0
	931232	CHEMBL803644	Inhibition of Ribosomal S6 kinase 3 at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Of control	%	63.0	CHEMBL2345	Homo sapiens	Of control	%	63.0
	1479411	CHEMBL829810	Inhibition of Ribosomal S6 kinase 2 (RSK2) at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	9.0	CHEMBL2345	Homo sapiens	Inhibition	%	9.0
	1479419	CHEMBL830620	Inhibition of Ribosomal S6 kinase 2 (RSK2) at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Inhibition	%	106.0	CHEMBL2345	Homo sapiens	Inhibition	%	106.0
	1489867	CHEMBL832898	Inhibition of Ribosomal S6 kinase 2; Range is 5-10	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	=	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
Not Active	1650603	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1650604	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1650605	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL2345	Homo sapiens	Kd		
	1650606	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	55.0	CHEMBL2345	Homo sapiens	Kd	uM	0.055
Not Active	1650607	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL2345	Homo sapiens	Kd		
	1650608	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2200.0	CHEMBL2345	Homo sapiens	Kd	uM	2.2
Not Active	1650609	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1650610	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1650611	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL2345	Homo sapiens	Kd		
	1652160	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	60.0	CHEMBL2345	Homo sapiens	Kd	uM	0.06
Not Active	1652161	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652162	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652163	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652164	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652165	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652166	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652167	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652168	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652169	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL2345	Homo sapiens	Kd		
Not Active	1652170	CHEMBL860796	Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL2345	Homo sapiens	Kd		
	1723383	CHEMBL862047	Inhibition of RSK2	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	7400.0	CHEMBL2345	Homo sapiens	Ki	nM	7400.0
	1723495	CHEMBL862047	Inhibition of RSK2	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	7400.0	CHEMBL2345	Homo sapiens	Ki	nM	7400.0
	1723799	CHEMBL862047	Inhibition of RSK2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	7400.0	CHEMBL2345	Homo sapiens	Ki	nM	7400.0
	1723813	CHEMBL862047	Inhibition of RSK2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	7400.0	CHEMBL2345	Homo sapiens	Ki	nM	7400.0
	1723814	CHEMBL862047	Inhibition of RSK2	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	=	Ki	nM	3300.0	CHEMBL2345	Homo sapiens	Ki	nM	3300.0
	1723815	CHEMBL862047	Inhibition of RSK2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	7400.0	CHEMBL2345	Homo sapiens	Ki	nM	7400.0
	1734083	CHEMBL862834	Residual activity at human Rsk3 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	73.0	CHEMBL2345	Homo sapiens	Activity	%	73.0
	1739095	CHEMBL865052	Inhibition of RSK2	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Ki	nM	580.0	CHEMBL2345	Homo sapiens	Ki	nM	580.0
	1744374	CHEMBL866674	Inhibition of Rsk2	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	7400.0	CHEMBL2345	Homo sapiens	Ki	uM	7.4
	1769448	CHEMBL910949	Inhibition of RSK2	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL2345	Homo sapiens	IC50	uM	1.0
	1790058	CHEMBL855319	Percentage activity of human Rsk3 in the presence of 10uM of compound and 10uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	97.0	CHEMBL2345	Homo sapiens	Activity	%	97.0
Not Determined	1916312	CHEMBL894166	Inhibition of recombinant Rsk2 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080		IC50			CHEMBL2345	Homo sapiens	IC50		
	1916366	CHEMBL894166	Inhibition of recombinant Rsk2 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
	1960601	CHEMBL892532	Inhibition of PKAP1	B	NC1=NC(=O)/C(=C/c2ccc3ncccc3c2)S1		CHEMBL396377	>	Ki	nM	2000.0	CHEMBL2345	Homo sapiens	Ki	uM	2.0
	1960602	CHEMBL892532	Inhibition of PKAP1	B	O=C1N=C(N[C@@H]2C[C@H]2c2ccccc2)S/C1=C\c1ccc2ncccc2c1		CHEMBL235345	>	Ki	nM	2000.0	CHEMBL2345	Homo sapiens	Ki	uM	2.0
	1960603	CHEMBL892532	Inhibition of PKAP1	B	O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1		CHEMBL393929	>	Ki	nM	2000.0	CHEMBL2345	Homo sapiens	Ki	uM	2.0
	1981742	CHEMBL899257	Inhibition of RSK2 assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	91.0	CHEMBL2345	Homo sapiens	Activity	%	91.0
	1981743	CHEMBL899258	Inhibition of RSK2 assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	28.0	CHEMBL2345	Homo sapiens	Activity	%	28.0
	2025196	CHEMBL887024	Inhibition of human Rsk3 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	5.0	CHEMBL2345	Homo sapiens	Inhibition	%	5.0
	2025480	CHEMBL887024	Inhibition of human Rsk3 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	33.0	CHEMBL2345	Homo sapiens	Inhibition	%	33.0
	2025481	CHEMBL887024	Inhibition of human Rsk3 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	25.0	CHEMBL2345	Homo sapiens	Inhibition	%	25.0
	2025482	CHEMBL887024	Inhibition of human Rsk3 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	5.0	CHEMBL2345	Homo sapiens	Inhibition	%	5.0
	2025520	CHEMBL887038	Inhibition of human Rsk3	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	IC50	nM	48.0	CHEMBL2345	Homo sapiens	IC50	nM	48.0
	2050279	CHEMBL925577	Inhibition of Rsk2 at 1 uM	B	CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1		CHEMBL400754	=	Inhibition	%	-1.0	CHEMBL2345	Homo sapiens	Inhibition	%	-1.0
	2051673	CHEMBL941809	Inhibition of RSK2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	7368.0	CHEMBL2345	Homo sapiens	Ki	uM	7.368
	2081814	CHEMBL928838	Inhibition of RSK2 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL2345	Homo sapiens	Inhibition	%	20.0
	2147382	CHEMBL922167	Activity of human Rsk2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	76.0	CHEMBL2345	Homo sapiens	Activity	%	76.0
	2182833	CHEMBL941459	Inhibition of RPS6KA3 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	7.0	CHEMBL2345	Homo sapiens	INH	%	7.0
	2197915	CHEMBL1004014	Inhibition of human RSK2	B	CNc1nccc(-c2nc(C3CCNCC3)[nH]c2-c2cccc(C(F)(F)F)c2)n1		CHEMBL489344	=	IC50	nM	76000.0	CHEMBL2345	Homo sapiens	IC50	uM	76.0
	2197923	CHEMBL1004014	Inhibition of human RSK2	B	CC1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)CC1		CHEMBL523938	=	IC50	nM	39000.0	CHEMBL2345	Homo sapiens	IC50	uM	39.0
	2206864	CHEMBL990539	Inhibition of RPSKA3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	55.0	CHEMBL2345	Homo sapiens	Kd	nM	55.0
	2251076	CHEMBL1022314	Inhibition of RSK2 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	104.0	CHEMBL2345	Homo sapiens	INH	%	104.0
	2251204	CHEMBL1009903	Inhibition of Rsk2	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	1.0	CHEMBL2345	Homo sapiens	IC50	nM	1.0
	2279749	CHEMBL958314	Inhibition of RSK2 at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
Not Active	2302175	CHEMBL950844	Inhibition of RSK2 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	2341426	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341467	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	17.0	CHEMBL2345	Homo sapiens	INH	%	17.0
	2341508	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341549	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	3.0	CHEMBL2345	Homo sapiens	INH	%	3.0
	2341590	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341631	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341672	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341713	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341754	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341795	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341836	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2341877	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	5.0	CHEMBL2345	Homo sapiens	INH	%	5.0
	2341918	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	62.0	CHEMBL2345	Homo sapiens	INH	%	62.0
	2341959	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342000	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342041	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	57.0	CHEMBL2345	Homo sapiens	INH	%	57.0
	2342082	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342123	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	5.0	CHEMBL2345	Homo sapiens	INH	%	5.0
	2342164	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342205	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342246	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342287	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	14.0	CHEMBL2345	Homo sapiens	INH	%	14.0
	2342328	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	3.0	CHEMBL2345	Homo sapiens	INH	%	3.0
	2342369	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	2342410	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342451	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	5.0	CHEMBL2345	Homo sapiens	INH	%	5.0
	2342492	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342533	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2342806	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	9.0	CHEMBL2345	Homo sapiens	INH	%	9.0
	2342839	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	5.0	CHEMBL2345	Homo sapiens	INH	%	5.0
	2343064	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343065	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343066	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343067	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343068	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343069	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343070	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343071	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343072	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343073	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343074	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343075	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343076	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343077	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343078	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343079	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343080	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343081	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343082	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343083	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343084	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343085	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343086	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343087	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343088	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343089	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2343114	CHEMBL953387	Inhibition of RSK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
Not Evaluated	2476698	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2476901	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2478740	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2479595	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2479798	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL2345	Homo sapiens	Activity		
Active	2480595	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL2345	Homo sapiens	Activity		
	2480797	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	34.1	CHEMBL2345	Homo sapiens	Activity	%	34.1
Not Active	2527089	CHEMBL984167	Inhibition of RSK2 at => 3 ug/mL	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Active	2527101	CHEMBL984155	Inhibition of MAPKAPK1B at => 3 ug/mL	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2577216	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2577419	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2593624	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL2345	Homo sapiens	Activity		
	2593890	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	3.8	CHEMBL2345	Homo sapiens	Activity	%	3.8
Not Evaluated	2594093	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2594833	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2595036	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2596233	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2596436	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Evaluated	2597705	CHEMBL982726	Binding affinity to human RSK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2345	Homo sapiens	Activity		
	2613330	CHEMBL1016940	Inhibition of MAPKAPK1b	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	2613352	CHEMBL1022064	Inhibition of RSK2 C-terminal kinase domain expressed in Escherichia coli preincubated for 30 mins	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1	Potential transcription error	CHEMBL515414	=	IC50	nM	15000.0	CHEMBL2345	Homo sapiens	IC50	mM	0.015
	2613353	CHEMBL1022064	Inhibition of RSK2 C-terminal kinase domain expressed in Escherichia coli preincubated for 30 mins	B	Cc1ccc(-c2cn(CCCO)c3ncnc(N)c23)cc1	Outside typical range	CHEMBL473965	=	IC50	nM	1200000.0	CHEMBL2345	Homo sapiens	IC50	mM	1.2
	2613354	CHEMBL1022065	Inhibition of RSK2 C-terminal kinase domain C436V mutant expressed in Escherichia coli preincubated for 30 mins	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1	Outside typical range	CHEMBL515414	>	IC50	nM	10000000.0	CHEMBL2345	Homo sapiens	IC50	mM	10.0
	2613355	CHEMBL1022065	Inhibition of RSK2 C-terminal kinase domain C436V mutant expressed in Escherichia coli preincubated for 30 mins	B	Cc1ccc(-c2cn(CCCO)c3ncnc(N)c23)cc1	Outside typical range	CHEMBL473965	=	IC50	nM	430000.0	CHEMBL2345	Homo sapiens	IC50	mM	0.43
	2613356	CHEMBL1022066	Inhibition of RSK2 C-terminal kinase domain T493M mutant expressed in Escherichia coli preincubated for 30 mins	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1	Outside typical range	CHEMBL515414	=	IC50	nM	3400000.0	CHEMBL2345	Homo sapiens	IC50	mM	3.4
	2613357	CHEMBL1022066	Inhibition of RSK2 C-terminal kinase domain T493M mutant expressed in Escherichia coli preincubated for 30 mins	B	Cc1ccc(-c2cn(CCCO)c3ncnc(N)c23)cc1	Outside typical range	CHEMBL473965	>	IC50	nM	30000000.0	CHEMBL2345	Homo sapiens	IC50	mM	30.0
Active	2613360	CHEMBL1016973	Binding affinity to wild type RSK2 at 1 uM preincubated for 1 hr by denaturing gel electrophoresis and Western blot	B	Cc1ccc(-c2c(C(=O)CF)n(CCCOC(=O)NCCCCNC(=O)CCCC[C@@H]3SC[C@H]4NC(=O)N[C@H]43)c3ncnc(N)c23)cc1		CHEMBL446278		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Active	2613361	CHEMBL1016974	Binding affinity to RSK2 C436V mutant at 1 uM preincubated for 1 hr by denaturing gel electrophoresis and Western blot	B	Cc1ccc(-c2c(C(=O)CF)n(CCCOC(=O)NCCCCNC(=O)CCCC[C@@H]3SC[C@H]4NC(=O)N[C@H]43)c3ncnc(N)c23)cc1		CHEMBL446278		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Active	2613362	CHEMBL1016975	Binding affinity to RSK2 T493M mutant at 1 uM preincubated for 1 hr by denaturing gel electrophoresis and Western blot	B	Cc1ccc(-c2c(C(=O)CF)n(CCCOC(=O)NCCCCNC(=O)CCCC[C@@H]3SC[C@H]4NC(=O)N[C@H]43)c3ncnc(N)c23)cc1		CHEMBL446278		Activity			CHEMBL2345	Homo sapiens	Activity		
Active	2613363	CHEMBL1016976	Binding affinity to RSK2 in HEK293 cells assessed as protein labeling at 1 mM preincubated for 1 hr by enhanced chemiluminescence detection	B	Cc1ccc(-c2c(C(=O)CF)n(CCCOC(=O)NCCCCNC(=O)CCCC[C@@H]3SC[C@H]4NC(=O)N[C@H]43)c3ncnc(N)c23)cc1		CHEMBL446278		Activity			CHEMBL2345	Homo sapiens	Activity		
Active	2613365	CHEMBL1016978	Binding affinity to RSK2 in HEK293 cells assessed as protein labeling at 1 mM preincubated for 1 hr by immunodepletion method	B	Cc1ccc(-c2c(C(=O)CF)n(CCCOC(=O)NCCCCNC(=O)CCCC[C@@H]3SC[C@H]4NC(=O)N[C@H]43)c3ncnc(N)c23)cc1		CHEMBL446278		Activity			CHEMBL2345	Homo sapiens	Activity		
Active	2613370	CHEMBL1016983	Inhibition of EGF-stimulated RSK2-mediated histone H3 Ser10 phosphorylation expressed in serum starved african green monkey COS7 cells by Western blot	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Active	2613371	CHEMBL1016984	Inhibition of EGF-stimulated RSK2 T493M mutant-mediated histone H3 Ser10 phosphorylation expressed in serum starved african green monkey COS7 cells up to 10 mM by Western blot	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Active	2613372	CHEMBL1016985	Inhibition of EGF-stimulated RSK2 C436V mutant phosphorylation expressed in serum starved african green monkey COS7 cells at 10 uM by Western blot	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414		Activity			CHEMBL2345	Homo sapiens	Activity		
	2635887	CHEMBL1003317	Inhibition of RSK2 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL2345	Homo sapiens	Residual_activity	%	100.0
	2635955	CHEMBL1003317	Inhibition of RSK2 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL2345	Homo sapiens	Residual_activity	%	100.0
	2636023	CHEMBL1003317	Inhibition of RSK2 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL2345	Homo sapiens	Residual_activity	%	75.0
	2721715	CHEMBL1055119	Inhibition of Rsk2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	2895581	CHEMBL1063682	Percentage RSK2 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	2895582	CHEMBL1063682	Percentage RSK2 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	74.0	CHEMBL2345	Homo sapiens	Activity	%	74.0
Antagonist	2895583	CHEMBL1063682	Percentage RSK2 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	29.0	CHEMBL2345	Homo sapiens	Activity	%	29.0
Antagonist	2895584	CHEMBL1063672	Percentage RSK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	2.0	CHEMBL2345	Homo sapiens	Activity	%	2.0
	2895585	CHEMBL1063672	Percentage RSK2 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	75.0	CHEMBL2345	Homo sapiens	Activity	%	75.0
Antagonist	2895586	CHEMBL1063672	Percentage RSK2 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	27.0	CHEMBL2345	Homo sapiens	Activity	%	27.0
	2895587	CHEMBL1063672	Percentage RSK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	71.0	CHEMBL2345	Homo sapiens	Activity	%	71.0
Antagonist	2895588	CHEMBL1063672	Percentage RSK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	4.0	CHEMBL2345	Homo sapiens	Activity	%	4.0
Antagonist	2895589	CHEMBL1063672	Percentage RSK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	5.0	CHEMBL2345	Homo sapiens	Activity	%	5.0
Antagonist	2895590	CHEMBL1063672	Percentage RSK2 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	12.0	CHEMBL2345	Homo sapiens	Activity	%	12.0
	2895591	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	92.0	CHEMBL2345	Homo sapiens	Activity	%	92.0
	2895592	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	81.0	CHEMBL2345	Homo sapiens	Activity	%	81.0
	2895593	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	84.0	CHEMBL2345	Homo sapiens	Activity	%	84.0
Antagonist	2895594	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	42.0	CHEMBL2345	Homo sapiens	Activity	%	42.0
	2895595	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	82.0	CHEMBL2345	Homo sapiens	Activity	%	82.0
	2895596	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	92.0	CHEMBL2345	Homo sapiens	Activity	%	92.0
	2895597	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	104.0	CHEMBL2345	Homo sapiens	Activity	%	104.0
	2895598	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	52.0	CHEMBL2345	Homo sapiens	Activity	%	52.0
	2895599	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	67.0	CHEMBL2345	Homo sapiens	Activity	%	67.0
Antagonist	2895600	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	45.0	CHEMBL2345	Homo sapiens	Activity	%	45.0
Antagonist	2895601	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	29.0	CHEMBL2345	Homo sapiens	Activity	%	29.0
Antagonist	2895602	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	45.0	CHEMBL2345	Homo sapiens	Activity	%	45.0
Antagonist	2895603	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	30.0	CHEMBL2345	Homo sapiens	Activity	%	30.0
Antagonist	2895604	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	43.0	CHEMBL2345	Homo sapiens	Activity	%	43.0
	2895605	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	90.0	CHEMBL2345	Homo sapiens	Activity	%	90.0
	2895606	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	71.0	CHEMBL2345	Homo sapiens	Activity	%	71.0
	2895607	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	68.0	CHEMBL2345	Homo sapiens	Activity	%	68.0
	2895608	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	69.0	CHEMBL2345	Homo sapiens	Activity	%	69.0
	2895609	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	54.0	CHEMBL2345	Homo sapiens	Activity	%	54.0
Antagonist	2895610	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	30.0	CHEMBL2345	Homo sapiens	Activity	%	30.0
	2895611	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	82.0	CHEMBL2345	Homo sapiens	Activity	%	82.0
	2895612	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	94.0	CHEMBL2345	Homo sapiens	Activity	%	94.0
	2895613	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	81.0	CHEMBL2345	Homo sapiens	Activity	%	81.0
	2895614	CHEMBL1052117	Percentage RSK2 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	74.0	CHEMBL2345	Homo sapiens	Activity	%	74.0
	2895615	CHEMBL1060219	Percentage RSK2 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	89.0	CHEMBL2345	Homo sapiens	Activity	%	89.0
	2895616	CHEMBL1060219	Percentage RSK2 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	63.0	CHEMBL2345	Homo sapiens	Activity	%	63.0
	2895617	CHEMBL1062027	Percentage RSK2 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	67.0	CHEMBL2345	Homo sapiens	Activity	%	67.0
	2895618	CHEMBL1061105	Percentage RSK2 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	74.0	CHEMBL2345	Homo sapiens	Activity	%	74.0
Antagonist	2895619	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	49.0	CHEMBL2345	Homo sapiens	Activity	%	49.0
	2895620	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	88.0	CHEMBL2345	Homo sapiens	Activity	%	88.0
	2895621	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	105.0	CHEMBL2345	Homo sapiens	Activity	%	105.0
	2895622	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	88.0	CHEMBL2345	Homo sapiens	Activity	%	88.0
	2895623	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	57.0	CHEMBL2345	Homo sapiens	Activity	%	57.0
Antagonist	2895624	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	50.0	CHEMBL2345	Homo sapiens	Activity	%	50.0
	2895625	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	83.0	CHEMBL2345	Homo sapiens	Activity	%	83.0
	2895626	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	93.0	CHEMBL2345	Homo sapiens	Activity	%	93.0
	2895627	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	89.0	CHEMBL2345	Homo sapiens	Activity	%	89.0
	2895628	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	90.0	CHEMBL2345	Homo sapiens	Activity	%	90.0
	2895629	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	71.0	CHEMBL2345	Homo sapiens	Activity	%	71.0
	2895630	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	73.0	CHEMBL2345	Homo sapiens	Activity	%	73.0
	2895631	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	83.0	CHEMBL2345	Homo sapiens	Activity	%	83.0
	2895632	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	105.0	CHEMBL2345	Homo sapiens	Activity	%	105.0
	2895633	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	70.0	CHEMBL2345	Homo sapiens	Activity	%	70.0
	2895634	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	89.0	CHEMBL2345	Homo sapiens	Activity	%	89.0
	2895635	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	104.0	CHEMBL2345	Homo sapiens	Activity	%	104.0
	2895636	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	83.0	CHEMBL2345	Homo sapiens	Activity	%	83.0
	2895637	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	94.0	CHEMBL2345	Homo sapiens	Activity	%	94.0
	2895638	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	112.0	CHEMBL2345	Homo sapiens	Activity	%	112.0
	2895639	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	70.0	CHEMBL2345	Homo sapiens	Activity	%	70.0
	2895640	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	55.0	CHEMBL2345	Homo sapiens	Activity	%	55.0
Antagonist	2895641	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	39.0	CHEMBL2345	Homo sapiens	Activity	%	39.0
	2895642	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	66.0	CHEMBL2345	Homo sapiens	Activity	%	66.0
	2895643	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	96.0	CHEMBL2345	Homo sapiens	Activity	%	96.0
	2895644	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	86.0	CHEMBL2345	Homo sapiens	Activity	%	86.0
	2895645	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	98.0	CHEMBL2345	Homo sapiens	Activity	%	98.0
	2895646	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	97.0	CHEMBL2345	Homo sapiens	Activity	%	97.0
Antagonist	2895647	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	50.0	CHEMBL2345	Homo sapiens	Activity	%	50.0
Antagonist	2895648	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	34.0	CHEMBL2345	Homo sapiens	Activity	%	34.0
	2895649	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	80.0	CHEMBL2345	Homo sapiens	Activity	%	80.0
	2895650	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	80.0	CHEMBL2345	Homo sapiens	Activity	%	80.0
	2895651	CHEMBL1063683	Percentage RSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	99.0	CHEMBL2345	Homo sapiens	Activity	%	99.0
	2907741	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907742	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907743	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907744	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907745	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907746	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907747	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	5600.0	CHEMBL2345	Homo sapiens	Kd	nM	5600.0
	2907748	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907749	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907750	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907751	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907752	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907753	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907754	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907755	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907756	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907757	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907758	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907759	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907760	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907761	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907762	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	3600.0	CHEMBL2345	Homo sapiens	Kd	nM	3600.0
	2907763	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907764	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907765	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907766	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	740.0	CHEMBL2345	Homo sapiens	Kd	nM	740.0
	2907767	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907768	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907769	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907770	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907771	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907772	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907773	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	69.0	CHEMBL2345	Homo sapiens	Kd	nM	69.0
	2907774	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2100.0	CHEMBL2345	Homo sapiens	Kd	nM	2100.0
	2907775	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	580.0	CHEMBL2345	Homo sapiens	Kd	nM	580.0
	2907776	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6400.0	CHEMBL2345	Homo sapiens	Kd	nM	6400.0
	2907777	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2907778	CHEMBL1062870	Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	2921988	CHEMBL1052956	Inhibition of RPS6KA3 kinase domain 1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	91.0	CHEMBL2345	Homo sapiens	Activity	%	91.0
	2924709	CHEMBL1056850	Inhibition of RSK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	107.0	CHEMBL2345	Homo sapiens	Activity	%	107.0
	2924710	CHEMBL1056850	Inhibition of RSK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	99.0	CHEMBL2345	Homo sapiens	Activity	%	99.0
	2924711	CHEMBL1056850	Inhibition of RSK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	78.0	CHEMBL2345	Homo sapiens	Activity	%	78.0
	2924712	CHEMBL1056850	Inhibition of RSK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	77.0	CHEMBL2345	Homo sapiens	Activity	%	77.0
	2926198	CHEMBL1049412	Inhibition of RSK2 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	105.0	CHEMBL2345	Homo sapiens	Activity	%	105.0
	2926292	CHEMBL1057676	Inhibition of RSK2 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	104.0	CHEMBL2345	Homo sapiens	Activity	%	104.0
	2928495	CHEMBL1043887	Binding affinity to RSK3 kinase domain 2 C-terminal assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	84.0	CHEMBL2345	Homo sapiens	Activity	%	84.0
	2938442	CHEMBL1036946	Inhibition of RSK2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	6.0	CHEMBL2345	Homo sapiens	INH	%	6.0
	2946942	CHEMBL1056104	Inhibition of Rsk2 at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	2992241	CHEMBL1044544	Inhibition of human RPS6KA3 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	2998990	CHEMBL1041962	Inhibition of RSK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	113.0	CHEMBL2345	Homo sapiens	Activity	%	113.0
	2999780	CHEMBL1041962	Inhibition of RSK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	120.0	CHEMBL2345	Homo sapiens	Activity	%	120.0
	2999857	CHEMBL1048102	Inhibition of RSK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	86.0	CHEMBL2345	Homo sapiens	Activity	%	86.0
	2999933	CHEMBL1048102	Inhibition of RSK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	94.0	CHEMBL2345	Homo sapiens	Activity	%	94.0
	3052473	CHEMBL1072511	Residual activity of RPS6KA3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL2345	Homo sapiens	Residual activity	%	95.0
	3052725	CHEMBL1043804	Residual activity of RPS6KA3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL2345	Homo sapiens	Residual activity	%	95.0
	3054034	CHEMBL1071364	Residual activity of RPS6KA3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	36.0	CHEMBL2345	Homo sapiens	Residual activity	%	36.0
	3055321	CHEMBL1072511	Residual activity of RPS6KA3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	93.0	CHEMBL2345	Homo sapiens	Residual activity	%	93.0
	3055573	CHEMBL1043804	Residual activity of RPS6KA3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	85.0	CHEMBL2345	Homo sapiens	Residual activity	%	85.0
	3056878	CHEMBL1071364	Residual activity of RPS6KA3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	50.0	CHEMBL2345	Homo sapiens	Residual activity	%	50.0
	3057130	CHEMBL1072511	Residual activity of RPS6KA3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	94.0	CHEMBL2345	Homo sapiens	Residual activity	%	94.0
	3058450	CHEMBL1043804	Residual activity of RPS6KA3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL2345	Homo sapiens	Residual activity	%	93.0
	3059734	CHEMBL1071364	Residual activity of RPS6KA3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	58.0	CHEMBL2345	Homo sapiens	Residual activity	%	58.0
	3063557	CHEMBL1050472	Binding affinity to human RPS6KA3 kinase domain 1 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	3063647	CHEMBL1043376	Binding affinity to human RPS6KA3 kinase domain 1 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	44.0	CHEMBL2345	Homo sapiens	Activity	%	44.0
	3063737	CHEMBL1045143	Binding affinity to human RPS6KA3 kinase domain 1 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	3066894	CHEMBL1066100	Inhibition of RPS6KA3 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	3066984	CHEMBL1066100	Inhibition of RPS6KA3 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	11.0	CHEMBL2345	Homo sapiens	INH	%	11.0
	3084410	CHEMBL1072689	Inhibition of RSK2	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	4000.0	CHEMBL2345	Homo sapiens	IC50	uM	4.0
	3127304	CHEMBL1074382	Inhibition of RSK2 at 1 uM	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	52.0	CHEMBL2345	Homo sapiens	INH	%	52.0
	3127323	CHEMBL1074382	Inhibition of RSK2 at 1 uM	B	CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1		CHEMBL597211	=	Inhibition	%	22.0	CHEMBL2345	Homo sapiens	INH	%	22.0
	3127342	CHEMBL1074382	Inhibition of RSK2 at 1 uM	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	62.0	CHEMBL2345	Homo sapiens	INH	%	62.0
	3130779	CHEMBL1065114	Inhibition of RSK2 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3130804	CHEMBL1065089	Inhibition of MAPKAPK1b at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3131760	CHEMBL1065764	Inhibition of MAPKAPK1b at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3214039	CHEMBL1103234	Inhibition of RSK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	16.0	CHEMBL2345	Homo sapiens	INH	%	16.0
	3219708	CHEMBL1114122	Inhibition of RSK2 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	103.0	CHEMBL2345	Homo sapiens	INH	%	103.0
	3224954	CHEMBL1101758	Inhibition of RSK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3226333	CHEMBL1101758	Inhibition of RSK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3260069	CHEMBL1104322	Inhibition of RSK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	74.0	CHEMBL2345	Homo sapiens	Activity	%	74.0
	3261404	CHEMBL1104322	Inhibition of RSK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	78.0	CHEMBL2345	Homo sapiens	Activity	%	78.0
	3306918	CHEMBL1117943	Inhibition of MAPKAPK1b at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	74.0	CHEMBL2345	Homo sapiens	INH	%	74.0
	3332142	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3333557	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3334962	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3336382	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3337646	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3338977	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3339231	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3340534	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3341924	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3343371	CHEMBL1167690	Inhibition of RPS6KA3 N-terminal domain1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3358800	CHEMBL1175328	Inhibition of RSK2 N-terminal domain1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	16.0	CHEMBL2345	Homo sapiens	INH	%	16.0
	3359242	CHEMBL1175328	Inhibition of RSK2 N-terminal domain1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	2.8	CHEMBL2345	Homo sapiens	INH	%	2.8
	3368292	CHEMBL1176573	Inhibition of RSK2 at 1 uM	B	CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12		CHEMBL1171647	>	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	3419134	CHEMBL1228802	Inhibition of Rsk2 at 100 uM relative to control	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	=	Inhibition	%	105.0	CHEMBL2345	Homo sapiens	INH	%	105.0
	3419435	CHEMBL1225085	Inhibition of PMA-stimulated RSK2 phosphorylation in HEK293 cells after 1 hr by Western blotting analysis	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	EC50	nM	150.0	CHEMBL2345	Homo sapiens	EC50	nM	150.0
	3419436	CHEMBL1225085	Inhibition of PMA-stimulated RSK2 phosphorylation in HEK293 cells after 1 hr by Western blotting analysis	B	CC1=CC(C)=C2C=C3C=CC(CCC(=O)NCCCCCC(=O)NCCCCNC(=O)OCCCn4c(C(=O)CF)c(-c5ccc(C)cc5)c5c(N)ncnc54)=[N+]3[B-](F)(F)C12		CHEMBL1221656	=	EC50	nM	10000.0	CHEMBL2345	Homo sapiens	EC50	uM	10.0
Active	3419437	CHEMBL1225086	Inhibition of fmk-BODIPY binding to recombinant RSK2 by TAMRA-N3 reporter gene assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	3419438	CHEMBL1226192	Binding affinity to RSK2 in HEK293 cells at 100 nM by immunoprecipitation assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Activity			CHEMBL2345	Homo sapiens	Activity		
Active	3419440	CHEMBL1225088	Binding affinity to RSK2 in HEK293 cells up to 300 nM by TAMRA-N3 reporter gene assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Activity			CHEMBL2345	Homo sapiens	Activity		
Not Active	3419444	CHEMBL1226194	Inhibition of RSK2 phosphorylation in HEK293 cells at 100 nM by immunoprecipitation assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Not Active	3419445	CHEMBL1226195	Inhibition of RSK2 phosphorylation in HEK293 cells at saturating concentration by immunoprecipitation assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Not Active	3419447	CHEMBL1226197	Inhibition of RSK2 phosphorylation in HEK293 cells at 3 uM after 1 hr by TAMARA-N3 assay in presence of 10% fetal bovine serum	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	3419458	CHEMBL1225084	Inhibition of His6-tagged RSK2 C-terminal domian expressed in Escherichia coli after 30 mins	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	IC50	nM	15.0	CHEMBL2345	Homo sapiens	IC50	uM	0.015
	3419459	CHEMBL1225084	Inhibition of His6-tagged RSK2 C-terminal domian expressed in Escherichia coli after 30 mins	B	CC1=CC(C)=C2C=C3C=CC(CCC(=O)NCCCCCC(=O)NCCCCNC(=O)OCCCn4c(C(=O)CF)c(-c5ccc(C)cc5)c5c(N)ncnc54)=[N+]3[B-](F)(F)C12		CHEMBL1221656	=	IC50	nM	1700.0	CHEMBL2345	Homo sapiens	IC50	uM	1.7
	3419460	CHEMBL1225084	Inhibition of His6-tagged RSK2 C-terminal domian expressed in Escherichia coli after 30 mins	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	uM	0.02
	3443517	CHEMBL1244283	Inhibition of RSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	7.0	CHEMBL2345	Homo sapiens	INH	%	7.0
	3443734	CHEMBL1244283	Inhibition of RSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	3444889	CHEMBL1244283	Inhibition of RSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	2.0	CHEMBL2345	Homo sapiens	INH	%	2.0
	3445295	CHEMBL1244970	Binding affinity to RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1300.0	CHEMBL2345	Homo sapiens	Kd	nM	1300.0
	3445513	CHEMBL1244283	Inhibition of RSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	4.0	CHEMBL2345	Homo sapiens	INH	%	4.0
	3445730	CHEMBL1244283	Inhibition of RSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	31.0	CHEMBL2345	Homo sapiens	INH	%	31.0
	3445923	CHEMBL1244283	Inhibition of RSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	-2.0	CHEMBL2345	Homo sapiens	INH	%	-2.0
	3446113	CHEMBL1244283	Inhibition of RSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	2.0	CHEMBL2345	Homo sapiens	INH	%	2.0
	3448617	CHEMBL1244970	Binding affinity to RPS6KA4(Kin.Dom.2-C-terminal)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	3449504	CHEMBL1244970	Binding affinity to RPS6KA4(Kin.Dom.2-C-terminal)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2000.0	CHEMBL2345	Homo sapiens	Kd	nM	2000.0
	3449844	CHEMBL1244970	Binding affinity to RPS6KA4(Kin.Dom.2-C-terminal)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	3450236	CHEMBL1244970	Binding affinity to RPS6KA4(Kin.Dom.2-C-terminal)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	3450862	CHEMBL1244970	Binding affinity to RPS6KA4(Kin.Dom.2-C-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	3451145	CHEMBL1244970	Binding affinity to RPS6KA4(Kin.Dom.2-C-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	uM	10.0
	3463350	CHEMBL1251683	Inhibition of RPS6KA3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	98.0	CHEMBL2345	Homo sapiens	INH	%	98.0
	3463894	CHEMBL1251683	Inhibition of RPS6KA3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	56.0	CHEMBL2345	Homo sapiens	INH	%	56.0
	3464113	CHEMBL1251683	Inhibition of RPS6KA3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	40.0	CHEMBL2345	Homo sapiens	INH	%	40.0
	3502346	CHEMBL1259609	Inhibition of Rsk3 at 1 uM	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)C4Cc5ccccc5C4)CC3)c12		CHEMBL1257283	>	Inhibition	%	90.0	CHEMBL2345	Homo sapiens	INH	%	90.0
	3521128	CHEMBL1272508	Inhibition of RSK2	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO		CHEMBL1232515	=	IC50	nM	180.0	CHEMBL2345	Homo sapiens	IC50	nM	180.0
	3521250	CHEMBL1272508	Inhibition of RSK2	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1270399	=	IC50	nM	330.0	CHEMBL2345	Homo sapiens	IC50	nM	330.0
	5120304	CHEMBL1646642	Inhibition of human Rsk2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	98.0	CHEMBL2345	Homo sapiens	INH	%	98.0
	5123820	CHEMBL1645764	Inhibition of RPS6KA3 kinase domain1 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	94.0	CHEMBL2345	Homo sapiens	INH	%	94.0
	5133699	CHEMBL1648713	Inhibition of RSK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	87.0	CHEMBL2345	Homo sapiens	Activity	%	87.0
	5133794	CHEMBL1648713	Inhibition of RSK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	82.0	CHEMBL2345	Homo sapiens	Activity	%	82.0
	5133877	CHEMBL1648713	Inhibition of RSK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	71.0	CHEMBL2345	Homo sapiens	Activity	%	71.0
	5143851	CHEMBL1656186	Inhibition of RSK2	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl		CHEMBL1650533	>	IC50	nM	100.0	CHEMBL2345	Homo sapiens	IC50	nM	100.0
	5143868	CHEMBL1656186	Inhibition of RSK2	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650545	>	IC50	nM	100.0	CHEMBL2345	Homo sapiens	IC50	nM	100.0
	5143885	CHEMBL1656186	Inhibition of RSK2	B	Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1		CHEMBL1650551	>	IC50	nM	100.0	CHEMBL2345	Homo sapiens	IC50	nM	100.0
	5191349	CHEMBL1663976	Inhibition of RSK2 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	4.0	CHEMBL2345	Homo sapiens	INH	%	4.0
	5191350	CHEMBL1663976	Inhibition of RSK2 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	31.0	CHEMBL2345	Homo sapiens	INH	%	31.0
	6169199	CHEMBL1768977	Inhibition of human RSK2 assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	28.0	CHEMBL2345	Homo sapiens	Activity	%	28.0
	6172875	CHEMBL1769115	Inhibition of RSK2 at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	>	Inhibition	%	85.0	CHEMBL2345	Homo sapiens	INH	%	85.0
	6172887	CHEMBL1769285	Inhibition of RSK2	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	=	Kd	nM	300.0	CHEMBL2345	Homo sapiens	Kd	nM	300.0
	6172939	CHEMBL1769115	Inhibition of RSK2 at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	>	Inhibition	%	85.0	CHEMBL2345	Homo sapiens	INH	%	85.0
	6172951	CHEMBL1769285	Inhibition of RSK2	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	=	Kd	nM	150.0	CHEMBL2345	Homo sapiens	Kd	nM	150.0
	6193870	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	IC50	nM	320.0	CHEMBL2345	Homo sapiens	IC50	uM	0.32
	6193871	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	IC50	nM	480.0	CHEMBL2345	Homo sapiens	IC50	uM	0.48
	6193872	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	O=C1c2ccccc2C(=O)N1CNc1ccc(N2CCOCC2)cc1		CHEMBL1775068	=	IC50	nM	950.0	CHEMBL2345	Homo sapiens	IC50	uM	0.95
	6193873	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Cc1cc(N)cc2[nH]c(-c3ccccc3)nc12		CHEMBL1775069	=	IC50	nM	1060.0	CHEMBL2345	Homo sapiens	IC50	uM	1.06
	6193874	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Cc1ccc2nc(-c3cc(N)cc(C)c3O)oc2c1		CHEMBL1775070	=	IC50	nM	1380.0	CHEMBL2345	Homo sapiens	IC50	uM	1.38
	6193875	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	O=C1NC(=O)C(=NNc2ccc(O)cc2)C(=O)N1		CHEMBL1775071	=	IC50	nM	1580.0	CHEMBL2345	Homo sapiens	IC50	uM	1.58
	6193876	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Clc1ccc2c(c1)SNC(c1ccccc1)=N2		CHEMBL1775072	=	IC50	nM	2880.0	CHEMBL2345	Homo sapiens	IC50	uM	2.88
	6193877	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	O=C(Nc1ccccc1O)c1cnns1		CHEMBL1775073	=	IC50	nM	3030.0	CHEMBL2345	Homo sapiens	IC50	uM	3.03
	6193878	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	O=C(O)c1ccc(/N=N/c2ccc(O)c3ncccc23)cc1		CHEMBL1775074	=	IC50	nM	3470.0	CHEMBL2345	Homo sapiens	IC50	uM	3.47
	6193879	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Nc1n[nH]c(N)c1/N=N/c1ccc(S(N)(=O)=O)cc1		CHEMBL1775075	=	IC50	nM	5500.0	CHEMBL2345	Homo sapiens	IC50	uM	5.5
	6193880	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	N#Cc1nc(/N=N/c2ccccc2)[nH]c1O		CHEMBL1775076	=	IC50	nM	7040.0	CHEMBL2345	Homo sapiens	IC50	uM	7.04
	6193881	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Nc1nc2nc(O)nc(O)c2s1		CHEMBL1775077	=	IC50	nM	9990.0	CHEMBL2345	Homo sapiens	IC50	uM	9.99
	6193882	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	O=C(NNc1ccc(C(F)(F)F)cn1)c1ccccc1Cl		CHEMBL1775078	=	IC50	nM	13180.0	CHEMBL2345	Homo sapiens	IC50	uM	13.18
	6193883	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Oc1ccc(-c2cnc3c(O)nc(O)nc3n2)cc1		CHEMBL1775079	=	IC50	nM	14450.0	CHEMBL2345	Homo sapiens	IC50	uM	14.45
	6193884	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Cc1c(O)ccc(/N=N/c2ccc(S(=O)(=O)O)cc2)c1C		CHEMBL1775080	=	IC50	nM	15140.0	CHEMBL2345	Homo sapiens	IC50	uM	15.14
	6193885	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	COc1cc(/C=N/n2cnnc2)cc(I)c1O		CHEMBL1775081	=	IC50	nM	16180.0	CHEMBL2345	Homo sapiens	IC50	uM	16.18
	6193886	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	IC50	nM	10.0	CHEMBL2345	Homo sapiens	IC50	uM	0.01
	6193930	CHEMBL1776531	Inhibition of RSK2 at 10 uM	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	95.5	CHEMBL2345	Homo sapiens	INH	%	95.5
	6193941	CHEMBL1776531	Inhibition of RSK2 at 10 uM	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	89.2	CHEMBL2345	Homo sapiens	INH	%	89.2
	6193950	CHEMBL1776540	Inhibition of RSK2 at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	98.0	CHEMBL2345	Homo sapiens	INH	%	98.0
Active	6194023	CHEMBL1776594	Binding affinity to recombinant full-length N-terminal kinase domain of RSK2 (1 to 740) by sepharose 4B beads pull-down assay	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177		Activity			CHEMBL2345	Homo sapiens	Activity		
Active	6194024	CHEMBL1776595	Binding affinity to RSK2 in human HCT116 cells by sepharose 4B beads pull-down assay	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177		Activity			CHEMBL2345	Homo sapiens	Activity		
Active	6194025	CHEMBL1776596	Binding affinity to recombinant full-length N-terminal kinase domain of RSK2 (44 to 367) by sepharose 4B beads pull-down assay	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177		Activity			CHEMBL2345	Homo sapiens	Activity		
Dose-dependent effect	6194026	CHEMBL1776597	Inhibition of RSK2-mediated GSK3-beta phosphorylation in human TPA-stimulated HCT116 cells after 2 hrs by Western blotting	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	6194027	CHEMBL1776598	Inhibition of RSK2-mediated CREB phosphorylation in human TPA-stimulated HCT116 cells at up to 25 uM after 2 hrs by Western blotting	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	6194029	CHEMBL1777645	Inhibition of RSK2 after 60 mins	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	IC50	nM	15.0	CHEMBL2345	Homo sapiens	IC50	nM	15.0
	6268173	CHEMBL1805365	Inhibition of RSK2	B	CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1270795	=	IC50	nM	1306.0	CHEMBL2345	Homo sapiens	IC50	nM	1306.0
	6273817	CHEMBL1806010	Inhibition of RSK2 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	90.0	CHEMBL2345	Homo sapiens	Activity	%	90.0
	6341126	CHEMBL1826698	Activity of RPS6KA3(Kin.Dom.1-N-terminal) kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	6352275	CHEMBL1826252	Inhibition of RSK2 assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	96.0	CHEMBL2345	Homo sapiens	Activity	%	96.0
	6385573	CHEMBL1837948	Inhibition of human RSK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	6385574	CHEMBL1837948	Inhibition of human RSK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	6385575	CHEMBL1837948	Inhibition of human RSK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	6385576	CHEMBL1837948	Inhibition of human RSK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	6385577	CHEMBL1837948	Inhibition of human RSK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	7567358	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7567817	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7568314	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7568746	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2100.0	CHEMBL2345	Homo sapiens	Kd	nM	2100.0
	7569331	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7569821	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7570284	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	9900.0	CHEMBL2345	Homo sapiens	Kd	nM	9900.0
	7570711	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	580.0	CHEMBL2345	Homo sapiens	Kd	nM	580.0
	7571322	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7571798	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7572261	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7572677	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	17.0	CHEMBL2345	Homo sapiens	Kd	nM	17.0
	7572846	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7573303	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7573779	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	440.0	CHEMBL2345	Homo sapiens	Kd	nM	440.0
	7574248	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	740.0	CHEMBL2345	Homo sapiens	Kd	nM	740.0
	7574656	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7574824	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	65.0	CHEMBL2345	Homo sapiens	Kd	nM	65.0
	7575285	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7575756	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7576221	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7576629	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	8100.0	CHEMBL2345	Homo sapiens	Kd	nM	8100.0
	7576798	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7577257	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7577735	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	280.0	CHEMBL2345	Homo sapiens	Kd	nM	280.0
	7578205	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	200.0	CHEMBL2345	Homo sapiens	Kd	nM	200.0
	7578806	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7579180	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7579630	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1000.0	CHEMBL2345	Homo sapiens	Kd	nM	1000.0
	7580104	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7580534	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7581164	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7581549	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7581994	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7582487	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7582887	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6400.0	CHEMBL2345	Homo sapiens	Kd	nM	6400.0
	7583510	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7583907	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7584352	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	3000.0	CHEMBL2345	Homo sapiens	Kd	nM	3000.0
	7584381	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	87.0	CHEMBL2345	Homo sapiens	Kd	nM	87.0
	7584843	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	8000.0	CHEMBL2345	Homo sapiens	Kd	nM	8000.0
	7585247	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7585840	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7586248	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7586723	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	3600.0	CHEMBL2345	Homo sapiens	Kd	nM	3600.0
	7587177	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7588231	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7588702	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7589153	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7589324	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7589748	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	290.0	CHEMBL2345	Homo sapiens	Kd	nM	290.0
	7590215	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	170.0	CHEMBL2345	Homo sapiens	Kd	nM	170.0
	7590689	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7591140	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7591297	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7591719	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	5600.0	CHEMBL2345	Homo sapiens	Kd	nM	5600.0
	7592191	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	190.0	CHEMBL2345	Homo sapiens	Kd	nM	190.0
	7592664	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7593117	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1200.0	CHEMBL2345	Homo sapiens	Kd	nM	1200.0
	7593264	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7593699	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7594171	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7594644	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7595232	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7595676	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7596150	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7596626	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7597204	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7597657	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7598130	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7598158	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2345	Homo sapiens	Kd	nM	10000.0
	7598600	CHEMBL1908657	Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	69.0	CHEMBL2345	Homo sapiens	Kd	nM	69.0
	7841902	CHEMBL1913893	Inhibition of RSK2 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910608	=	IC50	nM	607.1	CHEMBL2345	Homo sapiens	IC50	nM	607.1
	7841908	CHEMBL1913893	Inhibition of RSK2 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	183.9	CHEMBL2345	Homo sapiens	IC50	nM	183.9
	7841915	CHEMBL1913893	Inhibition of RSK2 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	IC50	nM	20000.0	CHEMBL2345	Homo sapiens	IC50	nM	20000.0
	7841922	CHEMBL1913893	Inhibition of RSK2 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	0.5	CHEMBL2345	Homo sapiens	IC50	nM	0.5
	7841928	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2sc(Cl)cn12		CHEMBL1910371	=	IC50	nM	8260.0	CHEMBL2345	Homo sapiens	IC50	uM	8.26
	7841929	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N#Cc1ccc(-c2nc3sc(Cl)cn3c2/C=N/NC(=N)N)cc1		CHEMBL1910375	=	IC50	nM	8550.0	CHEMBL2345	Homo sapiens	IC50	uM	8.55
	7841930	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(F)cn12		CHEMBL1910607	=	IC50	nM	2150.0	CHEMBL2345	Homo sapiens	IC50	uM	2.15
	7841931	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910608	=	IC50	nM	1230.0	CHEMBL2345	Homo sapiens	IC50	uM	1.23
	7841932	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2sc3ccccc3n12		CHEMBL1910616	=	IC50	nM	12000.0	CHEMBL2345	Homo sapiens	IC50	uM	12.0
	7841933	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc3ccccc3n2c1/C=N/NC(=N)N.Cl		CHEMBL1910614	=	IC50	nM	10150.0	CHEMBL2345	Homo sapiens	IC50	uM	10.15
	7841934	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2ccccn2c1/C=N/NC(=N)N.Cl		CHEMBL1910623	=	IC50	nM	7800.0	CHEMBL2345	Homo sapiens	IC50	uM	7.8
	7841935	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Cl)cn12		CHEMBL1910625	=	IC50	nM	970.0	CHEMBL2345	Homo sapiens	IC50	uM	0.97
	7841936	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3ccc([N+](=O)[O-])cc3)nc2s1.Cl		CHEMBL1910626	=	IC50	nM	2800.0	CHEMBL2345	Homo sapiens	IC50	uM	2.8
	7841937	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)c([N+](=O)[O-])c2)nc2ccccn12		CHEMBL1910627	=	IC50	nM	2890.0	CHEMBL2345	Homo sapiens	IC50	uM	2.89
	7841938	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(N)cc2)nc2sccn12		CHEMBL1910628	=	IC50	nM	3000.0	CHEMBL2345	Homo sapiens	IC50	uM	3.0
	7841939	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910629	=	IC50	nM	3130.0	CHEMBL2345	Homo sapiens	IC50	uM	3.13
	7841940	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sccn2c1/C=N/NC(=N)N.Cl		CHEMBL1910630	=	IC50	nM	3580.0	CHEMBL2345	Homo sapiens	IC50	uM	3.58
	7841941	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910631	=	IC50	nM	3760.0	CHEMBL2345	Homo sapiens	IC50	uM	3.76
	7841942	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3cc([N+](=O)[O-])c(Cl)cc3Cl)nc2s1.Cl		CHEMBL1910632	=	IC50	nM	4530.0	CHEMBL2345	Homo sapiens	IC50	uM	4.53
	7841943	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc([N+](=O)[O-])cc2)nc2sccn12		CHEMBL1910633	=	IC50	nM	5660.0	CHEMBL2345	Homo sapiens	IC50	uM	5.66
	7841944	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)c([N+](=O)[O-])c2)nc2sc(Cl)cn12		CHEMBL1910634	=	IC50	nM	5850.0	CHEMBL2345	Homo sapiens	IC50	uM	5.85
	7841945	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc([N+](=O)[O-])c(Cl)cc2Cl)nc2sccn12		CHEMBL1910635	=	IC50	nM	5930.0	CHEMBL2345	Homo sapiens	IC50	uM	5.93
	7841946	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCCc1cn2c(/C=N/NC(=N)N)c(-c3cc([N+](=O)[O-])c(Cl)cc3Cl)nc2s1.Cl		CHEMBL1910636	=	IC50	nM	5970.0	CHEMBL2345	Homo sapiens	IC50	uM	5.97
	7841947	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cccc([N+](=O)[O-])c2)nc2sc(Cl)cn12		CHEMBL1910637	=	IC50	nM	6030.0	CHEMBL2345	Homo sapiens	IC50	uM	6.03
	7841948	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCCc1cn2c(/C=N/NC(=N)N)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910744	=	IC50	nM	6430.0	CHEMBL2345	Homo sapiens	IC50	uM	6.43
	7841949	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)c([N+](=O)[O-])c2)nc2sc3ccccc3n12		CHEMBL1910745	=	IC50	nM	7320.0	CHEMBL2345	Homo sapiens	IC50	uM	7.32
	7841950	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc(Cl)cn2c1/C=N/NC(=N)N/N=C/c1c(-c2cc(OC)c([N+](=O)[O-])cc2OC)nc2sc(Cl)cn12.Cl		CHEMBL1910746	=	IC50	nM	11400.0	CHEMBL2345	Homo sapiens	IC50	uM	11.4
	7841951	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCCc1cn2c(/C=N/NC(=N)N)c(-c3cccc([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910747	=	IC50	nM	13250.0	CHEMBL2345	Homo sapiens	IC50	uM	13.25
	7841952	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1sc2nc(-c3ccc(Cl)c([N+](=O)[O-])c3)c(/C=N/NC(=N)N)n2c1C.Cl		CHEMBL1910748	=	IC50	nM	13930.0	CHEMBL2345	Homo sapiens	IC50	uM	13.93
	7841953	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)cc2)nc2sc(Cl)cn12		CHEMBL1910749	=	IC50	nM	14000.0	CHEMBL2345	Homo sapiens	IC50	uM	14.0
	7841954	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3cccc([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910750	=	IC50	nM	17500.0	CHEMBL2345	Homo sapiens	IC50	uM	17.5
	7842009	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(F)c([N+](=O)[O-])c2)nc2sc(Cl)cn12		CHEMBL1910374	=	IC50	nM	3930.0	CHEMBL2345	Homo sapiens	IC50	uM	3.93
	7842012	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccccc2)nc2sc(Cl)cn12		CHEMBL1910372	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842013	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(F)cc2)nc2sc(Cl)cn12		CHEMBL1910373	=	IC50	nM	86000.0	CHEMBL2345	Homo sapiens	IC50	uM	86.0
	7842014	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1nn2c(/C=N/NC(=N)N)c(-c3cc(Cl)sc3Cl)nc2s1.Cl		CHEMBL1910376	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842015	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc(C)nn2c1/C=N\NC(=N)N.Cl		CHEMBL1910595	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842016	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)cc2)nc2sccn12		CHEMBL1910597	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842017	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccccc2F)nc2sccn12		CHEMBL1910598	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842018	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2c(F)cccc2F)nc2sccn12		CHEMBL1910599	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842019	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)c(F)c2)nc2sccn12		CHEMBL1910600	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842020	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cc(F)c(F)cc2F)nc2sccn12		CHEMBL1910601	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842021	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910602	=	IC50	nM	53750.0	CHEMBL2345	Homo sapiens	IC50	uM	53.75
	7842022	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cccc([N+](=O)[O-])c2F)nc2sccn12		CHEMBL1910603	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842023	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cccc(C(F)(F)F)c2)nc2sccn12		CHEMBL1910604	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842024	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(Br)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1909651	=	IC50	nM	56730.0	CHEMBL2345	Homo sapiens	IC50	uM	56.73
	7842025	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N\NC(=N)N)c(-c3ccc(F)cc3)nc2s1.Cl		CHEMBL1910605	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842026	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N\NC(=N)N)c(-c3ccc(F)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910606	=	IC50	nM	30670.0	CHEMBL2345	Homo sapiens	IC50	uM	30.67
	7842027	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Br.Clc1cc(-c2nc3sc(Cl)cn3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910609	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842028	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Br.Cc1nn2c(/C=N/NC3=NCCN3)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1		CHEMBL1910610	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842029	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Br.Clc1cc(-c2nc3sc4ccccc4n3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910617	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842030	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2ccccn12		CHEMBL1910622	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842031	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Br.Clc1cc(-c2nc3ccccn3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910624	>	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842032	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)NN)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910751	=	IC50	nM	18000.0	CHEMBL2345	Homo sapiens	IC50	uM	18.0
	7842033	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cccc([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910752	=	IC50	nM	18500.0	CHEMBL2345	Homo sapiens	IC50	uM	18.5
	7842034	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC3=NCCN3)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910753	=	IC50	nM	20500.0	CHEMBL2345	Homo sapiens	IC50	uM	20.5
	7842035	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCCc1cn2c(/C=N/NC(=N)N)c(-c3ccc([N+](=O)[O-])cc3)nc2s1.Cl		CHEMBL1910754	=	IC50	nM	20950.0	CHEMBL2345	Homo sapiens	IC50	uM	20.95
	7842036	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3cc(Cl)sc3Cl)nc2s1.Cl		CHEMBL1910755	=	IC50	nM	26500.0	CHEMBL2345	Homo sapiens	IC50	uM	26.5
	7842037	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1csc2nc(-c3ccc(Cl)c([N+](=O)[O-])c3)c(/C=N/NC(=N)N)n12.Cl		CHEMBL1910756	=	IC50	nM	44800.0	CHEMBL2345	Homo sapiens	IC50	uM	44.8
	7842038	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2sccn12		CHEMBL1910757	=	IC50	nM	79000.0	CHEMBL2345	Homo sapiens	IC50	uM	79.0
	7842039	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCc1cn2c(/C=N/NC(=N)N)c(-c3cc([N+](=O)[O-])c(Cl)cc3Cl)nc2s1.Cl		CHEMBL1910758	=	IC50	nM	83000.0	CHEMBL2345	Homo sapiens	IC50	uM	83.0
	7842040	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1nn2c(/C=N/NC(=N)N)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910759	=	IC50	nM	94000.0	CHEMBL2345	Homo sapiens	IC50	uM	94.0
	7842041	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1sc2nc(-c3cc([N+](=O)[O-])c(Cl)cc3Cl)c(/C=N/NC(=N)N)n2c1C.Cl		CHEMBL1910760	=	IC50	nM	98500.0	CHEMBL2345	Homo sapiens	IC50	uM	98.5
	7842042	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1sc2nc(-c3cccnc3)c(/C=N/NC(=N)N)n2c1C.Cl		CHEMBL1910761	=	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842043	CHEMBL1913787	Inhibition of RSK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1csc2nc(-c3cccnc3)c(/C=N/NC(=N)N)n12.Cl		CHEMBL1910762	=	IC50	nM	100000.0	CHEMBL2345	Homo sapiens	IC50	uM	100.0
	7842117	CHEMBL1913736	Inhibition of RSK2-mediated GSK3alpha Ser21 phosphorylation in TPA-induced human MCF7 cells at 10 nM pretreated for 30 mins by immunoblotting	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(F)cn12		CHEMBL1910607	=	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	7842118	CHEMBL1913735	Inhibition of RSK2-mediated GSK3-beta Ser9 phosphorylation in TPA-induced human MCF7 cells at 10 nM pretreated for 30 mins by immunoblotting	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(F)cn12		CHEMBL1910607	=	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	7842120	CHEMBL1913736	Inhibition of RSK2-mediated GSK3alpha Ser21 phosphorylation in TPA-induced human MCF7 cells at 10 nM pretreated for 30 mins by immunoblotting	B	Cl.N=C(N)N/N=C/c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Cl)cn12		CHEMBL1910625	=	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	7842121	CHEMBL1913735	Inhibition of RSK2-mediated GSK3-beta Ser9 phosphorylation in TPA-induced human MCF7 cells at 10 nM pretreated for 30 mins by immunoblotting	B	Cl.N=C(N)N/N=C/c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Cl)cn12		CHEMBL1910625	=	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	7922650	CHEMBL1918998	Inhibition of human recombinant RPS6KA3 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	87.0	CHEMBL2345	Homo sapiens	INH	%	87.0
	7969793	CHEMBL1930365	Inhibition of RSK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	82.0	CHEMBL2345	Homo sapiens	Activity	%	82.0
	7978808	CHEMBL1930061	Inhibition of human RSK2 at 1 uM	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	82.0	CHEMBL2345	Homo sapiens	INH	%	82.0
	7989315	CHEMBL1936697	Inhibition of human RSK2	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	=	IC50	nM	19.0	CHEMBL2345	Homo sapiens	IC50	nM	19.0
	7989316	CHEMBL1936697	Inhibition of human RSK2	B	Cc1noc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)c1C		CHEMBL1933144	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	7989317	CHEMBL1936697	Inhibition of human RSK2	B	O=C(Nc1cc(C2CC2)no1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933068	=	IC50	nM	18.0	CHEMBL2345	Homo sapiens	IC50	nM	18.0
	7989318	CHEMBL1936697	Inhibition of human RSK2	B	CC(C)c1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933145	=	IC50	nM	26.0	CHEMBL2345	Homo sapiens	IC50	nM	26.0
	7989319	CHEMBL1936697	Inhibition of human RSK2	B	O=C(Nc1cc(-c2ccccc2)no1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933146	=	IC50	nM	86.0	CHEMBL2345	Homo sapiens	IC50	nM	86.0
	7989320	CHEMBL1936697	Inhibition of human RSK2	B	O=C(Nc1cc(Cc2ccccc2)no1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933147	=	IC50	nM	13.0	CHEMBL2345	Homo sapiens	IC50	nM	13.0
	7989321	CHEMBL1936697	Inhibition of human RSK2	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	=	IC50	nM	11.0	CHEMBL2345	Homo sapiens	IC50	nM	11.0
	7989322	CHEMBL1936697	Inhibition of human RSK2	B	O=C(Nc1cnn(CC2CCCCC2)c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933149	=	IC50	nM	7.0	CHEMBL2345	Homo sapiens	IC50	nM	7.0
	7989323	CHEMBL1936697	Inhibition of human RSK2	B	O=C(Nc1cnn(Cc2ccccn2)c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933277	=	IC50	nM	10.0	CHEMBL2345	Homo sapiens	IC50	nM	10.0
	7989324	CHEMBL1936697	Inhibition of human RSK2	B	O=C(Nc1cnn(Cc2ccncc2)c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933278	=	IC50	nM	2.0	CHEMBL2345	Homo sapiens	IC50	nM	2.0
	7989325	CHEMBL1936697	Inhibition of human RSK2	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	=	IC50	nM	9.0	CHEMBL2345	Homo sapiens	IC50	nM	9.0
	7989326	CHEMBL1936697	Inhibition of human RSK2	B	CCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933280	=	IC50	nM	1.0	CHEMBL2345	Homo sapiens	IC50	nM	1.0
	7989327	CHEMBL1936697	Inhibition of human RSK2	B	CC(C)n1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933281	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	nM	20.0
	7989328	CHEMBL1936697	Inhibition of human RSK2	B	O=C(Nc1nc2ccccc2n1-c1ccccc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933282	=	IC50	nM	61.0	CHEMBL2345	Homo sapiens	IC50	nM	61.0
	7989329	CHEMBL1936697	Inhibition of human RSK2	B	CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933283	=	IC50	nM	21.0	CHEMBL2345	Homo sapiens	IC50	nM	21.0
	7989330	CHEMBL1936697	Inhibition of human RSK2	B	CCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2cc(Cl)ccc21		CHEMBL1933284	=	IC50	nM	6.0	CHEMBL2345	Homo sapiens	IC50	nM	6.0
	7989331	CHEMBL1936697	Inhibition of human RSK2	B	CCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccc(Cl)cc21		CHEMBL1933285	=	IC50	nM	12.0	CHEMBL2345	Homo sapiens	IC50	nM	12.0
	7989332	CHEMBL1936697	Inhibition of human RSK2	B	CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccc(Cl)cc21		CHEMBL1933286	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	nM	20.0
	7989333	CHEMBL1936697	Inhibition of human RSK2	B	CCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2cccnc21		CHEMBL1933287	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	nM	4.0
	7989334	CHEMBL1936697	Inhibition of human RSK2	B	C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933288	=	IC50	nM	1.0	CHEMBL2345	Homo sapiens	IC50	nM	1.0
	7989335	CHEMBL1936697	Inhibition of human RSK2	B	C[C@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933289	=	IC50	nM	14.0	CHEMBL2345	Homo sapiens	IC50	nM	14.0
	7989336	CHEMBL1936697	Inhibition of human RSK2	B	CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CC(C)(C)CNC4=O)nc2ccccc21		CHEMBL1933290	=	IC50	nM	27.0	CHEMBL2345	Homo sapiens	IC50	nM	27.0
	7989337	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	=	IC50	nM	200.0	CHEMBL2345	Homo sapiens	IC50	nM	200.0
	7989338	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	O=C(Nc1cc(C2CC2)no1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933068	=	IC50	nM	250.0	CHEMBL2345	Homo sapiens	IC50	nM	250.0
	7989339	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CC(C)c1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933145	=	IC50	nM	460.0	CHEMBL2345	Homo sapiens	IC50	nM	460.0
	7989340	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	O=C(Nc1cc(-c2ccccc2)no1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933146	=	IC50	nM	360.0	CHEMBL2345	Homo sapiens	IC50	nM	360.0
	7989341	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	O=C(Nc1cc(Cc2ccccc2)no1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933147	=	IC50	nM	130.0	CHEMBL2345	Homo sapiens	IC50	nM	130.0
	7989342	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	=	IC50	nM	790.0	CHEMBL2345	Homo sapiens	IC50	nM	790.0
	7989343	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	O=C(Nc1cnn(CC2CCCCC2)c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933149	=	IC50	nM	120.0	CHEMBL2345	Homo sapiens	IC50	nM	120.0
	7989344	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	O=C(Nc1cnn(Cc2ccccn2)c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933277	=	IC50	nM	460.0	CHEMBL2345	Homo sapiens	IC50	nM	460.0
	7989345	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	O=C(Nc1cnn(Cc2ccncc2)c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933278	=	IC50	nM	90.0	CHEMBL2345	Homo sapiens	IC50	nM	90.0
	7989346	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	=	IC50	nM	200.0	CHEMBL2345	Homo sapiens	IC50	nM	200.0
	7989347	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933280	=	IC50	nM	40.0	CHEMBL2345	Homo sapiens	IC50	nM	40.0
	7989348	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CC(C)n1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933281	=	IC50	nM	180.0	CHEMBL2345	Homo sapiens	IC50	nM	180.0
	7989349	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	O=C(Nc1nc2ccccc2n1-c1ccccc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1933282	=	IC50	nM	1000.0	CHEMBL2345	Homo sapiens	IC50	nM	1000.0
	7989350	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933283	=	IC50	nM	200.0	CHEMBL2345	Homo sapiens	IC50	nM	200.0
	7989351	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2cc(Cl)ccc21		CHEMBL1933284	=	IC50	nM	130.0	CHEMBL2345	Homo sapiens	IC50	nM	130.0
	7989352	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccc(Cl)cc21		CHEMBL1933285	=	IC50	nM	90.0	CHEMBL2345	Homo sapiens	IC50	nM	90.0
	7989353	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccc(Cl)cc21		CHEMBL1933286	=	IC50	nM	160.0	CHEMBL2345	Homo sapiens	IC50	nM	160.0
	7989354	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CCn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2cccnc21		CHEMBL1933287	=	IC50	nM	80.0	CHEMBL2345	Homo sapiens	IC50	nM	80.0
	7989355	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933288	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	nM	20.0
	7989356	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	C[C@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933289	=	IC50	nM	100.0	CHEMBL2345	Homo sapiens	IC50	nM	100.0
	7989357	CHEMBL1936698	Inhibition of human RSK2-mediated CREB phosphorylation in HLR-CREB cells by cell based assay	B	CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CC(C)(C)CNC4=O)nc2ccccc21		CHEMBL1933290	=	IC50	nM	290.0	CHEMBL2345	Homo sapiens	IC50	nM	290.0
	7992218	CHEMBL1936090	Inhibition of RSK2 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	101.0	CHEMBL2345	Homo sapiens	INH	%	101.0
	8010868	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL255210	=	IC50	nM	1940.0	CHEMBL2345	Homo sapiens	IC50	nM	1940.0
	8010869	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n21		CHEMBL1938765	=	IC50	nM	890.0	CHEMBL2345	Homo sapiens	IC50	nM	890.0
	8010870	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2C1		CHEMBL272096	=	IC50	nM	4890.0	CHEMBL2345	Homo sapiens	IC50	nM	4890.0
	8010871	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CCNC3=O		CHEMBL404908	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010872	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n21		CHEMBL1938774	=	IC50	nM	1630.0	CHEMBL2345	Homo sapiens	IC50	nM	1630.0
	8010873	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n21		CHEMBL1938775	=	IC50	nM	1550.0	CHEMBL2345	Homo sapiens	IC50	nM	1550.0
	8010874	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	C[C@@H]1NC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2[C@@H]1C		CHEMBL1938776	=	IC50	nM	840.0	CHEMBL2345	Homo sapiens	IC50	nM	840.0
	8010875	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1ccccc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938781	=	IC50	nM	1930.0	CHEMBL2345	Homo sapiens	IC50	nM	1930.0
	8010876	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	NC(=O)c1ccccc1NC(=O)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938786	=	IC50	nM	560.0	CHEMBL2345	Homo sapiens	IC50	nM	560.0
	8010877	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1ccncc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938787	=	IC50	nM	620.0	CHEMBL2345	Homo sapiens	IC50	nM	620.0
	8010878	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1ccccn1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938788	=	IC50	nM	2630.0	CHEMBL2345	Homo sapiens	IC50	nM	2630.0
	8010879	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(NCc1cccnc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938790	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010880	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1ncc[nH]1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938792	=	IC50	nM	290.0	CHEMBL2345	Homo sapiens	IC50	nM	290.0
	8010881	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	=	IC50	nM	200.0	CHEMBL2345	Homo sapiens	IC50	nM	200.0
	8010882	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	=	IC50	nM	790.0	CHEMBL2345	Homo sapiens	IC50	nM	790.0
	8010883	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1cn[nH]c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938794	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010884	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1cnc2ccccc2c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938798	=	IC50	nM	340.0	CHEMBL2345	Homo sapiens	IC50	nM	340.0
	8010885	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	CC(C)n1ncc2cc(NC(=O)c3ccc4cc5n(c4c3)CCCNC5=O)cnc21		CHEMBL1938799	=	IC50	nM	840.0	CHEMBL2345	Homo sapiens	IC50	nM	840.0
	8010886	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1ccc2ccccc2n1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938800	=	IC50	nM	1130.0	CHEMBL2345	Homo sapiens	IC50	nM	1130.0
	8010887	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1nc2ccccc2o1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938802	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010888	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	O=C(Nc1nc2ccccc2[nH]1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938803	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010889	CHEMBL1941466	Inhibition of RSK2-mediated CREB phosphorylation in HeLa cells expressing luciferase reporter gene	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	=	IC50	nM	200.0	CHEMBL2345	Homo sapiens	IC50	nM	200.0
	8010890	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL255210	=	IC50	nM	240.0	CHEMBL2345	Homo sapiens	IC50	nM	240.0
	8010891	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n21		CHEMBL1938765	=	IC50	nM	41.0	CHEMBL2345	Homo sapiens	IC50	nM	41.0
	8010892	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2C1		CHEMBL272096	=	IC50	nM	1200.0	CHEMBL2345	Homo sapiens	IC50	nM	1200.0
	8010893	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	NCC1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2C1		CHEMBL272309	=	IC50	nM	1800.0	CHEMBL2345	Homo sapiens	IC50	nM	1800.0
	8010894	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	C[C@@H]1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2[C@@H]1C		CHEMBL1938766	=	IC50	nM	240.0	CHEMBL2345	Homo sapiens	IC50	nM	240.0
	8010895	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	C[C@H]1[C@H](C)CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n21		CHEMBL1938767	=	IC50	nM	1100.0	CHEMBL2345	Homo sapiens	IC50	nM	1100.0
	8010896	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2C1		CHEMBL1938768	=	IC50	nM	4600.0	CHEMBL2345	Homo sapiens	IC50	nM	4600.0
	8010897	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CC(F)(F)CNC3=O		CHEMBL1938769	=	IC50	nM	1700.0	CHEMBL2345	Homo sapiens	IC50	nM	1700.0
	8010898	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CC1(CC1)CNC3=O		CHEMBL1938770	=	IC50	nM	410.0	CHEMBL2345	Homo sapiens	IC50	nM	410.0
	8010899	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CC1(CCC1)CNC3=O		CHEMBL1938771	=	IC50	nM	3300.0	CHEMBL2345	Homo sapiens	IC50	nM	3300.0
	8010900	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CC1(CCOCC1)CNC3=O		CHEMBL1938772	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010901	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	CC1CCn2c(cc3ccc(C(=O)Nc4cccnc4)cc32)C(=O)N1		CHEMBL1938773	=	IC50	nM	2500.0	CHEMBL2345	Homo sapiens	IC50	nM	2500.0
	8010902	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2c1)CCNC3=O		CHEMBL404908	=	IC50	nM	730.0	CHEMBL2345	Homo sapiens	IC50	nM	730.0
	8010903	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n21		CHEMBL1938774	=	IC50	nM	170.0	CHEMBL2345	Homo sapiens	IC50	nM	170.0
	8010904	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n21		CHEMBL1938775	=	IC50	nM	210.0	CHEMBL2345	Homo sapiens	IC50	nM	210.0
	8010905	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	C[C@@H]1NC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2[C@@H]1C		CHEMBL1938776	=	IC50	nM	45.0	CHEMBL2345	Homo sapiens	IC50	nM	45.0
	8010906	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	C[C@H]1NC(=O)c2cc3ccc(C(=O)Nc4cccnc4)cc3n2[C@@H]1C		CHEMBL1938777	=	IC50	nM	871.0	CHEMBL2345	Homo sapiens	IC50	nM	871.0
	8010907	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	CC1Cn2c(cc3ccc(C(=O)Nc4cccnc4)cc32)C(=O)N1		CHEMBL257321	=	IC50	nM	350.0	CHEMBL2345	Homo sapiens	IC50	nM	350.0
	8010908	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	NCC1Cn2c(cc3ccc(C(=O)Nc4cccnc4)cc32)C(=O)N1		CHEMBL1938778	=	IC50	nM	970.0	CHEMBL2345	Homo sapiens	IC50	nM	970.0
	8010909	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	NC(=O)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938779	=	IC50	nM	9100.0	CHEMBL2345	Homo sapiens	IC50	nM	9100.0
	8010910	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(NC1CCCCC1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938780	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010911	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1ccccc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938781	=	IC50	nM	290.0	CHEMBL2345	Homo sapiens	IC50	nM	290.0
	8010912	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1ccc(Cl)cc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938782	=	IC50	nM	180.0	CHEMBL2345	Homo sapiens	IC50	nM	180.0
	8010913	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cccc(Cl)c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938783	=	IC50	nM	270.0	CHEMBL2345	Homo sapiens	IC50	nM	270.0
	8010914	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1ccccc1Cl)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938784	=	IC50	nM	6000.0	CHEMBL2345	Homo sapiens	IC50	nM	6000.0
	8010915	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	COc1ccccc1NC(=O)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938785	=	IC50	nM	400.0	CHEMBL2345	Homo sapiens	IC50	nM	400.0
	8010916	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	NC(=O)c1ccccc1NC(=O)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938786	=	IC50	nM	21.0	CHEMBL2345	Homo sapiens	IC50	nM	21.0
	8010917	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1ccncc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938787	=	IC50	nM	34.0	CHEMBL2345	Homo sapiens	IC50	nM	34.0
	8010918	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1ccccn1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938788	=	IC50	nM	220.0	CHEMBL2345	Homo sapiens	IC50	nM	220.0
	8010919	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1ncccn1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938789	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010920	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(NCc1cccnc1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938790	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010921	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cccc(-c2c[nH]cn2)c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938791	=	IC50	nM	52.0	CHEMBL2345	Homo sapiens	IC50	nM	52.0
	8010922	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1nccs1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL403436	=	IC50	nM	2200.0	CHEMBL2345	Homo sapiens	IC50	nM	2200.0
	8010923	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1ncc[nH]1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938792	=	IC50	nM	26.0	CHEMBL2345	Homo sapiens	IC50	nM	26.0
	8010924	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	Cn1ccnc1NC(=O)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938793	=	IC50	nM	2200.0	CHEMBL2345	Homo sapiens	IC50	nM	2200.0
	8010925	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	=	IC50	nM	19.0	CHEMBL2345	Homo sapiens	IC50	nM	19.0
	8010926	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	=	IC50	nM	11.0	CHEMBL2345	Homo sapiens	IC50	nM	11.0
	8010927	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cn[nH]c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938794	=	IC50	nM	43.0	CHEMBL2345	Homo sapiens	IC50	nM	43.0
	8010928	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	Cn1ccc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)n1		CHEMBL1938795	=	IC50	nM	540.0	CHEMBL2345	Homo sapiens	IC50	nM	540.0
	8010929	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cc[nH]n1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938796	=	IC50	nM	93.0	CHEMBL2345	Homo sapiens	IC50	nM	93.0
	8010930	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	Cn1nccc1NC(=O)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938797	>	IC50	nM	1000.0	CHEMBL2345	Homo sapiens	IC50	nM	1000.0
	8010931	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1cnc2ccccc2c1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938798	=	IC50	nM	34.0	CHEMBL2345	Homo sapiens	IC50	nM	34.0
	8010932	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	CC(C)n1ncc2cc(NC(=O)c3ccc4cc5n(c4c3)CCCNC5=O)cnc21		CHEMBL1938799	=	IC50	nM	53.0	CHEMBL2345	Homo sapiens	IC50	nM	53.0
	8010933	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1ccc2ccccc2n1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938800	=	IC50	nM	68.0	CHEMBL2345	Homo sapiens	IC50	nM	68.0
	8010934	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1nc2ccccc2s1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938801	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	8010935	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1nc2ccccc2o1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938802	=	IC50	nM	367.0	CHEMBL2345	Homo sapiens	IC50	nM	367.0
	8010936	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	O=C(Nc1nc2ccccc2[nH]1)c1ccc2cc3n(c2c1)CCCNC3=O		CHEMBL1938803	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	nM	4.0
	8010937	CHEMBL1941467	Inhibition of RSK2 phosphorylation by luminescence assay	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	=	IC50	nM	9.0	CHEMBL2345	Homo sapiens	IC50	nM	9.0
	8047169	CHEMBL1959394	Inhibition of RPS6KA3 Kin.Dom.1 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	8061246	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.01	CHEMBL2345	Homo sapiens	Inhibition	%	-1.01
	8061423	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.94	CHEMBL2345	Homo sapiens	Inhibition	%	3.94
	8061647	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.72	CHEMBL2345	Homo sapiens	Inhibition	%	1.72
	8061754	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.9	CHEMBL2345	Homo sapiens	Inhibition	%	3.9
	8061945	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.48	CHEMBL2345	Homo sapiens	Inhibition	%	1.48
	8062169	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	6.08	CHEMBL2345	Homo sapiens	Inhibition	%	6.08
	8062285	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.58	CHEMBL2345	Homo sapiens	Inhibition	%	3.58
	8062671	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.37	CHEMBL2345	Homo sapiens	Inhibition	%	2.37
	8062769	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.16	CHEMBL2345	Homo sapiens	Inhibition	%	0.16
	8062993	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.2	CHEMBL2345	Homo sapiens	Inhibition	%	0.2
	8063125	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.09	CHEMBL2345	Homo sapiens	Inhibition	%	-1.09
	8063516	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.67	CHEMBL2345	Homo sapiens	Inhibition	%	3.67
	8063624	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.01	CHEMBL2345	Homo sapiens	Inhibition	%	2.01
	8064030	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-0.79	CHEMBL2345	Homo sapiens	Inhibition	%	-0.79
	8064145	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	23.02	CHEMBL2345	Homo sapiens	Inhibition	%	23.02
	8064369	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	12.71	CHEMBL2345	Homo sapiens	Inhibition	%	12.71
	8064579	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.13	CHEMBL2345	Homo sapiens	Inhibition	%	1.13
	8064717	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.01	CHEMBL2345	Homo sapiens	Inhibition	%	0.01
	8065107	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.62	CHEMBL2345	Homo sapiens	Inhibition	%	1.62
	8065223	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.09	CHEMBL2345	Homo sapiens	Inhibition	%	2.09
	8065447	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.69	CHEMBL2345	Homo sapiens	Inhibition	%	1.69
	8065622	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-1.39	CHEMBL2345	Homo sapiens	Inhibition	%	-1.39
	8065961	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	52.83	CHEMBL2345	Homo sapiens	Inhibition	%	52.83
	8066171	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.22	CHEMBL2345	Homo sapiens	Inhibition	%	2.22
	8066307	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.14	CHEMBL2345	Homo sapiens	Inhibition	%	2.14
	8066531	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.72	CHEMBL2345	Homo sapiens	Inhibition	%	1.72
	8066697	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.0	CHEMBL2345	Homo sapiens	Inhibition	%	3.0
	8067045	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.56	CHEMBL2345	Homo sapiens	Inhibition	%	0.56
	8067220	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.77	CHEMBL2345	Homo sapiens	Inhibition	%	0.77
	8067565	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.87	CHEMBL2345	Homo sapiens	Inhibition	%	1.87
	8067775	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	15.6	CHEMBL2345	Homo sapiens	Inhibition	%	15.6
	8068134	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	4.75	CHEMBL2345	Homo sapiens	Inhibition	%	4.75
	8068298	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.02	CHEMBL2345	Homo sapiens	Inhibition	%	0.02
	8068647	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.9	CHEMBL2345	Homo sapiens	Inhibition	%	0.9
	8068821	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.41	CHEMBL2345	Homo sapiens	Inhibition	%	0.41
	8069045	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.33	CHEMBL2345	Homo sapiens	Inhibition	%	1.33
	8069170	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.24	CHEMBL2345	Homo sapiens	Inhibition	%	3.24
	8069465	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	3.51	CHEMBL2345	Homo sapiens	Inhibition	%	3.51
	8069626	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.64	CHEMBL2345	Homo sapiens	Inhibition	%	1.64
	8069850	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.6	CHEMBL2345	Homo sapiens	Inhibition	%	1.6
	8069976	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.51	CHEMBL2345	Homo sapiens	Inhibition	%	2.51
	8070372	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.81	CHEMBL2345	Homo sapiens	Inhibition	%	0.81
	8070497	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.1	CHEMBL2345	Homo sapiens	Inhibition	%	-0.1
	8070721	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.24	CHEMBL2345	Homo sapiens	Inhibition	%	0.24
	8070795	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	23.82	CHEMBL2345	Homo sapiens	Inhibition	%	23.82
	8071176	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.02	CHEMBL2345	Homo sapiens	Inhibition	%	3.02
	8071302	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.16	CHEMBL2345	Homo sapiens	Inhibition	%	1.16
	8071526	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.24	CHEMBL2345	Homo sapiens	Inhibition	%	1.24
	8071699	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.52	CHEMBL2345	Homo sapiens	Inhibition	%	0.52
	8072048	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.8	CHEMBL2345	Homo sapiens	Inhibition	%	0.8
	8072138	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.36	CHEMBL2345	Homo sapiens	Inhibition	%	0.36
	8072362	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.19	CHEMBL2345	Homo sapiens	Inhibition	%	1.19
	8072519	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.3	CHEMBL2345	Homo sapiens	Inhibition	%	2.3
	8072868	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.53	CHEMBL2345	Homo sapiens	Inhibition	%	-0.53
	8073035	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-0.3	CHEMBL2345	Homo sapiens	Inhibition	%	-0.3
	8073384	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	2.83	CHEMBL2345	Homo sapiens	Inhibition	%	2.83
	8073503	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.34	CHEMBL2345	Homo sapiens	Inhibition	%	0.34
	8073727	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.42	CHEMBL2345	Homo sapiens	Inhibition	%	2.42
	8073960	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.08	CHEMBL2345	Homo sapiens	Inhibition	%	1.08
	8074112	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.56	CHEMBL2345	Homo sapiens	Inhibition	%	3.56
	8074466	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.59	CHEMBL2345	Homo sapiens	Inhibition	%	0.59
	8074623	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.99	CHEMBL2345	Homo sapiens	Inhibition	%	0.99
	8074847	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.35	CHEMBL2345	Homo sapiens	Inhibition	%	1.35
	8074974	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.66	CHEMBL2345	Homo sapiens	Inhibition	%	1.66
	8075309	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.33	CHEMBL2345	Homo sapiens	Inhibition	%	0.33
	8075546	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.37	CHEMBL2345	Homo sapiens	Inhibition	%	2.37
	8075687	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.25	CHEMBL2345	Homo sapiens	Inhibition	%	1.25
	8075911	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.6	CHEMBL2345	Homo sapiens	Inhibition	%	1.6
	8076053	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.38	CHEMBL2345	Homo sapiens	Inhibition	%	1.38
	8076425	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.83	CHEMBL2345	Homo sapiens	Inhibition	%	0.83
	8076559	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	5.2	CHEMBL2345	Homo sapiens	Inhibition	%	5.2
	8076885	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.73	CHEMBL2345	Homo sapiens	Inhibition	%	-0.73
	8077132	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	17.96	CHEMBL2345	Homo sapiens	Inhibition	%	17.96
	8077484	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.23	CHEMBL2345	Homo sapiens	Inhibition	%	1.23
	8077635	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	6.99	CHEMBL2345	Homo sapiens	Inhibition	%	6.99
	8078002	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.32	CHEMBL2345	Homo sapiens	Inhibition	%	0.32
	8078141	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	13.09	CHEMBL2345	Homo sapiens	Inhibition	%	13.09
	8078365	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	56.36	CHEMBL2345	Homo sapiens	Inhibition	%	56.36
	8078467	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.0	CHEMBL2345	Homo sapiens	Inhibition	%	-1.0
	8078717	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	69.47	CHEMBL2345	Homo sapiens	Inhibition	%	69.47
	8079057	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.97	CHEMBL2345	Homo sapiens	Inhibition	%	2.97
	8079215	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.35	CHEMBL2345	Homo sapiens	Inhibition	%	1.35
	8079439	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	5.89	CHEMBL2345	Homo sapiens	Inhibition	%	5.89
	8079581	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.51	CHEMBL2345	Homo sapiens	Inhibition	%	-0.51
	8079944	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	26.51	CHEMBL2345	Homo sapiens	Inhibition	%	26.51
	8080049	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.39	CHEMBL2345	Homo sapiens	Inhibition	%	-0.39
	8080273	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.93	CHEMBL2345	Homo sapiens	Inhibition	%	1.93
	8080301	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	7.27	CHEMBL2345	Homo sapiens	Inhibition	%	7.27
	8080525	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	35.95	CHEMBL2345	Homo sapiens	Inhibition	%	35.95
	8080640	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.83	CHEMBL2345	Homo sapiens	Inhibition	%	1.83
	8081028	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.12	CHEMBL2345	Homo sapiens	Inhibition	%	-1.12
	8081163	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.78	CHEMBL2345	Homo sapiens	Inhibition	%	-0.78
	8081531	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	66.83	CHEMBL2345	Homo sapiens	Inhibition	%	66.83
	8081858	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	14.09	CHEMBL2345	Homo sapiens	Inhibition	%	14.09
	8082110	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	40.86	CHEMBL2345	Homo sapiens	Inhibition	%	40.86
	8082223	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.15	CHEMBL2345	Homo sapiens	Inhibition	%	1.15
	8082447	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.12	CHEMBL2345	Homo sapiens	Inhibition	%	-0.12
	8082620	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.29	CHEMBL2345	Homo sapiens	Inhibition	%	0.29
	8082743	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.97	CHEMBL2345	Homo sapiens	Inhibition	%	0.97
	8082967	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.47	CHEMBL2345	Homo sapiens	Inhibition	%	1.47
	8083123	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.08	CHEMBL2345	Homo sapiens	Inhibition	%	2.08
	8083446	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.31	CHEMBL2345	Homo sapiens	Inhibition	%	1.31
	8083700	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	81.43	CHEMBL2345	Homo sapiens	Inhibition	%	81.43
	8084034	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.82	CHEMBL2345	Homo sapiens	Inhibition	%	2.82
	8084219	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	7.41	CHEMBL2345	Homo sapiens	Inhibition	%	7.41
	8084561	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.41	CHEMBL2345	Homo sapiens	Inhibition	%	1.41
	8084722	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.61	CHEMBL2345	Homo sapiens	Inhibition	%	9.61
	8085044	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.41	CHEMBL2345	Homo sapiens	Inhibition	%	1.41
	8085300	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.86	CHEMBL2345	Homo sapiens	Inhibition	%	1.86
	8085632	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.15	CHEMBL2345	Homo sapiens	Inhibition	%	1.15
	8085821	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	39.36	CHEMBL2345	Homo sapiens	Inhibition	%	39.36
	8086160	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.13	CHEMBL2345	Homo sapiens	Inhibition	%	2.13
	8086322	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.78	CHEMBL2345	Homo sapiens	Inhibition	%	2.78
	8086546	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.6	CHEMBL2345	Homo sapiens	Inhibition	%	6.6
	8086645	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.32	CHEMBL2345	Homo sapiens	Inhibition	%	0.32
	8086856	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.14	CHEMBL2345	Homo sapiens	Inhibition	%	0.14
	8087080	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.94	CHEMBL2345	Homo sapiens	Inhibition	%	1.94
	8087238	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.82	CHEMBL2345	Homo sapiens	Inhibition	%	0.82
	8087576	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-0.3	CHEMBL2345	Homo sapiens	Inhibition	%	-0.3
	8087714	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.15	CHEMBL2345	Homo sapiens	Inhibition	%	4.15
	8087938	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.31	CHEMBL2345	Homo sapiens	Inhibition	%	-1.31
	8088080	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	-0.05	CHEMBL2345	Homo sapiens	Inhibition	%	-0.05
	8088228	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.7	CHEMBL2345	Homo sapiens	Inhibition	%	-0.7
	8088452	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.45	CHEMBL2345	Homo sapiens	Inhibition	%	0.45
	8088580	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.79	CHEMBL2345	Homo sapiens	Inhibition	%	1.79
	8088897	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	36.18	CHEMBL2345	Homo sapiens	Inhibition	%	36.18
	8089249	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.26	CHEMBL2345	Homo sapiens	Inhibition	%	3.26
	8089397	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.53	CHEMBL2345	Homo sapiens	Inhibition	%	1.53
	8089741	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.57	CHEMBL2345	Homo sapiens	Inhibition	%	0.57
	8089921	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.02	CHEMBL2345	Homo sapiens	Inhibition	%	-1.02
	8090310	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	10.29	CHEMBL2345	Homo sapiens	Inhibition	%	10.29
	8090477	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.6	CHEMBL2345	Homo sapiens	Inhibition	%	2.6
	8090840	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.29	CHEMBL2345	Homo sapiens	Inhibition	%	-0.29
	8091045	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.27	CHEMBL2345	Homo sapiens	Inhibition	%	2.27
	8091406	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	9.39	CHEMBL2345	Homo sapiens	Inhibition	%	9.39
	8091561	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.79	CHEMBL2345	Homo sapiens	Inhibition	%	0.79
	8091901	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.19	CHEMBL2345	Homo sapiens	Inhibition	%	0.19
	8092262	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.67	CHEMBL2345	Homo sapiens	Inhibition	%	-1.67
	8092413	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.24	CHEMBL2345	Homo sapiens	Inhibition	%	1.24
	8092785	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-1.22	CHEMBL2345	Homo sapiens	Inhibition	%	-1.22
	8092914	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.13	CHEMBL2345	Homo sapiens	Inhibition	%	5.13
	8093138	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.13	CHEMBL2345	Homo sapiens	Inhibition	%	-1.13
	8093226	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.38	CHEMBL2345	Homo sapiens	Inhibition	%	0.38
	8093590	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	3.04	CHEMBL2345	Homo sapiens	Inhibition	%	3.04
	8093729	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	8.42	CHEMBL2345	Homo sapiens	Inhibition	%	8.42
	8093953	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.11	CHEMBL2345	Homo sapiens	Inhibition	%	1.11
	8094073	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.01	CHEMBL2345	Homo sapiens	Inhibition	%	4.01
	8094253	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.67	CHEMBL2345	Homo sapiens	Inhibition	%	0.67
	8094477	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.7	CHEMBL2345	Homo sapiens	Inhibition	%	0.7
	8094652	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	14.99	CHEMBL2345	Homo sapiens	Inhibition	%	14.99
	8094808	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	7.74	CHEMBL2345	Homo sapiens	Inhibition	%	7.74
	8095032	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.71	CHEMBL2345	Homo sapiens	Inhibition	%	2.71
	8095172	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.29	CHEMBL2345	Homo sapiens	Inhibition	%	-0.29
	8095375	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.78	CHEMBL2345	Homo sapiens	Inhibition	%	2.78
	8095599	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.08	CHEMBL2345	Homo sapiens	Inhibition	%	0.08
	8095740	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	39.41	CHEMBL2345	Homo sapiens	Inhibition	%	39.41
	8095888	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.6	CHEMBL2345	Homo sapiens	Inhibition	%	0.6
	8096112	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.23	CHEMBL2345	Homo sapiens	Inhibition	%	2.23
	8096229	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.01	CHEMBL2345	Homo sapiens	Inhibition	%	1.01
	8096592	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-1.03	CHEMBL2345	Homo sapiens	Inhibition	%	-1.03
	8096748	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.57	CHEMBL2345	Homo sapiens	Inhibition	%	1.57
	8096972	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.67	CHEMBL2345	Homo sapiens	Inhibition	%	1.67
	8097119	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.28	CHEMBL2345	Homo sapiens	Inhibition	%	-0.28
	8097426	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.08	CHEMBL2345	Homo sapiens	Inhibition	%	1.08
	8097650	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.21	CHEMBL2345	Homo sapiens	Inhibition	%	1.21
	8097800	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	26.76	CHEMBL2345	Homo sapiens	Inhibition	%	26.76
	8098157	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.31	CHEMBL2345	Homo sapiens	Inhibition	%	1.31
	8098277	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.89	CHEMBL2345	Homo sapiens	Inhibition	%	0.89
	8098681	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.07	CHEMBL2345	Homo sapiens	Inhibition	%	2.07
	8098866	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	56.98	CHEMBL2345	Homo sapiens	Inhibition	%	56.98
	8099234	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.03	CHEMBL2345	Homo sapiens	Inhibition	%	3.03
	8099376	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.97	CHEMBL2345	Homo sapiens	Inhibition	%	0.97
	8099794	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.42	CHEMBL2345	Homo sapiens	Inhibition	%	0.42
	8099941	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.75	CHEMBL2345	Homo sapiens	Inhibition	%	0.75
	8100311	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-1.0	CHEMBL2345	Homo sapiens	Inhibition	%	-1.0
	8100427	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-0.14	CHEMBL2345	Homo sapiens	Inhibition	%	-0.14
	8100651	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.39	CHEMBL2345	Homo sapiens	Inhibition	%	1.39
	8100791	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.82	CHEMBL2345	Homo sapiens	Inhibition	%	0.82
	8101175	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.1	CHEMBL2345	Homo sapiens	Inhibition	%	4.1
	8101317	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.02	CHEMBL2345	Homo sapiens	Inhibition	%	0.02
	8101726	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.23	CHEMBL2345	Homo sapiens	Inhibition	%	-0.23
	8101979	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	7.47	CHEMBL2345	Homo sapiens	Inhibition	%	7.47
	8102134	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.11	CHEMBL2345	Homo sapiens	Inhibition	%	-0.11
	8102489	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.74	CHEMBL2345	Homo sapiens	Inhibition	%	0.74
	8102609	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.45	CHEMBL2345	Homo sapiens	Inhibition	%	-1.45
	8102833	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.34	CHEMBL2345	Homo sapiens	Inhibition	%	1.34
	8103011	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.71	CHEMBL2345	Homo sapiens	Inhibition	%	2.71
	8103207	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.74	CHEMBL2345	Homo sapiens	Inhibition	%	1.74
	8103569	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.35	CHEMBL2345	Homo sapiens	Inhibition	%	0.35
	8103719	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.14	CHEMBL2345	Homo sapiens	Inhibition	%	1.14
	8103943	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.77	CHEMBL2345	Homo sapiens	Inhibition	%	1.77
	8104128	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.65	CHEMBL2345	Homo sapiens	Inhibition	%	0.65
	8104276	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.14	CHEMBL2345	Homo sapiens	Inhibition	%	5.14
	8104500	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.17	CHEMBL2345	Homo sapiens	Inhibition	%	4.17
	8104646	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.65	CHEMBL2345	Homo sapiens	Inhibition	%	2.65
	8104984	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.85	CHEMBL2345	Homo sapiens	Inhibition	%	1.85
	8105124	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-1.56	CHEMBL2345	Homo sapiens	Inhibition	%	-1.56
	8105348	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.44	CHEMBL2345	Homo sapiens	Inhibition	%	-0.44
	8105514	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.29	CHEMBL2345	Homo sapiens	Inhibition	%	3.29
	8105652	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	2.83	CHEMBL2345	Homo sapiens	Inhibition	%	2.83
	8105876	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.01	CHEMBL2345	Homo sapiens	Inhibition	%	1.01
	8105932	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.9	CHEMBL2345	Homo sapiens	Inhibition	%	0.9
	8106156	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-0.35	CHEMBL2345	Homo sapiens	Inhibition	%	-0.35
	8106321	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.68	CHEMBL2345	Homo sapiens	Inhibition	%	0.68
	8106477	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	8.36	CHEMBL2345	Homo sapiens	Inhibition	%	8.36
	8106701	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	24.43	CHEMBL2345	Homo sapiens	Inhibition	%	24.43
	8106830	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.03	CHEMBL2345	Homo sapiens	Inhibition	%	-0.03
	8107175	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.78	CHEMBL2345	Homo sapiens	Inhibition	%	1.78
	8107347	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.26	CHEMBL2345	Homo sapiens	Inhibition	%	3.26
	8107548	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	14.53	CHEMBL2345	Homo sapiens	Inhibition	%	14.53
	8107772	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.91	CHEMBL2345	Homo sapiens	Inhibition	%	0.91
	8107907	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.16	CHEMBL2345	Homo sapiens	Inhibition	%	1.16
	8108289	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.02	CHEMBL2345	Homo sapiens	Inhibition	%	3.02
	8108464	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.37	CHEMBL2345	Homo sapiens	Inhibition	%	1.37
	8108835	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	22.53	CHEMBL2345	Homo sapiens	Inhibition	%	22.53
	8108977	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.82	CHEMBL2345	Homo sapiens	Inhibition	%	-0.82
	8109315	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.59	CHEMBL2345	Homo sapiens	Inhibition	%	1.59
	8109669	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.57	CHEMBL2345	Homo sapiens	Inhibition	%	-0.57
	8109840	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	21.79	CHEMBL2345	Homo sapiens	Inhibition	%	21.79
	8110196	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.61	CHEMBL2345	Homo sapiens	Inhibition	%	2.61
	8110475	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.12	CHEMBL2345	Homo sapiens	Inhibition	%	1.12
	8110641	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.23	CHEMBL2345	Homo sapiens	Inhibition	%	2.23
	8111023	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	72.93	CHEMBL2345	Homo sapiens	Inhibition	%	72.93
	8111146	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.58	CHEMBL2345	Homo sapiens	Inhibition	%	0.58
	8111497	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	3.35	CHEMBL2345	Homo sapiens	Inhibition	%	3.35
	8111663	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.31	CHEMBL2345	Homo sapiens	Inhibition	%	3.31
	8111887	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.73	CHEMBL2345	Homo sapiens	Inhibition	%	0.73
	8112092	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.43	CHEMBL2345	Homo sapiens	Inhibition	%	3.43
	8112229	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.34	CHEMBL2345	Homo sapiens	Inhibition	%	0.34
	8112453	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.55	CHEMBL2345	Homo sapiens	Inhibition	%	1.55
	8112621	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.5	CHEMBL2345	Homo sapiens	Inhibition	%	2.5
	8112793	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.27	CHEMBL2345	Homo sapiens	Inhibition	%	-0.27
	8113169	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.84	CHEMBL2345	Homo sapiens	Inhibition	%	1.84
	8113305	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.23	CHEMBL2345	Homo sapiens	Inhibition	%	1.23
	8113529	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.21	CHEMBL2345	Homo sapiens	Inhibition	%	-1.21
	8113653	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.56	CHEMBL2345	Homo sapiens	Inhibition	%	2.56
	8113993	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.82	CHEMBL2345	Homo sapiens	Inhibition	%	-1.82
	8114169	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	-0.35	CHEMBL2345	Homo sapiens	Inhibition	%	-0.35
	8114525	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.55	CHEMBL2345	Homo sapiens	Inhibition	%	1.55
	8114801	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.57	CHEMBL2345	Homo sapiens	Inhibition	%	0.57
	8114967	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.22	CHEMBL2345	Homo sapiens	Inhibition	%	3.22
	8115191	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	22.46	CHEMBL2345	Homo sapiens	Inhibition	%	22.46
	8115356	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.72	CHEMBL2345	Homo sapiens	Inhibition	%	1.72
	8115476	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.96	CHEMBL2345	Homo sapiens	Inhibition	%	0.96
	8115700	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.07	CHEMBL2345	Homo sapiens	Inhibition	%	1.07
	8115833	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	24.88	CHEMBL2345	Homo sapiens	Inhibition	%	24.88
	8116216	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	4.41	CHEMBL2345	Homo sapiens	Inhibition	%	4.41
	8116419	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.02	CHEMBL2345	Homo sapiens	Inhibition	%	3.02
	8116777	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.56	CHEMBL2345	Homo sapiens	Inhibition	%	-0.56
	8116949	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.98	CHEMBL2345	Homo sapiens	Inhibition	%	2.98
	8117120	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.04	CHEMBL2345	Homo sapiens	Inhibition	%	-0.04
	8117344	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.02	CHEMBL2345	Homo sapiens	Inhibition	%	2.02
	8117502	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.57	CHEMBL2345	Homo sapiens	Inhibition	%	5.57
	8117856	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.51	CHEMBL2345	Homo sapiens	Inhibition	%	1.51
	8117994	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.47	CHEMBL2345	Homo sapiens	Inhibition	%	-0.47
	8118334	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.72	CHEMBL2345	Homo sapiens	Inhibition	%	1.72
	8118506	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.53	CHEMBL2345	Homo sapiens	Inhibition	%	3.53
	8118730	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-0.53	CHEMBL2345	Homo sapiens	Inhibition	%	-0.53
	8118866	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.12	CHEMBL2345	Homo sapiens	Inhibition	%	3.12
	8119137	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.6	CHEMBL2345	Homo sapiens	Inhibition	%	4.6
	8119520	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.16	CHEMBL2345	Homo sapiens	Inhibition	%	1.16
	8119687	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.03	CHEMBL2345	Homo sapiens	Inhibition	%	4.03
	8120030	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.43	CHEMBL2345	Homo sapiens	Inhibition	%	2.43
	8120169	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.19	CHEMBL2345	Homo sapiens	Inhibition	%	1.19
	8120393	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.86	CHEMBL2345	Homo sapiens	Inhibition	%	1.86
	8120553	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.74	CHEMBL2345	Homo sapiens	Inhibition	%	0.74
	8120754	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	14.35	CHEMBL2345	Homo sapiens	Inhibition	%	14.35
	8121106	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.05	CHEMBL2345	Homo sapiens	Inhibition	%	2.05
	8121278	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.48	CHEMBL2345	Homo sapiens	Inhibition	%	1.48
	8121669	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.03	CHEMBL2345	Homo sapiens	Inhibition	%	2.03
	8121832	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.56	CHEMBL2345	Homo sapiens	Inhibition	%	1.56
	8122177	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.04	CHEMBL2345	Homo sapiens	Inhibition	%	1.04
	8122315	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.32	CHEMBL2345	Homo sapiens	Inhibition	%	1.32
	8122539	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.13	CHEMBL2345	Homo sapiens	Inhibition	%	6.13
	8122659	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.53	CHEMBL2345	Homo sapiens	Inhibition	%	2.53
	8123050	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.66	CHEMBL2345	Homo sapiens	Inhibition	%	2.66
	8123192	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-0.02	CHEMBL2345	Homo sapiens	Inhibition	%	-0.02
	8123470	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	23.09	CHEMBL2345	Homo sapiens	Inhibition	%	23.09
	8123844	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	6.18	CHEMBL2345	Homo sapiens	Inhibition	%	6.18
	8124011	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.12	CHEMBL2345	Homo sapiens	Inhibition	%	2.12
	8124354	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-0.39	CHEMBL2345	Homo sapiens	Inhibition	%	-0.39
	8124717	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.73	CHEMBL2345	Homo sapiens	Inhibition	%	2.73
	8124882	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.52	CHEMBL2345	Homo sapiens	Inhibition	%	1.52
	8125083	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.03	CHEMBL2345	Homo sapiens	Inhibition	%	3.03
	8125307	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.07	CHEMBL2345	Homo sapiens	Inhibition	%	4.07
	8125437	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.41	CHEMBL2345	Homo sapiens	Inhibition	%	0.41
	8125605	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.79	CHEMBL2345	Homo sapiens	Inhibition	%	1.79
	8125829	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.65	CHEMBL2345	Homo sapiens	Inhibition	%	1.65
	8125993	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.06	CHEMBL2345	Homo sapiens	Inhibition	%	1.06
	8126157	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.97	CHEMBL2345	Homo sapiens	Inhibition	%	2.97
	8126381	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-0.63	CHEMBL2345	Homo sapiens	Inhibition	%	-0.63
	8126496	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	15.79	CHEMBL2345	Homo sapiens	Inhibition	%	15.79
	8126856	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	36.03	CHEMBL2345	Homo sapiens	Inhibition	%	36.03
	8126978	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.73	CHEMBL2345	Homo sapiens	Inhibition	%	1.73
	8127202	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.37	CHEMBL2345	Homo sapiens	Inhibition	%	2.37
	8127369	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	1.12	CHEMBL2345	Homo sapiens	Inhibition	%	1.12
	8127511	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	11.05	CHEMBL2345	Homo sapiens	Inhibition	%	11.05
	8127735	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.15	CHEMBL2345	Homo sapiens	Inhibition	%	2.15
	8127799	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.9	CHEMBL2345	Homo sapiens	Inhibition	%	0.9
	8128023	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	8.61	CHEMBL2345	Homo sapiens	Inhibition	%	8.61
	8128175	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.25	CHEMBL2345	Homo sapiens	Inhibition	%	1.25
	8128342	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	4.76	CHEMBL2345	Homo sapiens	Inhibition	%	4.76
	8128566	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.15	CHEMBL2345	Homo sapiens	Inhibition	%	1.15
	8128685	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.48	CHEMBL2345	Homo sapiens	Inhibition	%	2.48
	8129046	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	9.07	CHEMBL2345	Homo sapiens	Inhibition	%	9.07
	8129217	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.48	CHEMBL2345	Homo sapiens	Inhibition	%	-0.48
	8129630	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.47	CHEMBL2345	Homo sapiens	Inhibition	%	0.47
	8129769	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.86	CHEMBL2345	Homo sapiens	Inhibition	%	0.86
	8130154	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.69	CHEMBL2345	Homo sapiens	Inhibition	%	2.69
	8130326	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.16	CHEMBL2345	Homo sapiens	Inhibition	%	2.16
	8130710	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.49	CHEMBL2345	Homo sapiens	Inhibition	%	2.49
	8130826	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.64	CHEMBL2345	Homo sapiens	Inhibition	%	1.64
	8131050	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.45	CHEMBL2345	Homo sapiens	Inhibition	%	1.45
	8131189	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-0.14	CHEMBL2345	Homo sapiens	Inhibition	%	-0.14
	8131533	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.53	CHEMBL2345	Homo sapiens	Inhibition	%	-0.53
	8131700	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	13.64	CHEMBL2345	Homo sapiens	Inhibition	%	13.64
	8132065	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	26.13	CHEMBL2345	Homo sapiens	Inhibition	%	26.13
	8132351	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.14	CHEMBL2345	Homo sapiens	Inhibition	%	1.14
	8132498	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.65	CHEMBL2345	Homo sapiens	Inhibition	%	2.65
	8132890	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.38	CHEMBL2345	Homo sapiens	Inhibition	%	1.38
	8133011	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.05	CHEMBL2345	Homo sapiens	Inhibition	%	0.05
	8133235	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.52	CHEMBL2345	Homo sapiens	Inhibition	%	0.52
	8133373	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.2	CHEMBL2345	Homo sapiens	Inhibition	%	3.2
	8133545	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.08	CHEMBL2345	Homo sapiens	Inhibition	%	-0.08
	8133769	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.77	CHEMBL2345	Homo sapiens	Inhibition	%	0.77
	8133949	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.98	CHEMBL2345	Homo sapiens	Inhibition	%	2.98
	8134097	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.43	CHEMBL2345	Homo sapiens	Inhibition	%	1.43
	8134321	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.31	CHEMBL2345	Homo sapiens	Inhibition	%	2.31
	8134481	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.62	CHEMBL2345	Homo sapiens	Inhibition	%	-0.62
	8134665	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	1.88	CHEMBL2345	Homo sapiens	Inhibition	%	1.88
	8134889	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	9.89	CHEMBL2345	Homo sapiens	Inhibition	%	9.89
	8135049	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-0.57	CHEMBL2345	Homo sapiens	Inhibition	%	-0.57
	8135388	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.54	CHEMBL2345	Homo sapiens	Inhibition	%	1.54
	8135529	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.74	CHEMBL2345	Homo sapiens	Inhibition	%	2.74
	8135874	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.25	CHEMBL2345	Homo sapiens	Inhibition	%	-1.25
	8136042	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.86	CHEMBL2345	Homo sapiens	Inhibition	%	0.86
	8136266	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.4	CHEMBL2345	Homo sapiens	Inhibition	%	1.4
	8136410	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-0.4	CHEMBL2345	Homo sapiens	Inhibition	%	-0.4
	8136700	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.43	CHEMBL2345	Homo sapiens	Inhibition	%	1.43
	8136835	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.88	CHEMBL2345	Homo sapiens	Inhibition	%	1.88
	8137059	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	18.93	CHEMBL2345	Homo sapiens	Inhibition	%	18.93
	8137222	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.62	CHEMBL2345	Homo sapiens	Inhibition	%	1.62
	8137566	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.6	CHEMBL2345	Homo sapiens	Inhibition	%	0.6
	8137714	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.53	CHEMBL2345	Homo sapiens	Inhibition	%	3.53
	8138104	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.33	CHEMBL2345	Homo sapiens	Inhibition	%	2.33
	8138283	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.21	CHEMBL2345	Homo sapiens	Inhibition	%	1.21
	8138655	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.65	CHEMBL2345	Homo sapiens	Inhibition	%	1.65
	8138813	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.11	CHEMBL2345	Homo sapiens	Inhibition	%	0.11
	8139222	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.27	CHEMBL2345	Homo sapiens	Inhibition	%	1.27
	8139381	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.01	CHEMBL2345	Homo sapiens	Inhibition	%	1.01
	8139719	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.72	CHEMBL2345	Homo sapiens	Inhibition	%	1.72
	8139860	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	0.59	CHEMBL2345	Homo sapiens	Inhibition	%	0.59
	8140084	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	0.78	CHEMBL2345	Homo sapiens	Inhibition	%	0.78
	8140207	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-0.13	CHEMBL2345	Homo sapiens	Inhibition	%	-0.13
	8140590	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.31	CHEMBL2345	Homo sapiens	Inhibition	%	1.31
	8140733	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.18	CHEMBL2345	Homo sapiens	Inhibition	%	2.18
	8141035	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.21	CHEMBL2345	Homo sapiens	Inhibition	%	0.21
	8141389	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.05	CHEMBL2345	Homo sapiens	Inhibition	%	-0.05
	8141549	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	4.75	CHEMBL2345	Homo sapiens	Inhibition	%	4.75
	8141892	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.28	CHEMBL2345	Homo sapiens	Inhibition	%	-0.28
	8142053	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.04	CHEMBL2345	Homo sapiens	Inhibition	%	0.04
	8142277	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.87	CHEMBL2345	Homo sapiens	Inhibition	%	0.87
	8142445	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	11.75	CHEMBL2345	Homo sapiens	Inhibition	%	11.75
	8142621	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.84	CHEMBL2345	Homo sapiens	Inhibition	%	1.84
	8142845	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.04	CHEMBL2345	Homo sapiens	Inhibition	%	0.04
	8142994	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.68	CHEMBL2345	Homo sapiens	Inhibition	%	1.68
	8143149	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.98	CHEMBL2345	Homo sapiens	Inhibition	%	0.98
	8143373	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.75	CHEMBL2345	Homo sapiens	Inhibition	%	1.75
	8143560	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.7	CHEMBL2345	Homo sapiens	Inhibition	%	1.7
	8143719	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-0.67	CHEMBL2345	Homo sapiens	Inhibition	%	-0.67
	8143943	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.59	CHEMBL2345	Homo sapiens	Inhibition	%	0.59
	8144057	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.55	CHEMBL2345	Homo sapiens	Inhibition	%	-0.55
	8144420	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.1	CHEMBL2345	Homo sapiens	Inhibition	%	1.1
	8144550	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.21	CHEMBL2345	Homo sapiens	Inhibition	%	1.21
	8144774	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-0.35	CHEMBL2345	Homo sapiens	Inhibition	%	-0.35
	8144927	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.69	CHEMBL2345	Homo sapiens	Inhibition	%	1.69
	8145064	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.92	CHEMBL2345	Homo sapiens	Inhibition	%	0.92
	8145288	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.8	CHEMBL2345	Homo sapiens	Inhibition	%	0.8
	8145377	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-1.32	CHEMBL2345	Homo sapiens	Inhibition	%	-1.32
	8145725	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.78	CHEMBL2345	Homo sapiens	Inhibition	%	0.78
	8145886	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.08	CHEMBL2345	Homo sapiens	Inhibition	%	2.08
	8146110	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.81	CHEMBL2345	Homo sapiens	Inhibition	%	3.81
	8146230	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.27	CHEMBL2345	Homo sapiens	Inhibition	%	-0.27
	8146614	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-6.28	CHEMBL2345	Homo sapiens	Inhibition	%	-6.28
	8146781	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	51.96	CHEMBL2345	Homo sapiens	Inhibition	%	51.96
	8147174	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.92	CHEMBL2345	Homo sapiens	Inhibition	%	1.92
	8147316	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.05	CHEMBL2345	Homo sapiens	Inhibition	%	1.05
	8147693	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.27	CHEMBL2345	Homo sapiens	Inhibition	%	1.27
	8147880	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.97	CHEMBL2345	Homo sapiens	Inhibition	%	1.97
	8148262	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.46	CHEMBL2345	Homo sapiens	Inhibition	%	0.46
	8148376	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.39	CHEMBL2345	Homo sapiens	Inhibition	%	-1.39
	8148600	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.28	CHEMBL2345	Homo sapiens	Inhibition	%	-0.28
	8148739	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.87	CHEMBL2345	Homo sapiens	Inhibition	%	1.87
	8149101	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.53	CHEMBL2345	Homo sapiens	Inhibition	%	0.53
	8149260	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.25	CHEMBL2345	Homo sapiens	Inhibition	%	-1.25
	8149618	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	54.47	CHEMBL2345	Homo sapiens	Inhibition	%	54.47
	8149716	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.05	CHEMBL2345	Homo sapiens	Inhibition	%	1.05
	8149940	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.39	CHEMBL2345	Homo sapiens	Inhibition	%	3.39
	8150065	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.5	CHEMBL2345	Homo sapiens	Inhibition	%	1.5
	8150449	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.84	CHEMBL2345	Homo sapiens	Inhibition	%	-0.84
	8150569	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-1.87	CHEMBL2345	Homo sapiens	Inhibition	%	-1.87
	8150793	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.32	CHEMBL2345	Homo sapiens	Inhibition	%	0.32
	8150958	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-1.3	CHEMBL2345	Homo sapiens	Inhibition	%	-1.3
	8151121	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	2.94	CHEMBL2345	Homo sapiens	Inhibition	%	2.94
	8151345	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	4.97	CHEMBL2345	Homo sapiens	Inhibition	%	4.97
	8151522	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.54	CHEMBL2345	Homo sapiens	Inhibition	%	1.54
	8151660	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.35	CHEMBL2345	Homo sapiens	Inhibition	%	1.35
	8151884	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.29	CHEMBL2345	Homo sapiens	Inhibition	%	1.29
	8152038	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.97	CHEMBL2345	Homo sapiens	Inhibition	%	1.97
	8152226	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.23	CHEMBL2345	Homo sapiens	Inhibition	%	4.23
	8152608	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.02	CHEMBL2345	Homo sapiens	Inhibition	%	0.02
	8152946	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.94	CHEMBL2345	Homo sapiens	Inhibition	%	0.94
	8153085	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.78	CHEMBL2345	Homo sapiens	Inhibition	%	0.78
	8153446	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	0.8	CHEMBL2345	Homo sapiens	Inhibition	%	0.8
	8153603	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.73	CHEMBL2345	Homo sapiens	Inhibition	%	-1.73
	8153960	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	78.71	CHEMBL2345	Homo sapiens	Inhibition	%	78.71
	8154281	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	7.22	CHEMBL2345	Homo sapiens	Inhibition	%	7.22
	8154407	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	6.22	CHEMBL2345	Homo sapiens	Inhibition	%	6.22
	8154631	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.89	CHEMBL2345	Homo sapiens	Inhibition	%	0.89
	8154790	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.62	CHEMBL2345	Homo sapiens	Inhibition	%	0.62
	8155134	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.35	CHEMBL2345	Homo sapiens	Inhibition	%	-0.35
	8155310	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.83	CHEMBL2345	Homo sapiens	Inhibition	%	-0.83
	8155695	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.2	CHEMBL2345	Homo sapiens	Inhibition	%	2.2
	8155873	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.91	CHEMBL2345	Homo sapiens	Inhibition	%	0.91
	8156235	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.88	CHEMBL2345	Homo sapiens	Inhibition	%	1.88
	8156447	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.27	CHEMBL2345	Homo sapiens	Inhibition	%	1.27
	8156597	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.54	CHEMBL2345	Homo sapiens	Inhibition	%	3.54
	8156821	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.14	CHEMBL2345	Homo sapiens	Inhibition	%	2.14
	8156964	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.01	CHEMBL2345	Homo sapiens	Inhibition	%	4.01
	8157308	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	17.22	CHEMBL2345	Homo sapiens	Inhibition	%	17.22
	8157449	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.91	CHEMBL2345	Homo sapiens	Inhibition	%	5.91
	8157673	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	31.76	CHEMBL2345	Homo sapiens	Inhibition	%	31.76
	8157803	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.36	CHEMBL2345	Homo sapiens	Inhibition	%	1.36
	8157964	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.8	CHEMBL2345	Homo sapiens	Inhibition	%	-0.8
	8158188	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.52	CHEMBL2345	Homo sapiens	Inhibition	%	1.52
	8158438	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	31.33	CHEMBL2345	Homo sapiens	Inhibition	%	31.33
	8158596	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.09	CHEMBL2345	Homo sapiens	Inhibition	%	6.09
	8158989	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.63	CHEMBL2345	Homo sapiens	Inhibition	%	1.63
	8159124	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.55	CHEMBL2345	Homo sapiens	Inhibition	%	1.55
	8159468	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.04	CHEMBL2345	Homo sapiens	Inhibition	%	3.04
	8159823	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	22.63	CHEMBL2345	Homo sapiens	Inhibition	%	22.63
	8159964	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	5.78	CHEMBL2345	Homo sapiens	Inhibition	%	5.78
	8160325	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.9	CHEMBL2345	Homo sapiens	Inhibition	%	0.9
	8160475	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.92	CHEMBL2345	Homo sapiens	Inhibition	%	-0.92
	8160769	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.17	CHEMBL2345	Homo sapiens	Inhibition	%	2.17
	8161143	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.69	CHEMBL2345	Homo sapiens	Inhibition	%	2.69
	8161286	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	0.94	CHEMBL2345	Homo sapiens	Inhibition	%	0.94
	8161635	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.65	CHEMBL2345	Homo sapiens	Inhibition	%	1.65
	8161997	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.09	CHEMBL2345	Homo sapiens	Inhibition	%	2.09
	8162127	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.83	CHEMBL2345	Homo sapiens	Inhibition	%	4.83
	8162511	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.48	CHEMBL2345	Homo sapiens	Inhibition	%	-0.48
	8162764	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	69.91	CHEMBL2345	Homo sapiens	Inhibition	%	69.91
	8162912	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	17.7	CHEMBL2345	Homo sapiens	Inhibition	%	17.7
	8163136	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	57.14	CHEMBL2345	Homo sapiens	Inhibition	%	57.14
	8163305	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.01	CHEMBL2345	Homo sapiens	Inhibition	%	1.01
	8163439	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.86	CHEMBL2345	Homo sapiens	Inhibition	%	5.86
	8163663	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.79	CHEMBL2345	Homo sapiens	Inhibition	%	2.79
	8163786	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	6.0	CHEMBL2345	Homo sapiens	Inhibition	%	6.0
	8164144	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	40.16	CHEMBL2345	Homo sapiens	Inhibition	%	40.16
	8164284	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.45	CHEMBL2345	Homo sapiens	Inhibition	%	1.45
	8164508	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.77	CHEMBL2345	Homo sapiens	Inhibition	%	2.77
	8164663	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	0.17	CHEMBL2345	Homo sapiens	Inhibition	%	0.17
	8164807	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.98	CHEMBL2345	Homo sapiens	Inhibition	%	-0.98
	8165031	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.62	CHEMBL2345	Homo sapiens	Inhibition	%	0.62
	8165101	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.99	CHEMBL2345	Homo sapiens	Inhibition	%	2.99
	8165466	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.19	CHEMBL2345	Homo sapiens	Inhibition	%	0.19
	8165609	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.28	CHEMBL2345	Homo sapiens	Inhibition	%	4.28
	8165833	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.64	CHEMBL2345	Homo sapiens	Inhibition	%	0.64
	8165959	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.49	CHEMBL2345	Homo sapiens	Inhibition	%	4.49
	8166321	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.61	CHEMBL2345	Homo sapiens	Inhibition	%	5.61
	8166451	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.36	CHEMBL2345	Homo sapiens	Inhibition	%	1.36
	8166675	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.76	CHEMBL2345	Homo sapiens	Inhibition	%	2.76
	8166776	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.03	CHEMBL2345	Homo sapiens	Inhibition	%	0.03
	8167088	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	12.23	CHEMBL2345	Homo sapiens	Inhibition	%	12.23
	8167453	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	17.25	CHEMBL2345	Homo sapiens	Inhibition	%	17.25
	8167617	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.5	CHEMBL2345	Homo sapiens	Inhibition	%	0.5
	8167974	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.91	CHEMBL2345	Homo sapiens	Inhibition	%	9.91
	8168098	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.28	CHEMBL2345	Homo sapiens	Inhibition	%	2.28
	8168322	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	11.24	CHEMBL2345	Homo sapiens	Inhibition	%	11.24
	8168463	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.96	CHEMBL2345	Homo sapiens	Inhibition	%	0.96
	8168823	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.8	CHEMBL2345	Homo sapiens	Inhibition	%	0.8
	8168987	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	4.03	CHEMBL2345	Homo sapiens	Inhibition	%	4.03
	8169353	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.96	CHEMBL2345	Homo sapiens	Inhibition	%	0.96
	8169433	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	14.48	CHEMBL2345	Homo sapiens	Inhibition	%	14.48
	8169657	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.21	CHEMBL2345	Homo sapiens	Inhibition	%	2.21
	8169791	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.69	CHEMBL2345	Homo sapiens	Inhibition	%	1.69
	8170160	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	9.39	CHEMBL2345	Homo sapiens	Inhibition	%	9.39
	8170285	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.33	CHEMBL2345	Homo sapiens	Inhibition	%	0.33
	8170509	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.26	CHEMBL2345	Homo sapiens	Inhibition	%	1.26
	8170649	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.16	CHEMBL2345	Homo sapiens	Inhibition	%	4.16
	8171008	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-0.01	CHEMBL2345	Homo sapiens	Inhibition	%	-0.01
	8171205	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.04	CHEMBL2345	Homo sapiens	Inhibition	%	1.04
	8171422	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	54.56	CHEMBL2345	Homo sapiens	Inhibition	%	54.56
	8171787	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	50.7	CHEMBL2345	Homo sapiens	Inhibition	%	50.7
	8171940	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.2	CHEMBL2345	Homo sapiens	Inhibition	%	2.2
	8172296	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.19	CHEMBL2345	Homo sapiens	Inhibition	%	2.19
	8172648	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.64	CHEMBL2345	Homo sapiens	Inhibition	%	0.64
	8172790	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.23	CHEMBL2345	Homo sapiens	Inhibition	%	1.23
	8173150	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.45	CHEMBL2345	Homo sapiens	Inhibition	%	2.45
	8173315	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	1.43	CHEMBL2345	Homo sapiens	Inhibition	%	1.43
	8173680	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.76	CHEMBL2345	Homo sapiens	Inhibition	%	0.76
	8173991	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	11.89	CHEMBL2345	Homo sapiens	Inhibition	%	11.89
	8174123	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.3	CHEMBL2345	Homo sapiens	Inhibition	%	1.3
	8174347	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.62	CHEMBL2345	Homo sapiens	Inhibition	%	2.62
	8174495	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.89	CHEMBL2345	Homo sapiens	Inhibition	%	0.89
	8174841	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-0.04	CHEMBL2345	Homo sapiens	Inhibition	%	-0.04
	8174984	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	19.02	CHEMBL2345	Homo sapiens	Inhibition	%	19.02
	8175344	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.08	CHEMBL2345	Homo sapiens	Inhibition	%	2.08
	8175600	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	8.64	CHEMBL2345	Homo sapiens	Inhibition	%	8.64
	8175763	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.39	CHEMBL2345	Homo sapiens	Inhibition	%	1.39
	8175987	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	6.38	CHEMBL2345	Homo sapiens	Inhibition	%	6.38
	8176140	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	43.44	CHEMBL2345	Homo sapiens	Inhibition	%	43.44
	8176289	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.55	CHEMBL2345	Homo sapiens	Inhibition	%	2.55
	8176513	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.82	CHEMBL2345	Homo sapiens	Inhibition	%	2.82
	8176645	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	14.71	CHEMBL2345	Homo sapiens	Inhibition	%	14.71
	8176999	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.85	CHEMBL2345	Homo sapiens	Inhibition	%	3.85
	8177141	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.94	CHEMBL2345	Homo sapiens	Inhibition	%	1.94
	8177365	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.24	CHEMBL2345	Homo sapiens	Inhibition	%	1.24
	8177503	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	44.86	CHEMBL2345	Homo sapiens	Inhibition	%	44.86
	8177667	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.26	CHEMBL2345	Homo sapiens	Inhibition	%	4.26
	8177891	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.7	CHEMBL2345	Homo sapiens	Inhibition	%	1.7
	8178031	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-1.29	CHEMBL2345	Homo sapiens	Inhibition	%	-1.29
	8178343	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.75	CHEMBL2345	Homo sapiens	Inhibition	%	0.75
	8178694	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.27	CHEMBL2345	Homo sapiens	Inhibition	%	1.27
	8178843	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-1.16	CHEMBL2345	Homo sapiens	Inhibition	%	-1.16
	8179190	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-1.01	CHEMBL2345	Homo sapiens	Inhibition	%	-1.01
	8179334	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.2	CHEMBL2345	Homo sapiens	Inhibition	%	2.2
	8179558	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.7	CHEMBL2345	Homo sapiens	Inhibition	%	6.7
	8179695	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.4	CHEMBL2345	Homo sapiens	Inhibition	%	0.4
	8179952	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.58	CHEMBL2345	Homo sapiens	Inhibition	%	1.58
	8180330	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.4	CHEMBL2345	Homo sapiens	Inhibition	%	2.4
	8180486	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	81.41	CHEMBL2345	Homo sapiens	Inhibition	%	81.41
	8180858	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	14.73	CHEMBL2345	Homo sapiens	Inhibition	%	14.73
	8180991	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	0.8	CHEMBL2345	Homo sapiens	Inhibition	%	0.8
	8181215	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.28	CHEMBL2345	Homo sapiens	Inhibition	%	1.28
	8181346	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.49	CHEMBL2345	Homo sapiens	Inhibition	%	1.49
	8181710	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.2	CHEMBL2345	Homo sapiens	Inhibition	%	1.2
	8181849	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	80.09	CHEMBL2345	Homo sapiens	Inhibition	%	80.09
	8182236	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.18	CHEMBL2345	Homo sapiens	Inhibition	%	3.18
	8182376	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.49	CHEMBL2345	Homo sapiens	Inhibition	%	-0.49
	8182600	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-1.74	CHEMBL2345	Homo sapiens	Inhibition	%	-1.74
	8182692	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.6	CHEMBL2345	Homo sapiens	Inhibition	%	1.6
	8183038	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.74	CHEMBL2345	Homo sapiens	Inhibition	%	2.74
	8183187	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.45	CHEMBL2345	Homo sapiens	Inhibition	%	-0.45
	8183411	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.81	CHEMBL2345	Homo sapiens	Inhibition	%	0.81
	8183540	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	2.19	CHEMBL2345	Homo sapiens	Inhibition	%	2.19
	8183906	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.84	CHEMBL2345	Homo sapiens	Inhibition	%	1.84
	8184042	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.24	CHEMBL2345	Homo sapiens	Inhibition	%	0.24
	8184308	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.98	CHEMBL2345	Homo sapiens	Inhibition	%	3.98
	8184679	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.56	CHEMBL2345	Homo sapiens	Inhibition	%	2.56
	8184836	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.37	CHEMBL2345	Homo sapiens	Inhibition	%	0.37
	8185060	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.36	CHEMBL2345	Homo sapiens	Inhibition	%	1.36
	8185209	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.76	CHEMBL2345	Homo sapiens	Inhibition	%	0.76
	8185564	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.14	CHEMBL2345	Homo sapiens	Inhibition	%	2.14
	8185695	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	14.59	CHEMBL2345	Homo sapiens	Inhibition	%	14.59
	8186058	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.07	CHEMBL2345	Homo sapiens	Inhibition	%	0.07
	8186199	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.49	CHEMBL2345	Homo sapiens	Inhibition	%	4.49
	8186423	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.14	CHEMBL2345	Homo sapiens	Inhibition	%	7.14
	8186587	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.95	CHEMBL2345	Homo sapiens	Inhibition	%	0.95
	8186950	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.87	CHEMBL2345	Homo sapiens	Inhibition	%	0.87
	8187048	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.07	CHEMBL2345	Homo sapiens	Inhibition	%	1.07
	8187272	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-0.35	CHEMBL2345	Homo sapiens	Inhibition	%	-0.35
	8187396	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.3	CHEMBL2345	Homo sapiens	Inhibition	%	1.3
	8187768	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.3	CHEMBL2345	Homo sapiens	Inhibition	%	0.3
	8187897	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.4	CHEMBL2345	Homo sapiens	Inhibition	%	5.4
	8188264	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.95	CHEMBL2345	Homo sapiens	Inhibition	%	3.95
	8188399	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.53	CHEMBL2345	Homo sapiens	Inhibition	%	1.53
	8188623	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.98	CHEMBL2345	Homo sapiens	Inhibition	%	0.98
	8188673	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.19	CHEMBL2345	Homo sapiens	Inhibition	%	2.19
	8188897	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.1	CHEMBL2345	Homo sapiens	Inhibition	%	7.1
	8189045	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.95	CHEMBL2345	Homo sapiens	Inhibition	%	0.95
	8189425	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.42	CHEMBL2345	Homo sapiens	Inhibition	%	2.42
	8189574	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.97	CHEMBL2345	Homo sapiens	Inhibition	%	1.97
	8189930	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.87	CHEMBL2345	Homo sapiens	Inhibition	%	3.87
	8190062	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.16	CHEMBL2345	Homo sapiens	Inhibition	%	0.16
	8190286	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.15	CHEMBL2345	Homo sapiens	Inhibition	%	1.15
	8190426	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.46	CHEMBL2345	Homo sapiens	Inhibition	%	1.46
	8190787	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	0.9	CHEMBL2345	Homo sapiens	Inhibition	%	0.9
	8190951	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.69	CHEMBL2345	Homo sapiens	Inhibition	%	1.69
	8191313	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.03	CHEMBL2345	Homo sapiens	Inhibition	%	2.03
	8191633	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.02	CHEMBL2345	Homo sapiens	Inhibition	%	-0.02
	8191755	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.1	CHEMBL2345	Homo sapiens	Inhibition	%	1.1
	8191979	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.88	CHEMBL2345	Homo sapiens	Inhibition	%	0.88
	8192128	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-0.37	CHEMBL2345	Homo sapiens	Inhibition	%	-0.37
	8192257	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.12	CHEMBL2345	Homo sapiens	Inhibition	%	2.12
	8192481	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.75	CHEMBL2345	Homo sapiens	Inhibition	%	5.75
	8192625	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.14	CHEMBL2345	Homo sapiens	Inhibition	%	2.14
	8192985	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.09	CHEMBL2345	Homo sapiens	Inhibition	%	-0.09
	8193257	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.17	CHEMBL2345	Homo sapiens	Inhibition	%	0.17
	8193402	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.27	CHEMBL2345	Homo sapiens	Inhibition	%	1.27
	8193626	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.95	CHEMBL2345	Homo sapiens	Inhibition	%	0.95
	8193783	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	15.16	CHEMBL2345	Homo sapiens	Inhibition	%	15.16
	8193932	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.44	CHEMBL2345	Homo sapiens	Inhibition	%	0.44
	8194156	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	4.5	CHEMBL2345	Homo sapiens	Inhibition	%	4.5
	8194287	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.52	CHEMBL2345	Homo sapiens	Inhibition	%	1.52
	8194642	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.23	CHEMBL2345	Homo sapiens	Inhibition	%	2.23
	8194785	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.47	CHEMBL2345	Homo sapiens	Inhibition	%	1.47
	8195142	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.09	CHEMBL2345	Homo sapiens	Inhibition	%	3.09
	8195306	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	0.85	CHEMBL2345	Homo sapiens	Inhibition	%	0.85
	8195530	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.32	CHEMBL2345	Homo sapiens	Inhibition	%	6.32
	8195669	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.79	CHEMBL2345	Homo sapiens	Inhibition	%	0.79
	8195991	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.71	CHEMBL2345	Homo sapiens	Inhibition	%	2.71
	8196332	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.69	CHEMBL2345	Homo sapiens	Inhibition	%	2.69
	8196482	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.24	CHEMBL2345	Homo sapiens	Inhibition	%	0.24
	8196834	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.71	CHEMBL2345	Homo sapiens	Inhibition	%	3.71
	8196975	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.84	CHEMBL2345	Homo sapiens	Inhibition	%	3.84
	8197199	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.24	CHEMBL2345	Homo sapiens	Inhibition	%	-0.24
	8197336	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-1.49	CHEMBL2345	Homo sapiens	Inhibition	%	-1.49
	8197611	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.79	CHEMBL2345	Homo sapiens	Inhibition	%	1.79
	8197975	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	7.69	CHEMBL2345	Homo sapiens	Inhibition	%	7.69
	8198132	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.5	CHEMBL2345	Homo sapiens	Inhibition	%	1.5
	8198494	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.81	CHEMBL2345	Homo sapiens	Inhibition	%	0.81
	8198624	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.02	CHEMBL2345	Homo sapiens	Inhibition	%	3.02
	8198848	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.84	CHEMBL2345	Homo sapiens	Inhibition	%	2.84
	8198979	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.24	CHEMBL2345	Homo sapiens	Inhibition	%	1.24
	8199127	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.23	CHEMBL2345	Homo sapiens	Inhibition	%	2.23
	8199351	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.55	CHEMBL2345	Homo sapiens	Inhibition	%	2.55
	8199485	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.92	CHEMBL2345	Homo sapiens	Inhibition	%	1.92
	8199872	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.52	CHEMBL2345	Homo sapiens	Inhibition	%	1.52
	8200010	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.24	CHEMBL2345	Homo sapiens	Inhibition	%	0.24
	8200338	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.47	CHEMBL2345	Homo sapiens	Inhibition	%	0.47
	8200677	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.74	CHEMBL2345	Homo sapiens	Inhibition	%	2.74
	8200827	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.63	CHEMBL2345	Homo sapiens	Inhibition	%	0.63
	8201051	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.87	CHEMBL2345	Homo sapiens	Inhibition	%	0.87
	8201181	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	11.85	CHEMBL2345	Homo sapiens	Inhibition	%	11.85
	8201540	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.92	CHEMBL2345	Homo sapiens	Inhibition	%	0.92
	8201673	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.38	CHEMBL2345	Homo sapiens	Inhibition	%	-0.38
	8201952	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.34	CHEMBL2345	Homo sapiens	Inhibition	%	1.34
	8202316	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.26	CHEMBL2345	Homo sapiens	Inhibition	%	-0.26
	8202483	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.71	CHEMBL2345	Homo sapiens	Inhibition	%	1.71
	8202832	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.36	CHEMBL2345	Homo sapiens	Inhibition	%	3.36
	8203186	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	12.1	CHEMBL2345	Homo sapiens	Inhibition	%	12.1
	8203317	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.97	CHEMBL2345	Homo sapiens	Inhibition	%	1.97
	8203687	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.98	CHEMBL2345	Homo sapiens	Inhibition	%	0.98
	8203821	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.01	CHEMBL2345	Homo sapiens	Inhibition	%	4.01
	8204045	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.84	CHEMBL2345	Homo sapiens	Inhibition	%	1.84
	8204211	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.88	CHEMBL2345	Homo sapiens	Inhibition	%	1.88
	8204348	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.48	CHEMBL2345	Homo sapiens	Inhibition	%	0.48
	8204572	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	-0.99	CHEMBL2345	Homo sapiens	Inhibition	%	-0.99
	8204677	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.89	CHEMBL2345	Homo sapiens	Inhibition	%	1.89
	8205016	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	11.69	CHEMBL2345	Homo sapiens	Inhibition	%	11.69
	8205389	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.33	CHEMBL2345	Homo sapiens	Inhibition	%	6.33
	8205525	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.74	CHEMBL2345	Homo sapiens	Inhibition	%	3.74
	8205888	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.73	CHEMBL2345	Homo sapiens	Inhibition	%	0.73
	8206020	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.28	CHEMBL2345	Homo sapiens	Inhibition	%	-0.28
	8206244	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.78	CHEMBL2345	Homo sapiens	Inhibition	%	-0.78
	8206296	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.93	CHEMBL2345	Homo sapiens	Inhibition	%	1.93
	8206520	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.0	CHEMBL2345	Homo sapiens	Inhibition	%	2.0
	8206663	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.6	CHEMBL2345	Homo sapiens	Inhibition	%	1.6
	8206843	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.45	CHEMBL2345	Homo sapiens	Inhibition	%	1.45
	8207067	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.61	CHEMBL2345	Homo sapiens	Inhibition	%	6.61
	8207193	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.82	CHEMBL2345	Homo sapiens	Inhibition	%	1.82
	8207547	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	10.35	CHEMBL2345	Homo sapiens	Inhibition	%	10.35
	8207679	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.86	CHEMBL2345	Homo sapiens	Inhibition	%	3.86
	8207903	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.82	CHEMBL2345	Homo sapiens	Inhibition	%	0.82
	8208048	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.86	CHEMBL2345	Homo sapiens	Inhibition	%	2.86
	8208404	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.06	CHEMBL2345	Homo sapiens	Inhibition	%	4.06
	8208570	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.4	CHEMBL2345	Homo sapiens	Inhibition	%	2.4
	8208927	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	46.06	CHEMBL2345	Homo sapiens	Inhibition	%	46.06
	8209032	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.3	CHEMBL2345	Homo sapiens	Inhibition	%	0.3
	8209256	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.84	CHEMBL2345	Homo sapiens	Inhibition	%	0.84
	8209372	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.06	CHEMBL2345	Homo sapiens	Inhibition	%	0.06
	8209746	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.4	CHEMBL2345	Homo sapiens	Inhibition	%	0.4
	8209882	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	17.12	CHEMBL2345	Homo sapiens	Inhibition	%	17.12
	8210106	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.39	CHEMBL2345	Homo sapiens	Inhibition	%	3.39
	8210247	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.14	CHEMBL2345	Homo sapiens	Inhibition	%	1.14
	8210607	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.3	CHEMBL2345	Homo sapiens	Inhibition	%	-0.3
	8210866	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.89	CHEMBL2345	Homo sapiens	Inhibition	%	2.89
	8211010	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.27	CHEMBL2345	Homo sapiens	Inhibition	%	0.27
	8211404	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.96	CHEMBL2345	Homo sapiens	Inhibition	%	0.96
	8211527	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.8	CHEMBL2345	Homo sapiens	Inhibition	%	4.8
	8211751	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.71	CHEMBL2345	Homo sapiens	Inhibition	%	2.71
	8211880	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	44.75	CHEMBL2345	Homo sapiens	Inhibition	%	44.75
	8212236	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.13	CHEMBL2345	Homo sapiens	Inhibition	%	2.13
	8212377	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.78	CHEMBL2345	Homo sapiens	Inhibition	%	4.78
	8212734	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.25	CHEMBL2345	Homo sapiens	Inhibition	%	1.25
	8212904	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	21.29	CHEMBL2345	Homo sapiens	Inhibition	%	21.29
	8213128	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.81	CHEMBL2345	Homo sapiens	Inhibition	%	0.81
	8213257	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	79.01	CHEMBL2345	Homo sapiens	Inhibition	%	79.01
	8213585	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.11	CHEMBL2345	Homo sapiens	Inhibition	%	-1.11
	8213698	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.07	CHEMBL2345	Homo sapiens	Inhibition	%	1.07
	8213922	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.07	CHEMBL2345	Homo sapiens	Inhibition	%	1.07
	8214069	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.28	CHEMBL2345	Homo sapiens	Inhibition	%	1.28
	8214430	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	16.35	CHEMBL2345	Homo sapiens	Inhibition	%	16.35
	8214564	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.82	CHEMBL2345	Homo sapiens	Inhibition	%	1.82
	8214940	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.55	CHEMBL2345	Homo sapiens	Inhibition	%	0.55
	8215191	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.92	CHEMBL2345	Homo sapiens	Inhibition	%	1.92
	8215344	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.3	CHEMBL2345	Homo sapiens	Inhibition	%	1.3
	8215568	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.05	CHEMBL2345	Homo sapiens	Inhibition	%	1.05
	8215732	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.89	CHEMBL2345	Homo sapiens	Inhibition	%	0.89
	8216075	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	7.3	CHEMBL2345	Homo sapiens	Inhibition	%	7.3
	8216194	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.56	CHEMBL2345	Homo sapiens	Inhibition	%	0.56
	8216554	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.82	CHEMBL2345	Homo sapiens	Inhibition	%	4.82
	8216692	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	9.26	CHEMBL2345	Homo sapiens	Inhibition	%	9.26
	8216916	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	47.05	CHEMBL2345	Homo sapiens	Inhibition	%	47.05
	8217050	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.76	CHEMBL2345	Homo sapiens	Inhibition	%	1.76
	8217448	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.91	CHEMBL2345	Homo sapiens	Inhibition	%	1.91
	8217579	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.02	CHEMBL2345	Homo sapiens	Inhibition	%	5.02
	8217904	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.86	CHEMBL2345	Homo sapiens	Inhibition	%	-1.86
	8218243	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.0	CHEMBL2345	Homo sapiens	Inhibition	%	2.0
	8218370	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.89	CHEMBL2345	Homo sapiens	Inhibition	%	0.89
	8218737	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.28	CHEMBL2345	Homo sapiens	Inhibition	%	4.28
	8218868	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.23	CHEMBL2345	Homo sapiens	Inhibition	%	2.23
	8219092	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	0.81	CHEMBL2345	Homo sapiens	Inhibition	%	0.81
	8219252	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.57	CHEMBL2345	Homo sapiens	Inhibition	%	0.57
	8219502	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.6	CHEMBL2345	Homo sapiens	Inhibition	%	2.6
	8219887	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.66	CHEMBL2345	Homo sapiens	Inhibition	%	1.66
	8220056	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.38	CHEMBL2345	Homo sapiens	Inhibition	%	1.38
	8220409	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.6	CHEMBL2345	Homo sapiens	Inhibition	%	1.6
	8220523	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.48	CHEMBL2345	Homo sapiens	Inhibition	%	2.48
	8220747	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	22.33	CHEMBL2345	Homo sapiens	Inhibition	%	22.33
	8220885	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	27.03	CHEMBL2345	Homo sapiens	Inhibition	%	27.03
	8221245	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	75.83	CHEMBL2345	Homo sapiens	Inhibition	%	75.83
	8221378	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.18	CHEMBL2345	Homo sapiens	Inhibition	%	2.18
	8221602	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	11.56	CHEMBL2345	Homo sapiens	Inhibition	%	11.56
	8221767	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.34	CHEMBL2345	Homo sapiens	Inhibition	%	0.34
	8221898	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	13.72	CHEMBL2345	Homo sapiens	Inhibition	%	13.72
	8222122	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.4	CHEMBL2345	Homo sapiens	Inhibition	%	0.4
	8222220	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.27	CHEMBL2345	Homo sapiens	Inhibition	%	1.27
	8222578	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.17	CHEMBL2345	Homo sapiens	Inhibition	%	1.17
	8222696	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	5.65	CHEMBL2345	Homo sapiens	Inhibition	%	5.65
	8222920	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.64	CHEMBL2345	Homo sapiens	Inhibition	%	1.64
	8223064	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	34.36	CHEMBL2345	Homo sapiens	Inhibition	%	34.36
	8223417	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.47	CHEMBL2345	Homo sapiens	Inhibition	%	1.47
	8223578	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.78	CHEMBL2345	Homo sapiens	Inhibition	%	0.78
	8223828	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.66	CHEMBL2345	Homo sapiens	Inhibition	%	4.66
	8224052	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	9.83	CHEMBL2345	Homo sapiens	Inhibition	%	9.83
	8224214	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.42	CHEMBL2345	Homo sapiens	Inhibition	%	2.42
	8224384	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.81	CHEMBL2345	Homo sapiens	Inhibition	%	1.81
	8224608	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.31	CHEMBL2345	Homo sapiens	Inhibition	%	0.31
	8224743	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.98	CHEMBL2345	Homo sapiens	Inhibition	%	1.98
	8225081	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	65.47	CHEMBL2345	Homo sapiens	Inhibition	%	65.47
	8225215	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.14	CHEMBL2345	Homo sapiens	Inhibition	%	2.14
	8225439	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.36	CHEMBL2345	Homo sapiens	Inhibition	%	6.36
	8225577	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.41	CHEMBL2345	Homo sapiens	Inhibition	%	4.41
	8225936	CHEMBL1961930	GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.56	CHEMBL2345	Homo sapiens	Inhibition	%	1.56
	8226094	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.05	CHEMBL2345	Homo sapiens	Inhibition	%	1.05
	8226443	CHEMBL1961931	GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.81	CHEMBL2345	Homo sapiens	Inhibition	%	0.81
active	9544711	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9544712	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9544713	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9544714	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9544715	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544716	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9544717	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9544718	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	25.12	CHEMBL2345	Homo sapiens	pKi		7.6
active	9544719	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9544720	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1980435	<	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9544721	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544722	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9544723	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9544724	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544725	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544726	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544727	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	5.012	CHEMBL2345	Homo sapiens	pKi		8.3
inactive	9544728	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544729	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9544730	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9544731	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	5.012	CHEMBL2345	Homo sapiens	pKi		8.3
inactive	9544732	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9544733	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544734	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
inactive	9544735	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544736	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544737	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	31622.78	CHEMBL2345	Homo sapiens	pKi		4.5
active	9544738	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9544739	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544740	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9544741	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
active	9544742	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9544743	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544744	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544745	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9544746	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9544747	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
active	9544748	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
active	9544749	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9544750	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544751	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9544752	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544753	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544754	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9544755	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9544756	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544757	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9544758	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
inactive	9544759	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544760	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9544761	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
active	9544762	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9544763	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544764	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9544765	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544766	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
active	9544767	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
inactive	9544768	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9544769	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
inactive	9544770	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9544771	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
inactive	9544772	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544773	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9544774	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9544775	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	25118.86	CHEMBL2345	Homo sapiens	pKi		4.6
inactive	9544776	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544777	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9544778	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9544779	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544780	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9544781	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544782	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544783	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544784	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9544785	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9544786	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9544787	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	50.12	CHEMBL2345	Homo sapiens	pKi		7.3
inactive	9544788	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544789	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9544790	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9544791	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544792	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9544793	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
active	9544794	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
active	9544795	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
active	9544796	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9544797	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9544798	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544799	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9544800	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
active	9544801	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9544802	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9544803	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9544804	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544805	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544806	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9544807	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548704	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9548705	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9548706	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548707	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548708	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
inactive	9548709	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548710	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9548711	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548712	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548713	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9548714	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548715	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548716	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548717	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
inactive	9548718	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548719	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9548720	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9548721	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
inactive	9548722	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548723	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9548724	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9548725	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9548726	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548727	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
inactive	9548728	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548729	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9548730	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9548731	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	19952.62	CHEMBL2345	Homo sapiens	pKi		4.7
inactive	9548732	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548733	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9548734	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
active	9548735	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9548736	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9548737	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9548738	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548739	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
inactive	9548740	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548741	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548742	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9548743	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9548744	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	15.85	CHEMBL2345	Homo sapiens	pKi		7.8
inactive	9548745	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548746	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
active	9548747	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	12.59	CHEMBL2345	Homo sapiens	pKi		7.9
active	9548748	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9548749	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548750	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548751	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548752	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548753	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
active	9548754	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	=	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548755	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9548756	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
active	9548757	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ccc2[nH]c(=O)cnc2c1		CHEMBL2002635	=	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548758	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9548759	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
active	9548760	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9548761	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548762	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548763	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548764	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548765	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9548766	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9548767	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9548768	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548769	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548770	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548771	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1		CHEMBL1990635	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9548772	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548773	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548774	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548775	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548776	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548777	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548778	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548779	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nccc2nc(-c3ccccc3)cn12		CHEMBL2004887	=	Ki	nM	50118.72	CHEMBL2345	Homo sapiens	pKi		4.3
active	9548780	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
inactive	9548781	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548782	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548783	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548784	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548785	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548786	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9548787	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548788	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9548789	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9548790	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548791	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548792	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9548793	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548794	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548795	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9548796	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9548797	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9548798	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548799	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9548800	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548801	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548802	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548803	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	19952.62	CHEMBL2345	Homo sapiens	pKi		4.7
inactive	9548804	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548805	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548806	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548807	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548808	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548809	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548810	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9548811	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548812	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548813	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9548814	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548815	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548816	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
active	9548817	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9548818	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
inactive	9548819	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9548820	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9548821	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9548822	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
active	9548823	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9548824	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548825	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548826	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548827	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9548828	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548829	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548830	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548831	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548832	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9548833	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9548834	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9548835	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548836	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548837	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548838	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9548839	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548840	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	79.43	CHEMBL2345	Homo sapiens	pKi		7.1
active	9548841	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	31622.78	CHEMBL2345	Homo sapiens	pKi		4.5
active	9548842	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
active	9548843	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
inactive	9548844	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548845	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548846	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9548847	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548848	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548849	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9548850	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548851	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	25118.86	CHEMBL2345	Homo sapiens	pKi		4.6
inactive	9548852	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9548853	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9548854	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9548855	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9548856	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O		CHEMBL260933	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9548857	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9548858	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9548859	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548860	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548861	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548862	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548863	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548864	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548865	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548866	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
active	9548867	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
active	9548868	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9548869	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9548870	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9548871	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548872	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548873	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9548874	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548875	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9548876	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548877	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	25118.86	CHEMBL2345	Homo sapiens	pKi		4.6
active	9548878	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	50.12	CHEMBL2345	Homo sapiens	pKi		7.3
active	9548879	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9548880	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9548881	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548882	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548883	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548884	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9548885	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548886	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9548887	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548888	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548889	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548890	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548891	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	1.585	CHEMBL2345	Homo sapiens	pKi		8.8
active	9548892	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	10.0	CHEMBL2345	Homo sapiens	pKi		8.0
active	9548893	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9548894	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548895	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9548896	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548897	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9548898	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548899	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548900	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548901	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9548902	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9548903	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	50118.72	CHEMBL2345	Homo sapiens	pKi		4.3
inactive	9548904	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548905	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9548906	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548907	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548908	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548909	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548910	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548911	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
active	9548912	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
inactive	9548913	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548914	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548915	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
inactive	9548916	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548917	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9548918	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548919	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548920	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548921	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	31622.78	CHEMBL2345	Homo sapiens	pKi		4.5
inactive	9548922	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548923	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548924	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9548925	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548926	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548927	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548928	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548929	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9548930	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548931	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548932	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
inactive	9548933	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548934	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548935	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9548936	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9548937	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
active	9548938	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
active	9548939	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
inactive	9548940	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9548941	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9548942	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9552838	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9552839	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
inactive	9552840	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552841	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552842	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9552843	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	<	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9552844	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
inactive	9552845	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552846	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
active	9552847	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9552848	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552849	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552850	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9552851	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552852	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552853	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
active	9552854	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	63095.73	CHEMBL2345	Homo sapiens	pKi		4.2
inactive	9552855	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552856	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552857	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552858	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
inactive	9552859	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552860	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552861	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552862	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9552863	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552864	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552865	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9552866	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552867	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	1.0	CHEMBL2345	Homo sapiens	pKi		9.0
inactive	9552868	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552869	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9552870	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	39810.72	CHEMBL2345	Homo sapiens	pKi		4.4
active	9552871	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9552872	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552873	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552874	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552875	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552876	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9552877	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552878	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	7.943	CHEMBL2345	Homo sapiens	pKi		8.1
inactive	9552879	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552880	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9552881	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552882	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552883	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552884	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9552885	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9552886	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9552887	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9552888	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9552889	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552890	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552891	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
inactive	9552892	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552893	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552894	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
active	9552895	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9552896	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552897	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9552898	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552899	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	10.0	CHEMBL2345	Homo sapiens	pKi		8.0
inactive	9552900	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552901	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552902	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	39.81	CHEMBL2345	Homo sapiens	pKi		7.4
active	9552903	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9552904	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9552905	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552906	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552907	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552908	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9552909	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552910	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552911	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9552912	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9552913	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552914	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552915	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	39810.72	CHEMBL2345	Homo sapiens	pKi		4.4
active	9552916	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
active	9552917	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	31622.78	CHEMBL2345	Homo sapiens	pKi		4.5
active	9552918	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
inactive	9552919	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552920	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
inactive	9552921	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552922	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552923	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552924	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552925	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	=	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552926	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	50.12	CHEMBL2345	Homo sapiens	pKi		7.3
inactive	9552927	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552928	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
inactive	9552929	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552930	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552931	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552932	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9552933	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552934	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552935	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9552936	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552937	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
active	9552938	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9552939	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552940	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552941	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552942	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
inactive	9552943	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552944	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552945	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9552946	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552947	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	7.943	CHEMBL2345	Homo sapiens	pKi		8.1
active	9552948	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
active	9552949	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9552950	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9552951	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9552952	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	63.1	CHEMBL2345	Homo sapiens	pKi		7.2
inactive	9552953	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552954	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	63095.73	CHEMBL2345	Homo sapiens	pKi		4.2
active	9552955	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9552956	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552957	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9552958	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9552959	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552960	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9552961	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9552962	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552963	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552964	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552965	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
inactive	9552966	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552967	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552968	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552969	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	<	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9552970	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552971	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552972	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552973	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9552974	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552975	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9552976	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
inactive	9552977	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9552978	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9552979	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552980	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552981	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9552982	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9552983	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552984	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9552985	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
inactive	9552986	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9552987	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9552988	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
active	9552989	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9552990	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9552991	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9552992	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552993	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	=	Ki	nM	39.81	CHEMBL2345	Homo sapiens	pKi		7.4
inactive	9552994	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9552995	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
active	9552996	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
inactive	9552997	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9552998	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9552999	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9553000	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9553001	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9553002	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9553003	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553004	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553005	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9553006	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9553007	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9553008	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9553009	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9553010	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553011	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9553012	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9553013	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9553014	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9553015	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9553016	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
inactive	9553017	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553018	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
active	9553019	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
active	9553020	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
inactive	9553021	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553022	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9553023	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	10.0	CHEMBL2345	Homo sapiens	pKi		8.0
active	9553024	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
inactive	9553025	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553026	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553027	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9553028	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553029	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9553030	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553031	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9553032	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9553033	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9553034	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553035	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553036	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
inactive	9553037	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553038	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553039	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
active	9553040	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9553041	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9553042	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553043	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553044	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553045	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	39810.72	CHEMBL2345	Homo sapiens	pKi		4.4
active	9553046	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9553047	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553048	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	50.12	CHEMBL2345	Homo sapiens	pKi		7.3
active	9553049	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	50118.72	CHEMBL2345	Homo sapiens	pKi		4.3
inactive	9553050	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9553051	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553052	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553053	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9553054	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	31.62	CHEMBL2345	Homo sapiens	pKi		7.5
active	9553055	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9553056	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9553057	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9553058	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
inactive	9553059	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553060	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553061	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
inactive	9553062	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553063	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9553064	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9553065	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553066	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553067	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9553068	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9553069	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9553070	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553071	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553072	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9553073	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9553074	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9553075	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9553076	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9553077	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9556985	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9556986	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9556987	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
active	9556988	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
active	9556989	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9556990	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9556991	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9556992	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9556993	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	7.943	CHEMBL2345	Homo sapiens	pKi		8.1
active	9556994	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9556995	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9556996	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9556997	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9556998	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9556999	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9557000	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
active	9557001	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9557002	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557003	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	12.59	CHEMBL2345	Homo sapiens	pKi		7.9
active	9557004	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9557005	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557006	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9557007	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	39.81	CHEMBL2345	Homo sapiens	pKi		7.4
active	9557008	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
active	9557009	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
inactive	9557010	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557011	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557012	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557013	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557014	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557015	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557016	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557017	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557018	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557019	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557020	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9557021	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557022	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
active	9557023	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9557024	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc2c(=O)[nH]cnc2c1		CHEMBL1949851	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9557025	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557026	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9557027	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557028	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	79.43	CHEMBL2345	Homo sapiens	pKi		7.1
active	9557029	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9557030	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	10000.0	CHEMBL2345	Homo sapiens	pKi		5.0
inactive	9557031	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557032	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9557033	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9557034	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9557035	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9557036	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
inactive	9557037	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557038	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9557039	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	=	Ki	nM	25.12	CHEMBL2345	Homo sapiens	pKi		7.6
inactive	9557040	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557041	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9557042	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9557043	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9557044	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9557045	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557046	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9557047	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557048	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9557049	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557050	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	<	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9557051	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557052	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557053	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9557054	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557055	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1		CHEMBL365617	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557056	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557057	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557058	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557059	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557060	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557061	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9557062	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9557063	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557064	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	39810.72	CHEMBL2345	Homo sapiens	pKi		4.4
active	9557065	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
inactive	9557066	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557067	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557068	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557069	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557070	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9557071	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9557072	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557073	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	63.1	CHEMBL2345	Homo sapiens	pKi		7.2
inactive	9557074	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557075	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9557076	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557077	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9557078	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557079	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9557080	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9557081	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557082	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557083	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557084	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557085	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9557086	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9557087	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557088	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557089	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557090	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9557091	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
inactive	9557092	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557093	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557094	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557095	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9557096	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9557097	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557098	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9557099	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
inactive	9557100	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557101	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9557102	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9557103	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557104	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557105	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557106	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557107	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557108	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9557109	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	15.85	CHEMBL2345	Homo sapiens	pKi		7.8
inactive	9557110	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557111	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
inactive	9557112	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557113	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9557114	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	7.943	CHEMBL2345	Homo sapiens	pKi		8.1
inactive	9557115	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557116	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	39810.72	CHEMBL2345	Homo sapiens	pKi		4.4
active	9557117	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	12.59	CHEMBL2345	Homo sapiens	pKi		7.9
inactive	9557118	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557119	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557120	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9557121	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9557122	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557123	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557124	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9557125	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557126	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557127	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557128	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557129	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557130	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557131	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557132	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9557133	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
inactive	9557134	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557135	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9557136	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557137	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	=	Ki	nM	50.12	CHEMBL2345	Homo sapiens	pKi		7.3
active	9557138	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9557139	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557140	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557141	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557142	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557143	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557144	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557145	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557146	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557147	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557148	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557149	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557150	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
active	9557151	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
inactive	9557152	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557153	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557154	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557155	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	12.59	CHEMBL2345	Homo sapiens	pKi		7.9
inactive	9557156	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557157	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557158	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557159	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557160	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557161	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9557162	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557163	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557164	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557165	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557166	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557167	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
active	9557168	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9557169	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9557170	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557171	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	31622.78	CHEMBL2345	Homo sapiens	pKi		4.5
inactive	9557172	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557173	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
active	9557174	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557175	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557176	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557177	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557178	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
active	9557179	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557180	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557181	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	=	Ki	nM	100000.0	CHEMBL2345	Homo sapiens	pKi		4.0
inactive	9557182	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557183	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557184	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
inactive	9557185	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557186	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557187	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557188	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557189	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557190	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9557191	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557192	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
inactive	9557193	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557194	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557195	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557196	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9557197	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9557198	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557199	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9557200	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557201	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9557202	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557203	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557204	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9557205	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557206	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9557207	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557208	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557209	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	19952.62	CHEMBL2345	Homo sapiens	pKi		4.7
inactive	9557210	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9557211	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
active	9557212	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
inactive	9557213	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557214	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557215	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9557216	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557217	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9557218	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557219	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9557220	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557221	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9557222	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9557223	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
inactive	9561135	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	19952.62	CHEMBL2345	Homo sapiens	pKi		4.7
active	9561136	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9561137	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561138	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561139	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9561140	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561141	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561142	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561143	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561144	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
inactive	9561145	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561146	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561147	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561148	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	39810.72	CHEMBL2345	Homo sapiens	pKi		4.4
active	9561149	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561150	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561151	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561152	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561153	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561154	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561155	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9561156	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
active	9561157	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9561158	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
active	9561159	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	5.012	CHEMBL2345	Homo sapiens	pKi		8.3
inactive	9561160	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561161	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1C(=O)NCCN2		CHEMBL1992607	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
inactive	9561162	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561163	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561164	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561165	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561166	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9561167	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9561168	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	<	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9561169	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561170	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	=	Ki	nM	39.81	CHEMBL2345	Homo sapiens	pKi		7.4
inactive	9561171	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561172	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561173	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561174	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9561175	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561176	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561177	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9561178	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561179	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561180	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561181	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561182	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9561183	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561184	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9561185	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
inactive	9561186	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561187	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561188	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
active	9561189	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9561190	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561191	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	100.0	CHEMBL2345	Homo sapiens	pKi		7.0
active	9561192	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	125.89	CHEMBL2345	Homo sapiens	pKi		6.9
inactive	9561193	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561194	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561195	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561196	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	15.85	CHEMBL2345	Homo sapiens	pKi		7.8
active	9561197	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
active	9561198	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
inactive	9561199	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561200	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561201	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
inactive	9561202	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561203	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561204	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	2.512	CHEMBL2345	Homo sapiens	pKi		8.6
active	9561205	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	251.19	CHEMBL2345	Homo sapiens	pKi		6.6
inactive	9561206	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9561207	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	15.85	CHEMBL2345	Homo sapiens	pKi		7.8
inactive	9561208	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561209	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
inactive	9561210	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561211	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	63095.73	CHEMBL2345	Homo sapiens	pKi		4.2
inactive	9561212	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561213	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
inactive	9561214	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561215	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561216	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
inactive	9561217	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561218	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561219	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561220	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
active	9561221	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
inactive	9561222	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561223	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561224	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561225	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561226	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561227	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	39810.72	CHEMBL2345	Homo sapiens	pKi		4.4
active	9561228	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9561229	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561230	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9561231	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9561232	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561233	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	316.23	CHEMBL2345	Homo sapiens	pKi		6.5
active	9561234	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	=	Ki	nM	19.95	CHEMBL2345	Homo sapiens	pKi		7.7
inactive	9561235	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561236	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561237	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	=	Ki	nM	79432.82	CHEMBL2345	Homo sapiens	pKi		4.1
inactive	9561238	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561239	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561240	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561241	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561242	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)c1c(NC(=O)C2C(C)(C)C2(C)C)sc2cnccc12		CHEMBL1990541	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9561243	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561244	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561245	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9561246	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561247	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561248	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	=	Ki	nM	63095.73	CHEMBL2345	Homo sapiens	pKi		4.2
active	9561249	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9561250	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561251	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561252	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561253	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561254	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
inactive	9561255	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561256	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
inactive	9561257	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561258	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9561259	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561260	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561261	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	=	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561262	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561263	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561264	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]nc2c(-c3ccccc3)cccn12		CHEMBL2002182	=	Ki	nM	39810.72	CHEMBL2345	Homo sapiens	pKi		4.4
active	9561265	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9561266	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	=	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561267	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9561268	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561269	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561270	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561271	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	25.12	CHEMBL2345	Homo sapiens	pKi		7.6
inactive	9561272	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561273	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561274	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561275	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561276	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561277	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	=	Ki	nM	794.33	CHEMBL2345	Homo sapiens	pKi		6.1
inactive	9561278	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561279	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561280	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561281	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	=	Ki	nM	398.11	CHEMBL2345	Homo sapiens	pKi		6.4
active	9561282	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	12589.25	CHEMBL2345	Homo sapiens	pKi		4.9
active	9561283	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	1995.26	CHEMBL2345	Homo sapiens	pKi		5.7
active	9561284	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9561285	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561286	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561287	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561288	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561289	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561290	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
inactive	9561291	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561292	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561293	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561294	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9561295	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561296	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561297	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
inactive	9561298	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561299	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	199.53	CHEMBL2345	Homo sapiens	pKi		6.7
active	9561300	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561301	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561302	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561303	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9561304	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9561305	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9561306	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561307	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561308	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561309	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
inactive	9561310	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561311	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	1000.0	CHEMBL2345	Homo sapiens	pKi		6.0
active	9561312	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	39.81	CHEMBL2345	Homo sapiens	pKi		7.4
inactive	9561313	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561314	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561315	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
inactive	9561316	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561317	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561318	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
inactive	9561319	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561320	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	=	Ki	nM	3162.28	CHEMBL2345	Homo sapiens	pKi		5.5
active	9561321	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
active	9561322	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	501.19	CHEMBL2345	Homo sapiens	pKi		6.3
active	9561323	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	630.96	CHEMBL2345	Homo sapiens	pKi		6.2
active	9561324	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	2511.89	CHEMBL2345	Homo sapiens	pKi		5.6
inactive	9561325	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	3981.07	CHEMBL2345	Homo sapiens	pKi		5.4
active	9561326	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	=	Ki	nM	1258.93	CHEMBL2345	Homo sapiens	pKi		5.9
inactive	9561327	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561328	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	1584.89	CHEMBL2345	Homo sapiens	pKi		5.8
inactive	9561329	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	5011.87	CHEMBL2345	Homo sapiens	pKi		5.3
active	9561330	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	6309.57	CHEMBL2345	Homo sapiens	pKi		5.2
active	9561331	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	10.0	CHEMBL2345	Homo sapiens	pKi		8.0
inactive	9561332	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
inactive	9561333	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
active	9561334	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	158.49	CHEMBL2345	Homo sapiens	pKi		6.8
inactive	9561335	CHEMBL1963690	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	7943.28	CHEMBL2345	Homo sapiens	pKi		5.1
	10839479	CHEMBL2015510	Inhibition of RSK2 N-terminal at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	28.0	CHEMBL2345	Homo sapiens	INH	%	28.0
	10839595	CHEMBL2014657	Inhibition of RSK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	24.0	CHEMBL2345	Homo sapiens	Activity	%	24.0
	10839639	CHEMBL2015807	Inhibition of RSK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	15.0	CHEMBL2345	Homo sapiens	Activity	%	15.0
	10840576	CHEMBL2014738	Inhibition of Rsk2	B	CCc1n[nH]c2ncnc(N3CCN(c4cc(Cl)cc(NCCN(C)C)c4C)CC3)c12		CHEMBL2012701	=	IC50	nM	68.0	CHEMBL2345	Homo sapiens	IC50	nM	68.0
	10840577	CHEMBL2014738	Inhibition of Rsk2	B	Cc1c(NCCN(C)C)cc(Cl)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL2012702	=	IC50	nM	248.0	CHEMBL2345	Homo sapiens	IC50	nM	248.0
	10840578	CHEMBL2014738	Inhibition of Rsk2	B	Cc1c(NCCN(C)C)cc(Cl)cc1N1CCN(c2ncnc3[nH]nc(C(F)(F)F)c23)CC1		CHEMBL2012703	=	IC50	nM	24.0	CHEMBL2345	Homo sapiens	IC50	nM	24.0
	10849728	CHEMBL2019687	Inhibition of RPS6KA3	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL2345	Homo sapiens	IC50	uM	40.0
	10860728	CHEMBL2020792	Inhibition of His-tagged RSK2 expressed in Sf9 cells using ERalpha-Ser167 RLASTND as substrate after 120 mins by chemiluminescence assay	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	IC50	nM	583.0	CHEMBL2345	Homo sapiens	IC50	uM	0.583
	10860729	CHEMBL2020792	Inhibition of His-tagged RSK2 expressed in Sf9 cells using ERalpha-Ser167 RLASTND as substrate after 120 mins by chemiluminescence assay	B	CC(=O)CO[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OCC(C)=O		CHEMBL2017518	=	IC50	nM	252.0	CHEMBL2345	Homo sapiens	IC50	uM	0.252
	10860730	CHEMBL2020792	Inhibition of His-tagged RSK2 expressed in Sf9 cells using ERalpha-Ser167 RLASTND as substrate after 120 mins by chemiluminescence assay	B	CCNC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(=O)NCC		CHEMBL2017517	=	IC50	nM	1130.0	CHEMBL2345	Homo sapiens	IC50	uM	1.13
	10860731	CHEMBL2020792	Inhibition of His-tagged RSK2 expressed in Sf9 cells using ERalpha-Ser167 RLASTND as substrate after 120 mins by chemiluminescence assay	B	CCCNC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(=O)NCCC		CHEMBL2017519	=	IC50	nM	869.0	CHEMBL2345	Homo sapiens	IC50	uM	0.869
	10860732	CHEMBL2020792	Inhibition of His-tagged RSK2 expressed in Sf9 cells using ERalpha-Ser167 RLASTND as substrate after 120 mins by chemiluminescence assay	B	CCC(C)NC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(=O)NC(C)CC		CHEMBL2017520	=	IC50	nM	1920.0	CHEMBL2345	Homo sapiens	IC50	uM	1.92
	10860733	CHEMBL2020792	Inhibition of His-tagged RSK2 expressed in Sf9 cells using ERalpha-Ser167 RLASTND as substrate after 120 mins by chemiluminescence assay	B	C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](OC(=O)N(C)C)[C@H]1OC(=O)N(C)C		CHEMBL2017521	=	IC50	nM	493.0	CHEMBL2345	Homo sapiens	IC50	uM	0.493
	10860734	CHEMBL2020792	Inhibition of His-tagged RSK2 expressed in Sf9 cells using ERalpha-Ser167 RLASTND as substrate after 120 mins by chemiluminescence assay	B	C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](OC(=O)N2CCCC2)[C@H]1OC(=O)N1CCCC1		CHEMBL2017522	=	IC50	nM	356.0	CHEMBL2345	Homo sapiens	IC50	uM	0.356
	10860735	CHEMBL2020792	Inhibition of His-tagged RSK2 expressed in Sf9 cells using ERalpha-Ser167 RLASTND as substrate after 120 mins by chemiluminescence assay	B	C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](OC(=O)N2CCOCC2)[C@H]1OC(=O)N1CCOCC1		CHEMBL2017523	=	IC50	nM	1430.0	CHEMBL2345	Homo sapiens	IC50	uM	1.43
	10860742	CHEMBL2020793	Ratio of SL0101 IC50 to compound IC50 for His-tagged RSK2	B	CC(=O)CO[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OCC(C)=O		CHEMBL2017518	=	Ratio IC50		2.0	CHEMBL2345	Homo sapiens	Ratio IC50		2.0
	10870935	CHEMBL2024841	Inhibition of RSK2	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL1739550	=	IC50	nM	360.0	CHEMBL2345	Homo sapiens	IC50	nM	360.0
	10870936	CHEMBL2024841	Inhibition of RSK2	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022369	=	IC50	nM	7700.0	CHEMBL2345	Homo sapiens	IC50	nM	7700.0
	10870937	CHEMBL2024841	Inhibition of RSK2	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022373	=	IC50	nM	4300.0	CHEMBL2345	Homo sapiens	IC50	nM	4300.0
	10870938	CHEMBL2024841	Inhibition of RSK2	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022379	=	IC50	nM	1100.0	CHEMBL2345	Homo sapiens	IC50	nM	1100.0
	10870939	CHEMBL2024841	Inhibition of RSK2	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022711	=	IC50	nM	6800.0	CHEMBL2345	Homo sapiens	IC50	nM	6800.0
	10980286	CHEMBL2065132	Inhibition of RPS6KA3 at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL2345	Homo sapiens	INH	%	25.0
	10980287	CHEMBL2065132	Inhibition of RPS6KA3 at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL2345	Homo sapiens	INH	%	15.0
	10980318	CHEMBL2065162	Inhibition of RPS6KA3 by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
	10981534	CHEMBL2066386	Inhibition of human Rsk2 at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL2345	Homo sapiens	INH	%	90.0
	10981549	CHEMBL2067597	Inhibition of human Rsk2	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	13.0	CHEMBL2345	Homo sapiens	IC50	nM	13.0
	11020087	CHEMBL2091835	Inhibition of RSK2	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	3.0	CHEMBL2345	Homo sapiens	IC50	nM	3.0
	12047343	CHEMBL2157696	Inhibition of Rsk2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	2.4	CHEMBL2345	Homo sapiens	INH	%	2.4
	12074660	CHEMBL2161222	Inhibition of RSK2 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	12094381	CHEMBL2166159	Inhibition of human RSK2 at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	Inhibition	%	9.0	CHEMBL2345	Homo sapiens	INH	%	9.0
	12145289	CHEMBL2186669	Inhibition of RSK2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL2345	Homo sapiens	INH	%	25.0
	12145290	CHEMBL2186669	Inhibition of RSK2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL2345	Homo sapiens	INH	%	25.0
	12170738	CHEMBL2214646	Inhibition of RSK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	83.0	CHEMBL2345	Homo sapiens	Activity	%	83.0
	12170869	CHEMBL2213188	Inhibition of RSK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	81.0	CHEMBL2345	Homo sapiens	Activity	%	81.0
	12172216	CHEMBL2211996	Inhibition of RSK2 C-terminal domain 2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	12172217	CHEMBL2211997	Inhibition of RSK2 N-terminal domain 1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL2345	Homo sapiens	Activity	%	93.0
	12183817	CHEMBL2214444	Inhibition of RPS6KA3	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	pIC50		5.0
	12187328	CHEMBL2216719	Inhibition of human RSK2 at 1 uM by radiometric assay in presence of ATP	B	COc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1		CHEMBL2203843	>	Inhibition	%	80.0	CHEMBL2345	Homo sapiens	INH	%	80.0
	12195402	CHEMBL2209628	Inhibition of recombinant RSK2 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	630.0	CHEMBL2345	Homo sapiens	Ki	nM	630.0
	12205236	CHEMBL2217235	Inhibition of RSK2 transfected in HEK293 cells	B	Cc1ccc(-c2c(/C=C(\C#N)C(=O)NC(C)(C)C)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL2216829	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	nM	4.0
	12205237	CHEMBL2217235	Inhibition of RSK2 transfected in HEK293 cells	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	IC50	nM	15.0	CHEMBL2345	Homo sapiens	IC50	nM	15.0
	12256130	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	100.0	CHEMBL2345	Homo sapiens	Residual Activity	%	100.0
	12256131	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	27.0	CHEMBL2345	Homo sapiens	Residual Activity	%	27.0
	12256132	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	106.0	CHEMBL2345	Homo sapiens	Residual Activity	%	106.0
	12256133	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	126.0	CHEMBL2345	Homo sapiens	Residual Activity	%	126.0
	12256134	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	110.0	CHEMBL2345	Homo sapiens	Residual Activity	%	110.0
	12256135	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	111.0	CHEMBL2345	Homo sapiens	Residual Activity	%	111.0
	12256136	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	9.0	CHEMBL2345	Homo sapiens	Residual Activity	%	9.0
	12256137	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	102.0	CHEMBL2345	Homo sapiens	Residual Activity	%	102.0
	12256138	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	102.0	CHEMBL2345	Homo sapiens	Residual Activity	%	102.0
	12256139	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	108.0	CHEMBL2345	Homo sapiens	Residual Activity	%	108.0
	12256140	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	104.0	CHEMBL2345	Homo sapiens	Residual Activity	%	104.0
	12256141	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	104.0	CHEMBL2345	Homo sapiens	Residual Activity	%	104.0
	12256142	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	120.0	CHEMBL2345	Homo sapiens	Residual Activity	%	120.0
	12256143	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	112.0	CHEMBL2345	Homo sapiens	Residual Activity	%	112.0
	12256144	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	97.0	CHEMBL2345	Homo sapiens	Residual Activity	%	97.0
	12256145	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	88.0	CHEMBL2345	Homo sapiens	Residual Activity	%	88.0
	12256146	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	94.0	CHEMBL2345	Homo sapiens	Residual Activity	%	94.0
	12256147	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	115.0	CHEMBL2345	Homo sapiens	Residual Activity	%	115.0
	12256148	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	111.0	CHEMBL2345	Homo sapiens	Residual Activity	%	111.0
	12256149	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	43.0	CHEMBL2345	Homo sapiens	Residual Activity	%	43.0
	12256150	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	122.0	CHEMBL2345	Homo sapiens	Residual Activity	%	122.0
	12256151	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	123.0	CHEMBL2345	Homo sapiens	Residual Activity	%	123.0
	12256152	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	118.0	CHEMBL2345	Homo sapiens	Residual Activity	%	118.0
	12256153	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	116.0	CHEMBL2345	Homo sapiens	Residual Activity	%	116.0
	12256154	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	108.0	CHEMBL2345	Homo sapiens	Residual Activity	%	108.0
	12256155	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	102.0	CHEMBL2345	Homo sapiens	Residual Activity	%	102.0
	12256156	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	30.0	CHEMBL2345	Homo sapiens	Residual Activity	%	30.0
	12256157	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	39.0	CHEMBL2345	Homo sapiens	Residual Activity	%	39.0
	12256158	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	56.0	CHEMBL2345	Homo sapiens	Residual Activity	%	56.0
	12256159	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	3.0	CHEMBL2345	Homo sapiens	Residual Activity	%	3.0
	12256160	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	60.0	CHEMBL2345	Homo sapiens	Residual Activity	%	60.0
	12256161	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	60.0	CHEMBL2345	Homo sapiens	Residual Activity	%	60.0
	12256162	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	68.0	CHEMBL2345	Homo sapiens	Residual Activity	%	68.0
	12256163	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	57.0	CHEMBL2345	Homo sapiens	Residual Activity	%	57.0
	12256164	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	64.0	CHEMBL2345	Homo sapiens	Residual Activity	%	64.0
	12256165	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	54.0	CHEMBL2345	Homo sapiens	Residual Activity	%	54.0
	12256166	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	63.0	CHEMBL2345	Homo sapiens	Residual Activity	%	63.0
	12256167	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	44.0	CHEMBL2345	Homo sapiens	Residual Activity	%	44.0
	12256168	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	67.0	CHEMBL2345	Homo sapiens	Residual Activity	%	67.0
	12256169	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	45.0	CHEMBL2345	Homo sapiens	Residual Activity	%	45.0
	12256170	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	67.0	CHEMBL2345	Homo sapiens	Residual Activity	%	67.0
	12256171	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	64.0	CHEMBL2345	Homo sapiens	Residual Activity	%	64.0
	12256172	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12256173	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	11.0	CHEMBL2345	Homo sapiens	Residual Activity	%	11.0
	12256174	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	70.0	CHEMBL2345	Homo sapiens	Residual Activity	%	70.0
	12256175	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	72.0	CHEMBL2345	Homo sapiens	Residual Activity	%	72.0
	12256176	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	75.0	CHEMBL2345	Homo sapiens	Residual Activity	%	75.0
	12256177	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	26.0	CHEMBL2345	Homo sapiens	Residual Activity	%	26.0
	12256178	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	67.0	CHEMBL2345	Homo sapiens	Residual Activity	%	67.0
	12256179	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	70.0	CHEMBL2345	Homo sapiens	Residual Activity	%	70.0
	12256180	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	2.0	CHEMBL2345	Homo sapiens	Residual Activity	%	2.0
	12256181	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	65.0	CHEMBL2345	Homo sapiens	Residual Activity	%	65.0
	12256182	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	18.0	CHEMBL2345	Homo sapiens	Residual Activity	%	18.0
	12256183	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	60.0	CHEMBL2345	Homo sapiens	Residual Activity	%	60.0
	12256184	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	67.0	CHEMBL2345	Homo sapiens	Residual Activity	%	67.0
	12256185	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	67.0	CHEMBL2345	Homo sapiens	Residual Activity	%	67.0
	12256186	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	67.0	CHEMBL2345	Homo sapiens	Residual Activity	%	67.0
	12256187	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	79.0	CHEMBL2345	Homo sapiens	Residual Activity	%	79.0
	12256188	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	66.0	CHEMBL2345	Homo sapiens	Residual Activity	%	66.0
	12256189	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	69.0	CHEMBL2345	Homo sapiens	Residual Activity	%	69.0
	12256190	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	68.0	CHEMBL2345	Homo sapiens	Residual Activity	%	68.0
	12256191	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12256192	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	49.0	CHEMBL2345	Homo sapiens	Residual Activity	%	49.0
	12256193	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	45.0	CHEMBL2345	Homo sapiens	Residual Activity	%	45.0
	12256194	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	57.0	CHEMBL2345	Homo sapiens	Residual Activity	%	57.0
	12256195	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	47.0	CHEMBL2345	Homo sapiens	Residual Activity	%	47.0
	12256196	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	50.0	CHEMBL2345	Homo sapiens	Residual Activity	%	50.0
	12256197	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	51.0	CHEMBL2345	Homo sapiens	Residual Activity	%	51.0
	12256198	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	61.0	CHEMBL2345	Homo sapiens	Residual Activity	%	61.0
	12256199	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	104.0	CHEMBL2345	Homo sapiens	Residual Activity	%	104.0
	12256200	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	50.0	CHEMBL2345	Homo sapiens	Residual Activity	%	50.0
	12256201	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	45.0	CHEMBL2345	Homo sapiens	Residual Activity	%	45.0
	12256202	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12256203	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	52.0	CHEMBL2345	Homo sapiens	Residual Activity	%	52.0
	12256204	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	56.0	CHEMBL2345	Homo sapiens	Residual Activity	%	56.0
	12256205	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	44.0	CHEMBL2345	Homo sapiens	Residual Activity	%	44.0
	12256206	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	56.0	CHEMBL2345	Homo sapiens	Residual Activity	%	56.0
	12256207	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	11.0	CHEMBL2345	Homo sapiens	Residual Activity	%	11.0
	12256208	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	54.0	CHEMBL2345	Homo sapiens	Residual Activity	%	54.0
	12256209	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL2345	Homo sapiens	Residual Activity	%	0.0
	12256210	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	86.0	CHEMBL2345	Homo sapiens	Residual Activity	%	86.0
	12256211	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	32.0	CHEMBL2345	Homo sapiens	Residual Activity	%	32.0
	12256212	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	49.0	CHEMBL2345	Homo sapiens	Residual Activity	%	49.0
	12256213	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	82.0	CHEMBL2345	Homo sapiens	Residual Activity	%	82.0
	12256214	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	61.0	CHEMBL2345	Homo sapiens	Residual Activity	%	61.0
	12256215	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	111.0	CHEMBL2345	Homo sapiens	Residual Activity	%	111.0
	12256216	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	81.0	CHEMBL2345	Homo sapiens	Residual Activity	%	81.0
	12256217	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	108.0	CHEMBL2345	Homo sapiens	Residual Activity	%	108.0
	12256218	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	106.0	CHEMBL2345	Homo sapiens	Residual Activity	%	106.0
	12256219	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	50.0	CHEMBL2345	Homo sapiens	Residual Activity	%	50.0
	12256220	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	99.0	CHEMBL2345	Homo sapiens	Residual Activity	%	99.0
	12256221	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	111.0	CHEMBL2345	Homo sapiens	Residual Activity	%	111.0
	12256222	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	58.0	CHEMBL2345	Homo sapiens	Residual Activity	%	58.0
	12256223	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	107.0	CHEMBL2345	Homo sapiens	Residual Activity	%	107.0
	12256224	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	122.0	CHEMBL2345	Homo sapiens	Residual Activity	%	122.0
	12256225	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	82.0	CHEMBL2345	Homo sapiens	Residual Activity	%	82.0
	12256226	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	108.0	CHEMBL2345	Homo sapiens	Residual Activity	%	108.0
	12256227	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	116.0	CHEMBL2345	Homo sapiens	Residual Activity	%	116.0
	12256228	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	117.0	CHEMBL2345	Homo sapiens	Residual Activity	%	117.0
	12256229	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	96.0	CHEMBL2345	Homo sapiens	Residual Activity	%	96.0
	12256230	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	57.0	CHEMBL2345	Homo sapiens	Residual Activity	%	57.0
	12256231	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12256232	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	118.0	CHEMBL2345	Homo sapiens	Residual Activity	%	118.0
	12256233	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	11.0	CHEMBL2345	Homo sapiens	Residual Activity	%	11.0
	12256234	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	56.0	CHEMBL2345	Homo sapiens	Residual Activity	%	56.0
	12256235	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	101.0	CHEMBL2345	Homo sapiens	Residual Activity	%	101.0
	12256236	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	88.0	CHEMBL2345	Homo sapiens	Residual Activity	%	88.0
	12256237	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	55.0	CHEMBL2345	Homo sapiens	Residual Activity	%	55.0
	12256238	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	63.0	CHEMBL2345	Homo sapiens	Residual Activity	%	63.0
	12256239	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	33.0	CHEMBL2345	Homo sapiens	Residual Activity	%	33.0
	12256240	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	60.0	CHEMBL2345	Homo sapiens	Residual Activity	%	60.0
	12256241	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	60.0	CHEMBL2345	Homo sapiens	Residual Activity	%	60.0
	12256242	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	9.0	CHEMBL2345	Homo sapiens	Residual Activity	%	9.0
	12256243	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	60.0	CHEMBL2345	Homo sapiens	Residual Activity	%	60.0
	12256244	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	30.0	CHEMBL2345	Homo sapiens	Residual Activity	%	30.0
	12256245	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	49.0	CHEMBL2345	Homo sapiens	Residual Activity	%	49.0
	12256246	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	33.0	CHEMBL2345	Homo sapiens	Residual Activity	%	33.0
	12256247	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	60.0	CHEMBL2345	Homo sapiens	Residual Activity	%	60.0
	12256248	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	54.0	CHEMBL2345	Homo sapiens	Residual Activity	%	54.0
	12256249	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	64.0	CHEMBL2345	Homo sapiens	Residual Activity	%	64.0
	12256250	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	42.0	CHEMBL2345	Homo sapiens	Residual Activity	%	42.0
	12256251	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	28.0	CHEMBL2345	Homo sapiens	Residual Activity	%	28.0
	12256252	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	15.0	CHEMBL2345	Homo sapiens	Residual Activity	%	15.0
	12256253	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	39.0	CHEMBL2345	Homo sapiens	Residual Activity	%	39.0
	12256254	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	15.0	CHEMBL2345	Homo sapiens	Residual Activity	%	15.0
	12256255	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	72.0	CHEMBL2345	Homo sapiens	Residual Activity	%	72.0
	12256256	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	62.0	CHEMBL2345	Homo sapiens	Residual Activity	%	62.0
	12256257	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	75.0	CHEMBL2345	Homo sapiens	Residual Activity	%	75.0
	12256258	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	55.0	CHEMBL2345	Homo sapiens	Residual Activity	%	55.0
	12256259	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2345	Homo sapiens	Residual Activity	%	0.0
	12256260	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	31.0	CHEMBL2345	Homo sapiens	Residual Activity	%	31.0
	12256261	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	61.0	CHEMBL2345	Homo sapiens	Residual Activity	%	61.0
	12256262	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	54.0	CHEMBL2345	Homo sapiens	Residual Activity	%	54.0
	12256263	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	73.0	CHEMBL2345	Homo sapiens	Residual Activity	%	73.0
	12256264	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	68.0	CHEMBL2345	Homo sapiens	Residual Activity	%	68.0
	12256265	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	19.0	CHEMBL2345	Homo sapiens	Residual Activity	%	19.0
	12256266	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	65.0	CHEMBL2345	Homo sapiens	Residual Activity	%	65.0
	12256267	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	30.0	CHEMBL2345	Homo sapiens	Residual Activity	%	30.0
	12256268	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	24.0	CHEMBL2345	Homo sapiens	Residual Activity	%	24.0
	12256269	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	58.0	CHEMBL2345	Homo sapiens	Residual Activity	%	58.0
	12256270	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	28.0	CHEMBL2345	Homo sapiens	Residual Activity	%	28.0
	12256271	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	26.0	CHEMBL2345	Homo sapiens	Residual Activity	%	26.0
	12256272	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	51.0	CHEMBL2345	Homo sapiens	Residual Activity	%	51.0
	12256273	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	46.0	CHEMBL2345	Homo sapiens	Residual Activity	%	46.0
	12256274	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	56.0	CHEMBL2345	Homo sapiens	Residual Activity	%	56.0
	12256275	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	46.0	CHEMBL2345	Homo sapiens	Residual Activity	%	46.0
	12256276	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	40.0	CHEMBL2345	Homo sapiens	Residual Activity	%	40.0
	12256277	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	51.0	CHEMBL2345	Homo sapiens	Residual Activity	%	51.0
	12256278	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	42.0	CHEMBL2345	Homo sapiens	Residual Activity	%	42.0
	12256279	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	52.0	CHEMBL2345	Homo sapiens	Residual Activity	%	52.0
	12256280	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	31.0	CHEMBL2345	Homo sapiens	Residual Activity	%	31.0
	12256281	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	59.0	CHEMBL2345	Homo sapiens	Residual Activity	%	59.0
	12256282	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	43.0	CHEMBL2345	Homo sapiens	Residual Activity	%	43.0
	12256283	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	41.0	CHEMBL2345	Homo sapiens	Residual Activity	%	41.0
	12256284	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	49.0	CHEMBL2345	Homo sapiens	Residual Activity	%	49.0
	12256285	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	49.0	CHEMBL2345	Homo sapiens	Residual Activity	%	49.0
	12256286	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	55.0	CHEMBL2345	Homo sapiens	Residual Activity	%	55.0
	12256287	CHEMBL2219165	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	0.0	CHEMBL2345	Homo sapiens	Residual Activity	%	0.0
	12256288	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	78.0	CHEMBL2345	Homo sapiens	Residual Activity	%	78.0
	12256289	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	3.0	CHEMBL2345	Homo sapiens	Residual Activity	%	3.0
	12256290	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	66.0	CHEMBL2345	Homo sapiens	Residual Activity	%	66.0
	12256291	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL2345	Homo sapiens	Residual Activity	%	101.0
	12256292	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	71.0	CHEMBL2345	Homo sapiens	Residual Activity	%	71.0
	12256293	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	111.0	CHEMBL2345	Homo sapiens	Residual Activity	%	111.0
	12256294	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12256295	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	59.0	CHEMBL2345	Homo sapiens	Residual Activity	%	59.0
	12256296	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	75.0	CHEMBL2345	Homo sapiens	Residual Activity	%	75.0
	12256297	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	93.0	CHEMBL2345	Homo sapiens	Residual Activity	%	93.0
	12256298	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	107.0	CHEMBL2345	Homo sapiens	Residual Activity	%	107.0
	12256299	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	83.0	CHEMBL2345	Homo sapiens	Residual Activity	%	83.0
	12256300	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	91.0	CHEMBL2345	Homo sapiens	Residual Activity	%	91.0
	12256301	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	80.0	CHEMBL2345	Homo sapiens	Residual Activity	%	80.0
	12256302	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	35.0	CHEMBL2345	Homo sapiens	Residual Activity	%	35.0
	12256303	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	75.0	CHEMBL2345	Homo sapiens	Residual Activity	%	75.0
	12256304	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	64.0	CHEMBL2345	Homo sapiens	Residual Activity	%	64.0
	12256305	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	91.0	CHEMBL2345	Homo sapiens	Residual Activity	%	91.0
	12256306	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	93.0	CHEMBL2345	Homo sapiens	Residual Activity	%	93.0
	12256307	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	17.0	CHEMBL2345	Homo sapiens	Residual Activity	%	17.0
	12256308	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	93.0	CHEMBL2345	Homo sapiens	Residual Activity	%	93.0
	12256309	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	77.0	CHEMBL2345	Homo sapiens	Residual Activity	%	77.0
	12256310	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	100.0	CHEMBL2345	Homo sapiens	Residual Activity	%	100.0
	12256311	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	97.0	CHEMBL2345	Homo sapiens	Residual Activity	%	97.0
	12256312	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	98.0	CHEMBL2345	Homo sapiens	Residual Activity	%	98.0
	12256313	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	40.0	CHEMBL2345	Homo sapiens	Residual Activity	%	40.0
	12256314	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	4.0	CHEMBL2345	Homo sapiens	Residual Activity	%	4.0
	12256315	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	12.0	CHEMBL2345	Homo sapiens	Residual Activity	%	12.0
	12256316	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	65.0	CHEMBL2345	Homo sapiens	Residual Activity	%	65.0
	12256317	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12256318	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	62.0	CHEMBL2345	Homo sapiens	Residual Activity	%	62.0
	12256319	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	35.0	CHEMBL2345	Homo sapiens	Residual Activity	%	35.0
	12257730	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	35.0	CHEMBL2345	Homo sapiens	Residual Activity	%	35.0
	12257731	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	46.0	CHEMBL2345	Homo sapiens	Residual Activity	%	46.0
	12257732	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	64.0	CHEMBL2345	Homo sapiens	Residual Activity	%	64.0
	12257733	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	52.0	CHEMBL2345	Homo sapiens	Residual Activity	%	52.0
	12257734	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	39.0	CHEMBL2345	Homo sapiens	Residual Activity	%	39.0
	12257735	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	55.0	CHEMBL2345	Homo sapiens	Residual Activity	%	55.0
	12257736	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	47.0	CHEMBL2345	Homo sapiens	Residual Activity	%	47.0
	12257737	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	37.0	CHEMBL2345	Homo sapiens	Residual Activity	%	37.0
	12257738	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	64.0	CHEMBL2345	Homo sapiens	Residual Activity	%	64.0
	12257739	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	56.0	CHEMBL2345	Homo sapiens	Residual Activity	%	56.0
	12257740	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12257741	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12257742	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	19.0	CHEMBL2345	Homo sapiens	Residual Activity	%	19.0
	12257743	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	43.0	CHEMBL2345	Homo sapiens	Residual Activity	%	43.0
	12257744	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	69.0	CHEMBL2345	Homo sapiens	Residual Activity	%	69.0
	12257745	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	5.0	CHEMBL2345	Homo sapiens	Residual Activity	%	5.0
	12257746	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	53.0	CHEMBL2345	Homo sapiens	Residual Activity	%	53.0
	12257747	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	64.0	CHEMBL2345	Homo sapiens	Residual Activity	%	64.0
	12257748	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	-1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	-1.0
	12257749	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	37.0	CHEMBL2345	Homo sapiens	Residual Activity	%	37.0
	12257750	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12257751	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	23.0	CHEMBL2345	Homo sapiens	Residual Activity	%	23.0
	12257752	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	45.0	CHEMBL2345	Homo sapiens	Residual Activity	%	45.0
	12257753	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	51.0	CHEMBL2345	Homo sapiens	Residual Activity	%	51.0
	12257754	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	40.0	CHEMBL2345	Homo sapiens	Residual Activity	%	40.0
	12257755	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	50.0	CHEMBL2345	Homo sapiens	Residual Activity	%	50.0
	12257756	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	44.0	CHEMBL2345	Homo sapiens	Residual Activity	%	44.0
	12257757	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	55.0	CHEMBL2345	Homo sapiens	Residual Activity	%	55.0
	12257758	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	20.0	CHEMBL2345	Homo sapiens	Residual Activity	%	20.0
	12257759	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	0.0	CHEMBL2345	Homo sapiens	Residual Activity	%	0.0
	12257760	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	27.0	CHEMBL2345	Homo sapiens	Residual Activity	%	27.0
	12257761	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	38.0	CHEMBL2345	Homo sapiens	Residual Activity	%	38.0
	12257762	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	40.0	CHEMBL2345	Homo sapiens	Residual Activity	%	40.0
	12257763	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	16.0	CHEMBL2345	Homo sapiens	Residual Activity	%	16.0
	12257764	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	36.0	CHEMBL2345	Homo sapiens	Residual Activity	%	36.0
	12257765	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	36.0	CHEMBL2345	Homo sapiens	Residual Activity	%	36.0
	12257766	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	35.0	CHEMBL2345	Homo sapiens	Residual Activity	%	35.0
	12257767	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	126.0	CHEMBL2345	Homo sapiens	Residual Activity	%	126.0
	12257768	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	40.0	CHEMBL2345	Homo sapiens	Residual Activity	%	40.0
	12257769	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	27.0	CHEMBL2345	Homo sapiens	Residual Activity	%	27.0
	12257770	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12257771	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	46.0	CHEMBL2345	Homo sapiens	Residual Activity	%	46.0
	12257772	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	36.0	CHEMBL2345	Homo sapiens	Residual Activity	%	36.0
	12257773	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	32.0	CHEMBL2345	Homo sapiens	Residual Activity	%	32.0
	12257774	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	35.0	CHEMBL2345	Homo sapiens	Residual Activity	%	35.0
	12257775	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12257776	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	25.0	CHEMBL2345	Homo sapiens	Residual Activity	%	25.0
	12257777	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	-1.0
	12257778	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	90.0	CHEMBL2345	Homo sapiens	Residual Activity	%	90.0
	12257779	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	8.0	CHEMBL2345	Homo sapiens	Residual Activity	%	8.0
	12257780	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	43.0	CHEMBL2345	Homo sapiens	Residual Activity	%	43.0
	12257781	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	34.0	CHEMBL2345	Homo sapiens	Residual Activity	%	34.0
	12257782	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	42.0	CHEMBL2345	Homo sapiens	Residual Activity	%	42.0
	12257783	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	129.0	CHEMBL2345	Homo sapiens	Residual Activity	%	129.0
	12257784	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	50.0	CHEMBL2345	Homo sapiens	Residual Activity	%	50.0
	12257785	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	97.0	CHEMBL2345	Homo sapiens	Residual Activity	%	97.0
	12257786	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	93.0	CHEMBL2345	Homo sapiens	Residual Activity	%	93.0
	12257787	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	7.0	CHEMBL2345	Homo sapiens	Residual Activity	%	7.0
	12257788	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	107.0	CHEMBL2345	Homo sapiens	Residual Activity	%	107.0
	12257789	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	96.0	CHEMBL2345	Homo sapiens	Residual Activity	%	96.0
	12257790	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	11.0	CHEMBL2345	Homo sapiens	Residual Activity	%	11.0
	12257791	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	86.0	CHEMBL2345	Homo sapiens	Residual Activity	%	86.0
	12257792	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	83.0	CHEMBL2345	Homo sapiens	Residual Activity	%	83.0
	12257793	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	38.0	CHEMBL2345	Homo sapiens	Residual Activity	%	38.0
	12257794	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	105.0	CHEMBL2345	Homo sapiens	Residual Activity	%	105.0
	12257795	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	120.0	CHEMBL2345	Homo sapiens	Residual Activity	%	120.0
	12257796	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	123.0	CHEMBL2345	Homo sapiens	Residual Activity	%	123.0
	12257797	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	86.0	CHEMBL2345	Homo sapiens	Residual Activity	%	86.0
	12257798	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	24.0	CHEMBL2345	Homo sapiens	Residual Activity	%	24.0
	12257799	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12257800	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	106.0	CHEMBL2345	Homo sapiens	Residual Activity	%	106.0
	12257801	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	3.0	CHEMBL2345	Homo sapiens	Residual Activity	%	3.0
	12257802	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	34.0	CHEMBL2345	Homo sapiens	Residual Activity	%	34.0
	12257803	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL2345	Homo sapiens	Residual Activity	%	87.0
	12257804	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	83.0	CHEMBL2345	Homo sapiens	Residual Activity	%	83.0
	12257805	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	50.0	CHEMBL2345	Homo sapiens	Residual Activity	%	50.0
	12257806	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	57.0	CHEMBL2345	Homo sapiens	Residual Activity	%	57.0
	12257807	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	19.0	CHEMBL2345	Homo sapiens	Residual Activity	%	19.0
	12257808	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	62.0	CHEMBL2345	Homo sapiens	Residual Activity	%	62.0
	12257809	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	64.0	CHEMBL2345	Homo sapiens	Residual Activity	%	64.0
	12257810	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	3.0	CHEMBL2345	Homo sapiens	Residual Activity	%	3.0
	12257811	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	25.0	CHEMBL2345	Homo sapiens	Residual Activity	%	25.0
	12257812	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	11.0	CHEMBL2345	Homo sapiens	Residual Activity	%	11.0
	12257813	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	65.0	CHEMBL2345	Homo sapiens	Residual Activity	%	65.0
	12257814	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	9.0	CHEMBL2345	Homo sapiens	Residual Activity	%	9.0
	12257815	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	61.0	CHEMBL2345	Homo sapiens	Residual Activity	%	61.0
	12257816	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	36.0	CHEMBL2345	Homo sapiens	Residual Activity	%	36.0
	12257817	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	52.0	CHEMBL2345	Homo sapiens	Residual Activity	%	52.0
	12257818	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	29.0	CHEMBL2345	Homo sapiens	Residual Activity	%	29.0
	12257819	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	4.0	CHEMBL2345	Homo sapiens	Residual Activity	%	4.0
	12257820	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	6.0	CHEMBL2345	Homo sapiens	Residual Activity	%	6.0
	12257821	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	28.0	CHEMBL2345	Homo sapiens	Residual Activity	%	28.0
	12257822	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12257823	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	72.0	CHEMBL2345	Homo sapiens	Residual Activity	%	72.0
	12257824	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	15.0	CHEMBL2345	Homo sapiens	Residual Activity	%	15.0
	12257825	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	86.0	CHEMBL2345	Homo sapiens	Residual Activity	%	86.0
	12257826	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	52.0	CHEMBL2345	Homo sapiens	Residual Activity	%	52.0
	12257827	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	-1.0
	12257828	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	22.0	CHEMBL2345	Homo sapiens	Residual Activity	%	22.0
	12257829	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	61.0	CHEMBL2345	Homo sapiens	Residual Activity	%	61.0
	12257830	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	32.0	CHEMBL2345	Homo sapiens	Residual Activity	%	32.0
	12257831	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	75.0	CHEMBL2345	Homo sapiens	Residual Activity	%	75.0
	12257832	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	32.0	CHEMBL2345	Homo sapiens	Residual Activity	%	32.0
	12257833	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	2.0	CHEMBL2345	Homo sapiens	Residual Activity	%	2.0
	12257834	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	54.0	CHEMBL2345	Homo sapiens	Residual Activity	%	54.0
	12257835	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	1.0
	12257836	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	6.0	CHEMBL2345	Homo sapiens	Residual Activity	%	6.0
	12257837	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	42.0	CHEMBL2345	Homo sapiens	Residual Activity	%	42.0
	12257838	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	15.0	CHEMBL2345	Homo sapiens	Residual Activity	%	15.0
	12257839	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	6.0	CHEMBL2345	Homo sapiens	Residual Activity	%	6.0
	12257840	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	37.0	CHEMBL2345	Homo sapiens	Residual Activity	%	37.0
	12257841	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	28.0	CHEMBL2345	Homo sapiens	Residual Activity	%	28.0
	12257842	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	53.0	CHEMBL2345	Homo sapiens	Residual Activity	%	53.0
	12257843	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	29.0	CHEMBL2345	Homo sapiens	Residual Activity	%	29.0
	12257844	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	28.0	CHEMBL2345	Homo sapiens	Residual Activity	%	28.0
	12257845	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	27.0	CHEMBL2345	Homo sapiens	Residual Activity	%	27.0
	12257846	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	24.0	CHEMBL2345	Homo sapiens	Residual Activity	%	24.0
	12257847	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	55.0	CHEMBL2345	Homo sapiens	Residual Activity	%	55.0
	12257848	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	9.0	CHEMBL2345	Homo sapiens	Residual Activity	%	9.0
	12257849	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	43.0	CHEMBL2345	Homo sapiens	Residual Activity	%	43.0
	12257850	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	52.0	CHEMBL2345	Homo sapiens	Residual Activity	%	52.0
	12257851	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	45.0	CHEMBL2345	Homo sapiens	Residual Activity	%	45.0
	12257852	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	51.0	CHEMBL2345	Homo sapiens	Residual Activity	%	51.0
	12257853	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	45.0	CHEMBL2345	Homo sapiens	Residual Activity	%	45.0
	12257854	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	45.0	CHEMBL2345	Homo sapiens	Residual Activity	%	45.0
	12257855	CHEMBL2219166	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	-1.0	CHEMBL2345	Homo sapiens	Residual Activity	%	-1.0
Active	12652496	CHEMBL2327514	Inhibition of RSK2 in human PMA-stimulated MCF7 cells assessed as decrease in expression of 27kDa protein harboring (Lys/Arg)X(Lys/Arg)XX(pSer/pThr) motif at 100 uM pretreated for 2 hrs prior to PMA addition measured after 20 mins by immunoblot analysis	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	12652497	CHEMBL2327515	Inhibition of RSK2 in human PMA-stimulated MCF7 cells assessed as decrease in expression of 27kDa protein harboring (Lys/Arg)X(Lys/Arg)XX(pSer/pThr) motif at 25 uM pretreated for 24 hrs prior to PMA addition measured after 20 mins immunoblot analysis	B	CCC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL2321925		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	12652500	CHEMBL2327518	Inhibition of RSK2 in human MCF7 cells assessed as reduction of PMA-induced decrease in EF2 kinase phosphorylation at 100 uM pretreated for 2 hrs prior to PMA addition measured after 20 mins by immunoblot analysis	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	12652501	CHEMBL2327520	Inhibition of RSK2 in human MCF7 cells assessed as reduction of PMA-induced decrease in EF2 kinase phosphorylation at 25 uM pretreated for 24 hrs prior to PMA addition measured after 20 mins by immunoblot analysis	B	CCC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL2321925		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	12653708	CHEMBL2328036	Ratio of SL0101 IC50 to compound IC50 for recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells by chemiluminescence analysis	B	CCC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL2321925	>	Ratio IC50		40.0	CHEMBL2345	Homo sapiens	Ratio IC50		40.0
	12653709	CHEMBL2328037	Inhibition of recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in substrate phosphorylation using GST-fusion protein containing ERalpha-Ser167 sequence-RLASTND as substrate by chemiluminescence analysis	B	CCC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL2326709	=	IC50	nM	1770.0	CHEMBL2345	Homo sapiens	IC50	uM	1.77
	12653710	CHEMBL2328037	Inhibition of recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in substrate phosphorylation using GST-fusion protein containing ERalpha-Ser167 sequence-RLASTND as substrate by chemiluminescence analysis	B	CCC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL2321925	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	uM	0.02
	12653711	CHEMBL2328037	Inhibition of recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in substrate phosphorylation using GST-fusion protein containing ERalpha-Ser167 sequence-RLASTND as substrate by chemiluminescence analysis	B	CCC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](OC(C)=O)[C@H](O)[C@H]1OC(C)=O		CHEMBL2326708	=	IC50	nM	620.0	CHEMBL2345	Homo sapiens	IC50	uM	0.62
	12653712	CHEMBL2328037	Inhibition of recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in substrate phosphorylation using GST-fusion protein containing ERalpha-Ser167 sequence-RLASTND as substrate by chemiluminescence analysis	B	CCC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1OC(C)=O		CHEMBL2326707	=	IC50	nM	1500.0	CHEMBL2345	Homo sapiens	IC50	uM	1.5
	12653713	CHEMBL2328037	Inhibition of recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in substrate phosphorylation using GST-fusion protein containing ERalpha-Ser167 sequence-RLASTND as substrate by chemiluminescence analysis	B	CC(C)C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL2326706	=	IC50	nM	480.0	CHEMBL2345	Homo sapiens	IC50	uM	0.48
	12653714	CHEMBL2328037	Inhibition of recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in substrate phosphorylation using GST-fusion protein containing ERalpha-Ser167 sequence-RLASTND as substrate by chemiluminescence analysis	B	CCC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL2326705	=	IC50	nM	710.0	CHEMBL2345	Homo sapiens	IC50	uM	0.71
	12653715	CHEMBL2328037	Inhibition of recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in substrate phosphorylation using GST-fusion protein containing ERalpha-Ser167 sequence-RLASTND as substrate by chemiluminescence analysis	B	CC[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL2326704	=	IC50	nM	1510.0	CHEMBL2345	Homo sapiens	IC50	uM	1.51
	12653716	CHEMBL2328037	Inhibition of recombinant RSK2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in substrate phosphorylation using GST-fusion protein containing ERalpha-Ser167 sequence-RLASTND as substrate by chemiluminescence analysis	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	IC50	nM	990.0	CHEMBL2345	Homo sapiens	IC50	uM	0.99
	12660669	CHEMBL2330659	Inhibition of RSK2 (unknown origin) at 1 uM	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Inhibition	%	75.0	CHEMBL2345	Homo sapiens	INH	%	75.0
	12672901	CHEMBL2341618	Inhibition of recombinant RSK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	17.0	CHEMBL2345	Homo sapiens	Activity	%	17.0
	12672902	CHEMBL2341618	Inhibition of recombinant RSK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	35.0	CHEMBL2345	Homo sapiens	Activity	%	35.0
	12693263	CHEMBL2343948	Inhibition of RSK2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	12700149	CHEMBL2342687	Inhibition of recombinant RPS6KA3 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	77.0	CHEMBL2345	Homo sapiens	INH	%	77.0
	12718773	CHEMBL2353270	Inhibition of RSK2 (unknown origin)	B	O=C1Nc2ccccc2/C1=C/c1ccco1		CHEMBL2347073	=	IC50	nM	7760.0	CHEMBL2345	Homo sapiens	IC50	uM	7.76
	12718774	CHEMBL2353271	Inhibition of His6x-tagged RSK2 C-terminal domain (unknown origin) expressed in Escherichia coli	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	IC50	nM	15.0	CHEMBL2345	Homo sapiens	IC50	nM	15.0
	12718775	CHEMBL2353272	Inhibition of GST-fused RSK2 (unknown origin) after 10 to 45 mins by immunoblotting analysis	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	IC50	nM	89.0	CHEMBL2345	Homo sapiens	IC50	nM	89.0
	12718798	CHEMBL2350682	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	1.6	CHEMBL2345	Homo sapiens	IC50	nM	1.6
	12718821	CHEMBL2350705	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 3 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	61.0	CHEMBL2345	Homo sapiens	INH	%	61.0
Not Determined	12718864	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	COc1ccc(-n2c(/C=C3\C(=O)Nc4ccccc43)nc3ccc(I)cc3c2=O)cc1		CHEMBL2347072		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718865	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	CCn1c(/C=C2\C(=O)Nc3ccccc32)nc2ccccc2c1=O		CHEMBL1595681		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718866	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	CCc1ccc2c(c1)/C(=N\NC(=O)CSc1ccc(Cl)cc1)C(=O)N2		CHEMBL2347071		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718867	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	NC(=O)c1ccc(/N=C2/C(=O)Nc3ccccc32)cc1		CHEMBL2347070		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718868	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	Cc1ccc(N/N=C2/C(=O)Nc3ccc(F)cc32)cc1		CHEMBL2347069		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718869	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Br)cc2/C1=N/NC(=O)c1ccc2c(c1)OCO2		CHEMBL572335		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718870	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=N/N=C1\CCCc2c1[nH]c1ccc(Cl)cc21		CHEMBL2347068		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718871	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Br)cc2/C1=N/NC(=O)c1ccco1		CHEMBL2347067		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718872	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	Oc1[nH]c2ccc(F)cc2c1/N=N/c1ccccc1		CHEMBL371713		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718873	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Cl)cc2/C1=C1/S/C(=N\c2ccccc2)N(c2ccccc2)C1=O		CHEMBL2347066		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718874	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	CC(=O)NN1C(=O)/C(=C2/C(=O)Nc3ccc(C)cc32)SC1=S		CHEMBL2347065		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718875	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	N=C1NC(=O)/C(=C2/C(=O)Nc3cc(Cl)ccc32)S1		CHEMBL2347064		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718876	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	Cc1c(Cl)ccc2c1NC(=O)/C2=C1\SC(=S)NC1=O		CHEMBL2347063		IC50			CHEMBL2345	Homo sapiens	IC50		
	12718877	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	CCc1cccc2c1NC(=O)/C2=C1\SC(=S)NC1=O		CHEMBL2347062	=	IC50	nM	17000.0	CHEMBL2345	Homo sapiens	IC50	uM	17.0
	12718878	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	Cc1cccc2c1NC(=O)/C2=C1\SC(=S)NC1=O		CHEMBL2347061	=	IC50	nM	1680.0	CHEMBL2345	Homo sapiens	IC50	uM	1.68
Not Determined	12718879	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1c[nH]nc1-c1ccc(Cl)cc1		CHEMBL2347060		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718880	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1c[nH]nc1-c1ccc(F)cc1		CHEMBL2347059		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718881	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL2347058		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718882	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Br)cc2/C1=C/c1c[nH]nc1-c1ccc(F)cc1		CHEMBL2347057		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718883	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Br)cc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL2347056		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718884	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(F)cc2/C1=C/c1c[nH]nc1-c1ccc(F)cc1		CHEMBL2347055		IC50			CHEMBL2345	Homo sapiens	IC50		
	12718885	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(F)cc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL2347054	=	IC50	nM	8590.0	CHEMBL2345	Homo sapiens	IC50	uM	8.59
	12718886	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	500.0	CHEMBL2345	Homo sapiens	IC50	uM	0.5
Not Determined	12718887	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccc(F)cc1		CHEMBL2347052		IC50			CHEMBL2345	Homo sapiens	IC50		
	12718888	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL1778710	=	IC50	nM	2720.0	CHEMBL2345	Homo sapiens	IC50	uM	2.72
Not Determined	12718889	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	COc1ccc2c(c1)/C(=C\c1ccco1)C(=O)N2		CHEMBL2347051		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718890	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C\c1ccco1		CHEMBL2347086		IC50			CHEMBL2345	Homo sapiens	IC50		
	12718891	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	Nc1ccc2c(c1)/C(=C\c1ccco1)C(=O)N2		CHEMBL2347085	=	IC50	nM	2490.0	CHEMBL2345	Homo sapiens	IC50	uM	2.49
Not Determined	12718892	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(F)cc2/C1=C/c1ccc(-c2cccc(Br)c2)o1		CHEMBL2347084		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718893	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(F)cc2/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL2347083		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718894	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1ccc(-c2cccc(Br)c2)o1		CHEMBL2347082		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718895	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL2347081		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718896	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Br)cc2/C1=C/c1ccc(-c2cccc(Br)c2)o1		CHEMBL2347080		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718897	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Br)cc2/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL2347079		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718898	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(CN2C(=O)c3ccccc3C2=O)o1		CHEMBL2347078		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718899	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(-c2c(Cl)cc(C(F)(F)F)cc2Cl)o1		CHEMBL2347077		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718900	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(-c2cccc(Br)c2)o1		CHEMBL2347076		IC50			CHEMBL2345	Homo sapiens	IC50		
Not Determined	12718901	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL2346669		IC50			CHEMBL2345	Homo sapiens	IC50		
	12718902	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Br)cc2/C1=C\c1ccco1		CHEMBL2347075	=	IC50	nM	1510.0	CHEMBL2345	Homo sapiens	IC50	uM	1.51
	12718903	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccco1		CHEMBL2347074	=	IC50	nM	2020.0	CHEMBL2345	Homo sapiens	IC50	uM	2.02
	12718904	CHEMBL2350997	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate after 60 mins by fluorescence assay	B	O=C1Nc2ccccc2/C1=C/c1ccco1		CHEMBL2347073	=	IC50	nM	3470.0	CHEMBL2345	Homo sapiens	IC50	uM	3.47
	12718905	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	COc1ccc(-n2c(/C=C3\C(=O)Nc4ccccc43)nc3ccc(I)cc3c2=O)cc1		CHEMBL2347072	=	Inhibition	%	13.42	CHEMBL2345	Homo sapiens	INH	%	13.42
	12718906	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	CCn1c(/C=C2\C(=O)Nc3ccccc32)nc2ccccc2c1=O		CHEMBL1595681	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718907	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	CCc1ccc2c(c1)/C(=N\NC(=O)CSc1ccc(Cl)cc1)C(=O)N2		CHEMBL2347071	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718908	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	NC(=O)c1ccc(/N=C2/C(=O)Nc3ccccc32)cc1		CHEMBL2347070	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718909	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	Cc1ccc(N/N=C2/C(=O)Nc3ccc(F)cc32)cc1		CHEMBL2347069	=	Inhibition	%	30.05	CHEMBL2345	Homo sapiens	INH	%	30.05
	12718910	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Br)cc2/C1=N/NC(=O)c1ccc2c(c1)OCO2		CHEMBL572335	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718911	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=N/N=C1\CCCc2c1[nH]c1ccc(Cl)cc21		CHEMBL2347068	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718912	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Br)cc2/C1=N/NC(=O)c1ccco1		CHEMBL2347067	=	Inhibition	%	11.48	CHEMBL2345	Homo sapiens	INH	%	11.48
	12718913	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	Oc1[nH]c2ccc(F)cc2c1/N=N/c1ccccc1		CHEMBL371713	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718914	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C1/S/C(=N\c2ccccc2)N(c2ccccc2)C1=O		CHEMBL2347066	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718915	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	CC(=O)NN1C(=O)/C(=C2/C(=O)Nc3ccc(C)cc32)SC1=S		CHEMBL2347065	=	Inhibition	%	41.07	CHEMBL2345	Homo sapiens	INH	%	41.07
	12718916	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	N=C1NC(=O)/C(=C2/C(=O)Nc3cc(Cl)ccc32)S1		CHEMBL2347064	=	Inhibition	%	18.43	CHEMBL2345	Homo sapiens	INH	%	18.43
	12718917	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	Cc1c(Cl)ccc2c1NC(=O)/C2=C1\SC(=S)NC1=O		CHEMBL2347063	=	Inhibition	%	39.58	CHEMBL2345	Homo sapiens	INH	%	39.58
	12718918	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	CCc1cccc2c1NC(=O)/C2=C1\SC(=S)NC1=O		CHEMBL2347062	=	Inhibition	%	50.11	CHEMBL2345	Homo sapiens	INH	%	50.11
	12718919	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	Cc1cccc2c1NC(=O)/C2=C1\SC(=S)NC1=O		CHEMBL2347061	=	Inhibition	%	92.36	CHEMBL2345	Homo sapiens	INH	%	92.36
	12718920	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1c[nH]nc1-c1ccc(Cl)cc1		CHEMBL2347060	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718921	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1c[nH]nc1-c1ccc(F)cc1		CHEMBL2347059	=	Inhibition	%	44.46	CHEMBL2345	Homo sapiens	INH	%	44.46
	12718922	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL2347058	=	Inhibition	%	33.25	CHEMBL2345	Homo sapiens	INH	%	33.25
	12718923	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Br)cc2/C1=C/c1c[nH]nc1-c1ccc(F)cc1		CHEMBL2347057	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718924	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Br)cc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL2347056	=	Inhibition	%	33.57	CHEMBL2345	Homo sapiens	INH	%	33.57
	12718925	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(F)cc2/C1=C/c1c[nH]nc1-c1ccc(F)cc1		CHEMBL2347055	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718926	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(F)cc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL2347054	=	Inhibition	%	78.43	CHEMBL2345	Homo sapiens	INH	%	78.43
	12718927	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	80.0	CHEMBL2345	Homo sapiens	INH	%	80.0
	12718928	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccc(F)cc1		CHEMBL2347052	=	Inhibition	%	38.56	CHEMBL2345	Homo sapiens	INH	%	38.56
	12718929	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL1778710	=	Inhibition	%	79.48	CHEMBL2345	Homo sapiens	INH	%	79.48
	12718930	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	COc1ccc2c(c1)/C(=C\c1ccco1)C(=O)N2		CHEMBL2347051	=	Inhibition	%	25.63	CHEMBL2345	Homo sapiens	INH	%	25.63
	12718931	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C\c1ccco1		CHEMBL2347086	=	Inhibition	%	29.84	CHEMBL2345	Homo sapiens	INH	%	29.84
	12718932	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	Nc1ccc2c(c1)/C(=C\c1ccco1)C(=O)N2		CHEMBL2347085	=	Inhibition	%	100.0	CHEMBL2345	Homo sapiens	INH	%	100.0
	12718933	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(F)cc2/C1=C/c1ccc(-c2cccc(Br)c2)o1		CHEMBL2347084	=	Inhibition	%	26.29	CHEMBL2345	Homo sapiens	INH	%	26.29
	12718934	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(F)cc2/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL2347083	=	Inhibition	%	17.12	CHEMBL2345	Homo sapiens	INH	%	17.12
	12718935	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1ccc(-c2cccc(Br)c2)o1		CHEMBL2347082	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718936	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL2347081	=	Inhibition	%	32.11	CHEMBL2345	Homo sapiens	INH	%	32.11
	12718937	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Br)cc2/C1=C/c1ccc(-c2cccc(Br)c2)o1		CHEMBL2347080	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718938	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Br)cc2/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL2347079	=	Inhibition	%	22.28	CHEMBL2345	Homo sapiens	INH	%	22.28
	12718939	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc(CN2C(=O)c3ccccc3C2=O)o1		CHEMBL2347078	=	Inhibition	%	16.47	CHEMBL2345	Homo sapiens	INH	%	16.47
	12718940	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc(-c2c(Cl)cc(C(F)(F)F)cc2Cl)o1		CHEMBL2347077	<	Inhibition	%	10.0	CHEMBL2345	Homo sapiens	INH	%	10.0
	12718941	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc(-c2cccc(Br)c2)o1		CHEMBL2347076	=	Inhibition	%	21.89	CHEMBL2345	Homo sapiens	INH	%	21.89
	12718942	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL2346669	=	Inhibition	%	16.83	CHEMBL2345	Homo sapiens	INH	%	16.83
	12718943	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Br)cc2/C1=C\c1ccco1		CHEMBL2347075	=	Inhibition	%	87.35	CHEMBL2345	Homo sapiens	INH	%	87.35
	12718944	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccco1		CHEMBL2347074	=	Inhibition	%	84.75	CHEMBL2345	Homo sapiens	INH	%	84.75
	12718945	CHEMBL2350998	Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccco1		CHEMBL2347073	=	Inhibition	%	69.59	CHEMBL2345	Homo sapiens	INH	%	69.59
	12721796	CHEMBL2351852	Inhibition of RSK2 (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	58.0	CHEMBL2345	Homo sapiens	INH	%	58.0
	12727655	CHEMBL2351119	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	78.0	CHEMBL2345	Homo sapiens	Activity	%	78.0
	12728941	CHEMBL2352840	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	95.0	CHEMBL2345	Homo sapiens	Activity	%	95.0
	12729828	CHEMBL2352159	Inhibition of RSK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	84.0	CHEMBL2345	Homo sapiens	Activity	%	84.0
	12730084	CHEMBL2351119	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL2345	Homo sapiens	Activity	%	98.0
	13311853	CHEMBL2384675	Inhibition of human RSK2	B	COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cs1)C2		CHEMBL2381116	=	IC50	nM	1300.0	CHEMBL2345	Homo sapiens	IC50	nM	1300.0
	13315787	CHEMBL2389251	Inhibition of RSK2 (unknown origin) at 100 x Ki relative to control	B	N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1		CHEMBL2387223	>	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	13315800	CHEMBL2389261	Inhibition of RSK2 (unknown origin) at 180 nM relative to control	B	N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1		CHEMBL2387124	=	Inhibition	%	73.0	CHEMBL2345	Homo sapiens	INH	%	73.0
	13351561	CHEMBL2399772	Inhibition of human RSK2 at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	34.0	CHEMBL2345	Homo sapiens	INH	%	34.0
	13374355	CHEMBL2406299	Inhibition of RSK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-4.0	CHEMBL2345	Homo sapiens	INH	%	-4.0
	13419772	CHEMBL2422290	Inhibition of RSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	63.0	CHEMBL2345	Homo sapiens	INH	%	63.0
	13419773	CHEMBL2422290	Inhibition of RSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	94.0	CHEMBL2345	Homo sapiens	INH	%	94.0
	13419774	CHEMBL2422290	Inhibition of RSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	84.0	CHEMBL2345	Homo sapiens	INH	%	84.0
	13434474	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434475	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434476	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434477	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434478	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434479	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434480	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434481	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434482	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434483	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434484	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13434485	CHEMBL2424229	Inhibition of RSK2 domain2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	13439928	CHEMBL2429471	Competitive binding affinity to RPS6KA3 domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	13440855	CHEMBL2429598	Inhibition of MAPKAP-K1-b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-88.0	CHEMBL2345	Homo sapiens	INH	%	-88.0
	13445438	CHEMBL2429471	Competitive binding affinity to RPS6KA3 domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	97.0	CHEMBL2345	Homo sapiens	INH	%	97.0
	13448493	CHEMBL2429471	Competitive binding affinity to RPS6KA3 domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	13448629	CHEMBL2429471	Competitive binding affinity to RPS6KA3 domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	90.0	CHEMBL2345	Homo sapiens	INH	%	90.0
	13451424	CHEMBL2429471	Competitive binding affinity to RPS6KA3 domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	84.0	CHEMBL2345	Homo sapiens	INH	%	84.0
	13453033	CHEMBL2429598	Inhibition of MAPKAP-K1-b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1	Outside typical range	CHEMBL2425156	=	Inhibition	%	-68.0	CHEMBL2345	Homo sapiens	INH	%	-68.0
	13453081	CHEMBL2429598	Inhibition of MAPKAP-K1-b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-38.0	CHEMBL2345	Homo sapiens	INH	%	-38.0
	13454609	CHEMBL2429471	Competitive binding affinity to RPS6KA3 domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	77.0	CHEMBL2345	Homo sapiens	INH	%	77.0
	13464317	CHEMBL2433447	Inhibition of human RSK2 assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	92.0	CHEMBL2345	Homo sapiens	Activity	%	92.0
	13464344	CHEMBL2433478	Inhibition of human RSK2 assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	87.0	CHEMBL2345	Homo sapiens	Activity	%	87.0
	13465288	CHEMBL2432956	Inhibition of human RSK2 assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	89.0	CHEMBL2345	Homo sapiens	Activity	%	89.0
	13465311	CHEMBL2433478	Inhibition of human RSK2 assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	82.0	CHEMBL2345	Homo sapiens	Activity	%	82.0
	13465337	CHEMBL2433447	Inhibition of human RSK2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	78.67	CHEMBL2345	Homo sapiens	Activity	%	78.67
	13465368	CHEMBL2433478	Inhibition of human RSK2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	103.31	CHEMBL2345	Homo sapiens	Activity	%	103.31
	13465399	CHEMBL2433447	Inhibition of human RSK2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	93.79	CHEMBL2345	Homo sapiens	Activity	%	93.79
	13465430	CHEMBL2433478	Inhibition of human RSK2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	78.32	CHEMBL2345	Homo sapiens	Activity	%	78.32
	13502857	CHEMBL2446251	Inhibition of human RSK2 kinase	B	COc1ccc(C2CC(c3c(O)ccc4ccccc34)=NN2)c(OC)c1	Non standard unit for type	CHEMBL2442816	=	INH	uM	13.1	CHEMBL2345	Homo sapiens	INH	uM	13.1
	13871752	CHEMBL3100917	Inhibition of human Rsk2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	94.0	CHEMBL2345	Homo sapiens	Activity	%	94.0
	13928581	CHEMBL3124205	Inhibition of RSK2 (unknown origin) at 0.1 uM relative to control	B	CNc1nc(Nc2cn(C(C)(C)C#N)nc2C)ncc1C(F)(F)F		CHEMBL3122113	=	Inhibition	%	52.0	CHEMBL2345	Homo sapiens	INH	%	52.0
	13966052	CHEMBL3136668	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	68.5	CHEMBL2345	Homo sapiens	INH	%	68.5
	13973327	CHEMBL3135065	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	59.5	CHEMBL2345	Homo sapiens	INH	%	59.5
	13974045	CHEMBL3136637	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	42.0	CHEMBL2345	Homo sapiens	INH	%	42.0
	13974136	CHEMBL3136350	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	95.5	CHEMBL2345	Homo sapiens	INH	%	95.5
	13974227	CHEMBL3135452	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	99.0	CHEMBL2345	Homo sapiens	INH	%	99.0
	13974965	CHEMBL3136987	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	95.0	CHEMBL2345	Homo sapiens	INH	%	95.0
	13975056	CHEMBL3136134	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	2.0	CHEMBL2345	Homo sapiens	INH	%	2.0
	13975147	CHEMBL3134752	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.5	CHEMBL2345	Homo sapiens	INH	%	0.5
	13975238	CHEMBL3136519	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	2.0	CHEMBL2345	Homo sapiens	INH	%	2.0
	13975881	CHEMBL3135652	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	32.0	CHEMBL2345	Homo sapiens	INH	%	32.0
	13975974	CHEMBL3136171	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	55.0	CHEMBL2345	Homo sapiens	INH	%	55.0
	13976065	CHEMBL3136049	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	87.5	CHEMBL2345	Homo sapiens	INH	%	87.5
	13976156	CHEMBL3135093	Inhibition of human full length RSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	75.0	CHEMBL2345	Homo sapiens	INH	%	75.0
	14585325	CHEMBL3241841	Inhibition of human Rsk2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	121.0	CHEMBL2345	Homo sapiens	Activity	%	121.0
	14648056	CHEMBL3265838	Inhibition of human RSK2 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	14648057	CHEMBL3265838	Inhibition of human RSK2 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	14659156	CHEMBL3269731	Inhibition of RSK2 (unknown origin) at 25 uM	B	CC(=O)c1cccc(NC(=O)c2sc3nc4cc5c(cc4cc3c2N)OCCO5)c1		CHEMBL3261343	=	Inhibition	%	27.0	CHEMBL2345	Homo sapiens	INH	%	27.0
Not Active	14982899	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@@H]1CC[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@@H](O)[C@H]1OC(C)=O		CHEMBL3356442		IC50			CHEMBL2345	Homo sapiens	IC50		
	14982900	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@H]1CC[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL3356441	=	IC50	nM	8930.0	CHEMBL2345	Homo sapiens	IC50	uM	8.93
Not Active	14982901	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@@H]1[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)C[C@H](C)[C@@H](OC(C)=O)[C@@H]1O		CHEMBL3356440		IC50			CHEMBL2345	Homo sapiens	IC50		
	14982902	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@H]1[C@H](C)C[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](OC(C)=O)[C@@H]1O		CHEMBL3356439	=	IC50	nM	1600.0	CHEMBL2345	Homo sapiens	IC50	uM	1.6
Not Active	14982903	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@@H]1[C@@H](C)C[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@@H](O)[C@H]1O		CHEMBL3356438		IC50			CHEMBL2345	Homo sapiens	IC50		
	14982904	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)C[C@H]1C		CHEMBL3356437	=	IC50	nM	1230.0	CHEMBL2345	Homo sapiens	IC50	uM	1.23
Not Active	14982905	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@@H]1[C@@H](C)C[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@@H](O)[C@H]1OC(C)=O		CHEMBL3356436		IC50			CHEMBL2345	Homo sapiens	IC50		
	14982906	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](C)C[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@@H]1O		CHEMBL3356435	=	IC50	nM	270.0	CHEMBL2345	Homo sapiens	IC50	uM	0.27
Not Active	14982907	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@@H]1[C@H](O)[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)O[C@H](C)[C@H]1OC(C)=O		CHEMBL3356434		IC50			CHEMBL2345	Homo sapiens	IC50		
	14982908	CHEMBL3378501	Inhibition of RSK2 (unknown origin) assessed as phosphorylation by Western lightning enhanced chemiluminescent reagent/HRP activity assay	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	IC50	nM	370.0	CHEMBL2345	Homo sapiens	IC50	uM	0.37
	14983167	CHEMBL3377041	Inhibition of RSK2 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	52.0	CHEMBL2345	Homo sapiens	INH	%	52.0
	14984409	CHEMBL3384382	Inhibition of RSK2 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	13.0	CHEMBL2345	Homo sapiens	INH	%	13.0
	15008108	CHEMBL3369113	Inhibition of human Rsk2 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	25.0	CHEMBL2345	Homo sapiens	INH	%	25.0
	15008109	CHEMBL3369113	Inhibition of human Rsk2 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	12.0	CHEMBL2345	Homo sapiens	INH	%	12.0
	15008110	CHEMBL3369113	Inhibition of human Rsk2 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	33.0	CHEMBL2345	Homo sapiens	INH	%	33.0
	15018691	CHEMBL3369191	Inhibition of RSK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	6.3	CHEMBL2345	Homo sapiens	INH	%	6.3
	15053962	CHEMBL3371226	Inhibition of RSK2 (unknown origin)	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140	>	IC50	nM	30000.0	CHEMBL2345	Homo sapiens	IC50	uM	30.0
	15055372	CHEMBL3371389	Inhibition of RPS6KA3 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	27.0	CHEMBL2345	Homo sapiens	Activity	%	27.0
Not Active	15062584	CHEMBL3370297	Inhibition of human RSK2 by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	15072482	CHEMBL3379513	Inhibition of RSK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	86.0	CHEMBL2345	Homo sapiens	Activity	%	86.0
	15116502	CHEMBL3377056	Inhibition of RSK2 (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	=	IC50	nM	27000.0	CHEMBL2345	Homo sapiens	IC50	uM	27.0
	15118087	CHEMBL3362076	Inhibition of his-tagged active RSK2 (unknown origin) expressed in Sf9 cells after 10 to 45 mins by ELISA	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	IC50	nM	89.0	CHEMBL2345	Homo sapiens	IC50	nM	89.0
	15251886	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	15.0	CHEMBL2345	Homo sapiens	Activity	%	15.0
	15251911	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	40.0	CHEMBL2345	Homo sapiens	Activity	%	40.0
	15252013	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	85.0	CHEMBL2345	Homo sapiens	Activity	%	85.0
	15252658	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	49.0	CHEMBL2345	Homo sapiens	Activity	%	49.0
	15252760	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	28.0	CHEMBL2345	Homo sapiens	Activity	%	28.0
	15252862	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	31.0	CHEMBL2345	Homo sapiens	Activity	%	31.0
	15253536	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	66.0	CHEMBL2345	Homo sapiens	Activity	%	66.0
	15253638	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	83.0	CHEMBL2345	Homo sapiens	Activity	%	83.0
	15253740	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	53.0	CHEMBL2345	Homo sapiens	Activity	%	53.0
	15254406	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	52.0	CHEMBL2345	Homo sapiens	Activity	%	52.0
	15254508	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	63.0	CHEMBL2345	Homo sapiens	Activity	%	63.0
	15254610	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	60.0	CHEMBL2345	Homo sapiens	Activity	%	60.0
	15255301	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	23.0	CHEMBL2345	Homo sapiens	Activity	%	23.0
	15255403	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	55.0	CHEMBL2345	Homo sapiens	Activity	%	55.0
	15255506	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	78.0	CHEMBL2345	Homo sapiens	Activity	%	78.0
	15256237	CHEMBL3427816	Inhibition of RSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	83.0	CHEMBL2345	Homo sapiens	Activity	%	83.0
	15258375	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	8.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	8.5
	15258376	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	6.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.8
	15258435	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15258436	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	6.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.3
	15258495	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15258496	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	-0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.6
	15258555	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15258556	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	6.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.4
	15258615	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15258616	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	5.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.7
	15258675	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15258676	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15258735	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.5
	15258736	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	6.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.3
	15258795	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15258796	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	1.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.1
	15258855	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	1.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.3
	15258856	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	1.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.4
	15258915	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	5.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.2
	15258916	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	2.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.5
	15258975	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	2.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.1
	15258976	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	-0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.4
	15259035	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	5.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.8
	15259036	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	6.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.0
	15259095	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	4.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.1
	15259096	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	1.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.4
	15259155	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	7.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.5
	15259156	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	4.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.1
	15259215	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	9.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	9.6
	15259216	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	9.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	9.6
	15259275	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	7.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.8
	15259276	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	4.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.8
	15259335	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	-1.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-1.4
	15259336	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15259395	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15259396	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15259455	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	1.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.2
	15259456	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15259515	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15259516	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15259575	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15259576	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259635	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15259636	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15259695	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	8.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	8.1
	15259696	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15259755	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	7.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.3
	15259756	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	8.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	8.6
	15259815	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	5.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.8
	15259816	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	10.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	10.7
	15259875	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	5.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.5
	15259876	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	9.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	9.4
	15259935	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.3
	15259936	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259995	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	3.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.3
	15259996	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	2.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.6
	15260055	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	7.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.7
	15260056	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	11.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	11.3
	15260115	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	3.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.0
	15260116	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	1.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.7
	15260175	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	2.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.2
	15260176	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	2.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.8
	15260235	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	7.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.3
	15260236	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	9.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	9.0
	15260295	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	5.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.6
	15260296	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	2.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.6
	15260355	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	8.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	8.5
	15260356	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	1.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.7
	15260415	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	-0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.9
	15260416	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	3.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.5
	15260475	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-0.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.5
	15260476	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.9
	15260535	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	5.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.9
	15260536	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	10.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	10.7
	15260595	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	4.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.8
	15260596	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	5.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.7
	15260655	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15260656	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	1.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.4
	15260715	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15260716	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	3.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.4
	15260775	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	2.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.2
	15260776	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15260835	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15260836	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15260895	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	4.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.2
	15260896	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15260955	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
Not Determined	15260956	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Thermal melting change			CHEMBL2345	Homo sapiens	Thermal melting change		
	15261015	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	-0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.4
Not Determined	15261016	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Thermal melting change			CHEMBL2345	Homo sapiens	Thermal melting change		
Not Determined	15261075	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940		Thermal melting change			CHEMBL2345	Homo sapiens	Thermal melting change		
Not Determined	15261076	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940		Thermal melting change			CHEMBL2345	Homo sapiens	Thermal melting change		
	15261135	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	1.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.3
	15261136	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	5.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.3
	15261158	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15261159	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261218	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	1.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.8
	15261219	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15261278	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	1.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.5
	15261279	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	1.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.7
	15261338	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15261339	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	0.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.5
	15261453	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	2.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.6
	15261454	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	6.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.4
	15261513	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261514	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261573	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	4.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.4
	15261574	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	5.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.1
	15261633	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-1.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-1.3
	15261634	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.3
	15261646	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	2.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.5
	15261647	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15261706	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	1.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.5
	15261707	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15261766	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15261767	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15261826	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	2.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.7
	15261827	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	2.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.4
	15261886	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15261887	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	1.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.5
	15261942	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15261943	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15262002	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15262003	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15262062	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15262063	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262122	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	5.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.1
	15262123	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15262195	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	2.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.4
	15262196	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15262255	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	2.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.1
	15262256	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15262315	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	1.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.7
	15262316	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	1.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.4
	15262375	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	-1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-1.0
	15262376	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15262435	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	1.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.3
	15262436	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15262495	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262496	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	1.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.7
	15262555	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	2.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.7
	15262556	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	5.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.1
	15262615	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15262616	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	2.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.5
	15262675	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15262676	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15262735	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15262736	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	1.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.9
	15262795	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15262796	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15262855	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	1.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.8
	15262856	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15262915	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	3.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.0
	15262916	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	1.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.9
	15262975	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15262976	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	-0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.4
	15263035	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	1.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.8
	15263036	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15263095	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	2.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.4
	15263096	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15263155	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15263156	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	2.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.7
	15263215	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15263216	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	1.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.2
	15263275	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15263276	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15263335	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	2.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.1
	15263336	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15263431	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15263432	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	4.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.6
	15263486	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15263487	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15263546	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	3.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.5
	15263547	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	7.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.0
	15263606	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	1.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.3
	15263607	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15263666	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	2.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.8
	15263667	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	2.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.9
	15263740	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15263741	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15263800	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	2.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.4
	15263801	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	5.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.5
	15263860	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	3.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.0
	15263861	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15263920	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	3.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.6
	15263921	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15263974	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	3.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.7
	15263975	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	1.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.8
	15264034	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	4.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.4
	15264035	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15264094	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264095	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15264154	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15264155	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.3
	15264214	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	1.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.6
	15264215	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	1.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.8
	15264227	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	3.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.1
	15264228	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	2.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.1
	15264287	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	5.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.8
	15264288	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15264347	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.5
	15264348	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264407	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	3.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.4
	15264408	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	3.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.0
	15264467	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	4.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.2
	15264468	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	6.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.3
	15264523	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	5.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.5
	15264524	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15264583	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	7.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.3
	15264584	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	5.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.1
	15264643	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	-0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.9
	15264644	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15264703	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.5
	15264704	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15264775	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	1.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.8
	15264776	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	-7.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-7.9
	15264835	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.5
	15264836	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	-5.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-5.0
	15264895	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	5.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.5
	15264896	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	7.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.5
	15264955	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	6.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.0
	15264956	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15265011	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15265012	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15265071	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	8.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	8.0
	15265072	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	-0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.7
	15265131	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.5
	15265132	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265191	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	6.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.6
	15265192	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	2.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.3
	15265264	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	4.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.6
	15265265	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	2.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.1
	15265324	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15265325	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265384	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15265385	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15265444	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	1.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.3
	15265445	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	1.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.7
	15265500	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	2.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.2
	15265501	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15265560	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15265561	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265620	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15265621	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	-0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.6
	15265680	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.2
	15265681	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15265752	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15265753	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15265812	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	1.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.1
	15265813	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	1.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.4
	15265872	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15265873	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15265932	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265933	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265989	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	7.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.5
	15265990	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266049	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15266050	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.7
	15266109	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15266110	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266169	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	2.7	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.7
	15266170	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	3.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.3
	15266241	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	3.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.8
	15266242	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15266301	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.8
	15266302	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-2.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-2.4
	15266361	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.6
	15266362	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15266421	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	5.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.6
	15266422	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	2.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.2
	15266476	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	5.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.6
	15266477	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	6.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.1
	15266536	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	2.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.5
	15266537	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	4.5	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	4.5
	15266596	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	7.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.8
	15266597	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15266656	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	8.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	8.1
	15266657	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	1.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.9
	15266729	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	5.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.6
	15266730	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	6.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.6
	15266789	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	-0.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.2
	15266790	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15266849	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	5.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	5.2
	15266850	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	2.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.1
	15266909	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	1.2	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.2
	15266910	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15266964	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	3.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	3.6
	15266965	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15267024	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	10.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	10.0
	15267025	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	2.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	2.1
	15267084	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	6.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	6.0
	15267085	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.1
	15267144	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	7.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	7.4
	15267145	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15267217	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.4
	15267218	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15267277	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	0.8	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.8
	15267278	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	1.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.1
	15267337	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.9	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.9
	15267338	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15267397	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	0.6	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.6
	15267398	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.3
	15267452	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	12.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	12.3
	15267453	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	13.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	13.1
	15267512	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15267513	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	-0.4	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.4
	15267572	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15267573	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	1.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	1.0
	15267632	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	-0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.3
	15267633	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	-0.3	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.3
	15267692	CHEMBL3430834	Delta TM value showing the stabilisation of RSK2a produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-0.1	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267693	CHEMBL3430835	Delta TM value showing the stabilisation of RSK2b produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.0	CHEMBL2345	Homo sapiens	Thermal melting change	degrees C	0.0
	15650176	CHEMBL3595496	Inhibition of human RSK2 at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	-1.0	CHEMBL2345	Homo sapiens	INH	%	-1.0
	15684301	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)[C@H]1C		CHEMBL3604889	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	uM	0.004
	15684302	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CC(C)Nc1ncc(-c2cc(F)c(O)c(F)c2)c(-c2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL3604888	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	uM	0.02
	15684303	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Cc1ccc(-c2nc(NC(C)C)ncc2-c2cc(F)c(O)c(F)c2)cc1		CHEMBL3604887	=	IC50	nM	23.0	CHEMBL2345	Homo sapiens	IC50	uM	0.023
	15684304	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CNc1ncc(-c2cc(F)c(O)c(F)c2)c(-c2ccc(C)cc2)n1		CHEMBL3604886	=	IC50	nM	13.0	CHEMBL2345	Homo sapiens	IC50	uM	0.013
	15684305	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Cc1ccc(-c2nc(N)ncc2-c2cc(F)c(O)c(F)c2)cc1		CHEMBL3604885	=	IC50	nM	10.0	CHEMBL2345	Homo sapiens	IC50	uM	0.01
	15684306	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Cc1ccc(Nc2cc(-c3ccc(N4CCN(C)CC4)cc3)c(-c3cc(F)c(O)c(F)c3)cn2)cc1		CHEMBL3604884	=	IC50	nM	6.0	CHEMBL2345	Homo sapiens	IC50	uM	0.006
	15684307	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CC(C)CNc1cc(-c2ccc(N3CCN(C)CC3)cc2)c(-c2cc(F)c(O)c(F)c2)cn1		CHEMBL3604883	=	IC50	nM	22.0	CHEMBL2345	Homo sapiens	IC50	uM	0.022
	15684308	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CNc1cc(-c2ccc(N3CCN(C)CC3)cc2)c(-c2cc(F)c(O)c(F)c2)cn1		CHEMBL3604882	=	IC50	nM	14.0	CHEMBL2345	Homo sapiens	IC50	uM	0.014
	15684309	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CN1CCN(c2ccc(-c3cc(N)ncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		CHEMBL3604881	=	IC50	nM	6.0	CHEMBL2345	Homo sapiens	IC50	uM	0.006
	15684310	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(Cl)cc(-c2cnccc2-c2ccc(F)cc2)cc1Cl		CHEMBL3604796	=	IC50	nM	4800.0	CHEMBL2345	Homo sapiens	IC50	uM	4.8
	15684311	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	COc1ccc(-c2ccncc2-c2cc(F)c(O)c(F)c2)cn1		CHEMBL3604795	=	IC50	nM	80.0	CHEMBL2345	Homo sapiens	IC50	uM	0.08
	15684312	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	uM	0.004
	15684313	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		CHEMBL3604793	=	IC50	nM	5.0	CHEMBL2345	Homo sapiens	IC50	uM	0.005
	15684314	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCNCC3)cc2)cc1F		CHEMBL3604792	=	IC50	nM	6.0	CHEMBL2345	Homo sapiens	IC50	uM	0.006
	15684315	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CNC(=O)c1ccc(-c2ccncc2-c2cc(F)c(O)c(F)c2)cc1		CHEMBL3604791	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	uM	0.02
	15684316	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	COc1ccc(-c2ccncc2-c2cc(F)c(O)c(F)c2)cc1		CHEMBL3604790	=	IC50	nM	8.0	CHEMBL2345	Homo sapiens	IC50	uM	0.008
	15684317	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Cc1ccc(-c2ccncc2-c2cc(F)c(O)c(F)c2)cc1		CHEMBL3604789	=	IC50	nM	7.0	CHEMBL2345	Homo sapiens	IC50	uM	0.007
	15684318	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(F)cc(-c2cnccc2-c2ccc(F)cc2)cc1F		CHEMBL3604788	=	IC50	nM	94.0	CHEMBL2345	Homo sapiens	IC50	uM	0.094
	15684319	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CN1CCN(c2cccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)c2)CC1		CHEMBL3604787	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	uM	0.004
	15684320	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(F)cc(-c2cnccc2-c2cccc(N3CCOCC3)c2)cc1F		CHEMBL3604786	=	IC50	nM	18.0	CHEMBL2345	Homo sapiens	IC50	uM	0.018
	15684321	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(F)cc(-c2cnccc2-c2cccc(-c3cn[nH]c3)c2)cc1F		CHEMBL3604785	=	IC50	nM	5.0	CHEMBL2345	Homo sapiens	IC50	uM	0.005
	15684322	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	NCCOc1cccc(-c2ccncc2-c2cc(F)c(O)c(F)c2)c1		CHEMBL3604784	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	uM	0.004
	15684323	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	COc1cccc(-c2ccncc2-c2cc(F)c(O)c(F)c2)c1		CHEMBL3604783	=	IC50	nM	46.0	CHEMBL2345	Homo sapiens	IC50	uM	0.046
	15684324	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Cc1cccc(-c2ccncc2-c2cc(F)c(O)c(F)c2)c1		CHEMBL3604782	=	IC50	nM	32.0	CHEMBL2345	Homo sapiens	IC50	uM	0.032
	15684325	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	CC(C)c1ccncc1-c1cc(F)c(O)c(F)c1		CHEMBL3604781	=	IC50	nM	780.0	CHEMBL2345	Homo sapiens	IC50	uM	0.78
	15684326	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(F)cc(-c2cnccc2C2CCNCC2)cc1F		CHEMBL3604780	=	IC50	nM	2100.0	CHEMBL2345	Homo sapiens	IC50	uM	2.1
	15684327	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(F)cc(-c2cnccc2C2CCOCC2)cc1F		CHEMBL3604779	=	IC50	nM	130.0	CHEMBL2345	Homo sapiens	IC50	uM	0.13
	15684328	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1c(F)cc(-c2cnccc2-c2ccccc2)cc1F		CHEMBL3604778	=	IC50	nM	60.0	CHEMBL2345	Homo sapiens	IC50	uM	0.06
	15684329	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1ccc(-c2ccncc2-c2cc(F)c(O)c(F)c2)cc1		CHEMBL3604777	=	IC50	nM	50.0	CHEMBL2345	Homo sapiens	IC50	uM	0.05
	15684330	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1ccc(-c2ccncc2-c2ccc(O)cc2)cc1		CHEMBL3604776	=	IC50	nM	180.0	CHEMBL2345	Homo sapiens	IC50	uM	0.18
	15684331	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1ccc(-c2cn[nH]c2-c2cc(F)c(O)c(F)c2)cc1		CHEMBL3604775	=	IC50	nM	6.0	CHEMBL2345	Homo sapiens	IC50	uM	0.006
	15684332	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Nc1n[nH]c(-c2ccc(O)cc2)c1-c1ccccc1		CHEMBL3604774	=	IC50	nM	53.0	CHEMBL2345	Homo sapiens	IC50	uM	0.053
	15684333	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1ccc(-c2cn[nH]c2-c2ccccc2)cc1		CHEMBL3604773	=	IC50	nM	2500.0	CHEMBL2345	Homo sapiens	IC50	uM	2.5
	15684334	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1ccc(-c2[nH]ncc2-c2ccccc2)cc1		CHEMBL3604772	=	IC50	nM	150.0	CHEMBL2345	Homo sapiens	IC50	uM	0.15
	15684335	CHEMBL3607765	Inhibition of human recombinant Histidine-tagged RSK2 using biotin-AGAGRSRHSSYPAGT-OH as substrate preincubated for 30 mins followed by ATP and substrate addition measured after 180 mins by AlphaScreen assay	B	Oc1ccc(-c2cn[nH]c2-c2ccc(O)cc2)cc1		CHEMBL3604771	=	IC50	nM	24.0	CHEMBL2345	Homo sapiens	IC50	uM	0.024
	15684365	CHEMBL3607887	Binding affinity to DNA-tagged RSK2 N-terminal kinase domain (unknown origin) assessed as level of protein captured on solid support at 10 uM by qPCR analysis relative to control	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	Activity	%	0.0	CHEMBL2345	Homo sapiens	Activity	%	0.0
	15754267	CHEMBL3631693	Inhibition of Rsk2 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	5.7	CHEMBL2345	Homo sapiens	INH	%	5.7
	15755930	CHEMBL3631581	Inhibition of RSK2 Kin.Dom1.1-N-terminal (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	77.0	CHEMBL2345	Homo sapiens	Activity	%	77.0
	15756822	CHEMBL3631464	Inhibition of RSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	46.27	CHEMBL2345	Homo sapiens	INH	%	46.27
	15757901	CHEMBL3631464	Inhibition of RSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	66.84	CHEMBL2345	Homo sapiens	INH	%	66.84
	15758880	CHEMBL3631464	Inhibition of RSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	5.36	CHEMBL2345	Homo sapiens	INH	%	5.36
	16413508	CHEMBL3742672	Inhibition of PRSK2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
	16425409	CHEMBL3749850	Inhibition of Rsk2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	1.9	CHEMBL2345	Homo sapiens	INH	%	1.9
	16431996	CHEMBL3750035	Inhibition of human RSK2 using [KKLNRTLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
	16451600	CHEMBL3761181	Inhibition of RSK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-5.9	CHEMBL2345	Homo sapiens	INH	%	-5.9
	16486389	CHEMBL3772123	Inhibition of human recombinant N-terminal RSK2 kinase domain 1 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	94.0	CHEMBL2345	Homo sapiens	Activity	%	94.0
	16495216	CHEMBL3777758	Inhibition of N-terminal His6-tagged recombinant human RSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	12.0	CHEMBL2345	Homo sapiens	Activity	%	12.0
	16496135	CHEMBL3777758	Inhibition of N-terminal His6-tagged recombinant human RSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL2345	Homo sapiens	Activity	%	-4.0
	16508925	CHEMBL3777758	Inhibition of N-terminal His6-tagged recombinant human RSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	10.0	CHEMBL2345	Homo sapiens	Activity	%	10.0
	16611965	CHEMBL3815436	Inhibition of human MAPKAPK1beta assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-46.0	CHEMBL2345	Homo sapiens	Activity	%	-46.0
	16611966	CHEMBL3815436	Inhibition of human MAPKAPK1beta assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-17.0	CHEMBL2345	Homo sapiens	Activity	%	-17.0
	16611967	CHEMBL3815436	Inhibition of human MAPKAPK1beta assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-71.0	CHEMBL2345	Homo sapiens	Activity	%	-71.0
	16611968	CHEMBL3815436	Inhibition of human MAPKAPK1beta assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-92.0	CHEMBL2345	Homo sapiens	Activity	%	-92.0
	16614623	CHEMBL3816839	Inhibition of human RSK2 at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	1.0	CHEMBL2345	Homo sapiens	INH	%	1.0
	16614624	CHEMBL3816840	Inhibition of human RSK3 at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-3.0	CHEMBL2345	Homo sapiens	INH	%	-3.0
	16618650	CHEMBL3816527	Inhibition of full length recombinant human GST-tagged RSK3 expressed in insect cells at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	16619696	CHEMBL3820363	Inhibition of recombinant human full length GST-tagged RSK3 expressed in insect cells at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL2345	Homo sapiens	INH	%	75.0
	16628499	CHEMBL3820311	Inhibition of MAPKAPK1B (unknown origin) at 1 uM	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL2345	Homo sapiens	INH	%	80.0
	16837394	CHEMBL3876052	Inhibition of human recombinant full length His-tagged RPS6KA3 expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	692.0	CHEMBL2345	Homo sapiens	IC50	nM	692.0
311875	17692141	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cccnc1)c1ccc2nc3n(c2c1)CCCNC3=O		CHEMBL3673565	=	IC50	nM	5600.0	CHEMBL2345	Homo sapiens	IC50	nM	5600.0
311876	17692142	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1c(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL3673566	=	IC50	nM	35.0	CHEMBL2345	Homo sapiens	IC50	nM	35.0
311877	17692143	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL3673567	=	IC50	nM	5.5	CHEMBL2345	Homo sapiens	IC50	nM	5.5
311878	17692144	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1c(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL3639724	=	IC50	nM	33.0	CHEMBL2345	Homo sapiens	IC50	nM	33.0
311879	17692145	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1ccnc(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)c1		CHEMBL3673568	=	IC50	nM	3200.0	CHEMBL2345	Homo sapiens	IC50	nM	3200.0
311880	17692146	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cnn(Cc2ccccc2)c1)c1ccc2nc3n(c2c1)CCCNC3=O		CHEMBL3673569	=	IC50	nM	44.0	CHEMBL2345	Homo sapiens	IC50	nM	44.0
311881	17692147	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1nc(-c2cccc(NC(=O)c3ccc4nc5n(c4c3)CCCNC5=O)c2)cs1		CHEMBL3673570	=	IC50	nM	1700.0	CHEMBL2345	Homo sapiens	IC50	nM	1700.0
311882	17692148	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cccc(F)c1)c1ccc2nc3n(c2c1)CCCNC3=O		CHEMBL3673571	=	IC50	nM	960.0	CHEMBL2345	Homo sapiens	IC50	nM	960.0
311883	17692149	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	NC(=O)c1ccccc1NC(=O)c1ccc2nc3n(c2c1)CCCNC3=O		CHEMBL3673572	=	IC50	nM	295.0	CHEMBL2345	Homo sapiens	IC50	nM	295.0
311884	17692150	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1cc(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)nc1C(=O)NC1CCCC1		CHEMBL3673573	=	IC50	nM	69.0	CHEMBL2345	Homo sapiens	IC50	nM	69.0
311885	17692151	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1ncc2cc(NC(=O)c3ccc4nc5n(c4c3)CCCNC5=O)cnc21		CHEMBL3673574	=	IC50	nM	870.0	CHEMBL2345	Homo sapiens	IC50	nM	870.0
311886	17692152	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cnc2ccccc2c1)c1ccc2nc3n(c2c1)CCCNC3=O		CHEMBL3673575	=	IC50	nM	1200.0	CHEMBL2345	Homo sapiens	IC50	nM	1200.0
311887	17692153	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1cc(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)cn1		CHEMBL3673576	=	IC50	nM	320.0	CHEMBL2345	Homo sapiens	IC50	nM	320.0
311888	17692154	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1cc(NC(=O)c2ccc3nc4n(c3c2)C(C)(C)CCNC4=O)cn1		CHEMBL3673577	=	IC50	nM	4000.0	CHEMBL2345	Homo sapiens	IC50	nM	4000.0
311889	17692155	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)nc2ccc(Cl)nc21		CHEMBL3673578	=	IC50	nM	45.0	CHEMBL2345	Homo sapiens	IC50	nM	45.0
311890	17692156	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CN(C)CCCn1c(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL3673579	=	IC50	nM	92.0	CHEMBL2345	Homo sapiens	IC50	nM	92.0
311891	17692157	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)nc2cccnc21		CHEMBL3673580	=	IC50	nM	23.0	CHEMBL2345	Homo sapiens	IC50	nM	23.0
311892	17692158	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1c(NC(=O)c2ccc3nc4n(c3c2)C(C)(C)CCNC4=O)nc2ccccc21		CHEMBL3673581	=	IC50	nM	4.7	CHEMBL2345	Homo sapiens	IC50	nM	4.7
311893	17692159	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cc(-c2ccccc2)no1)c1ccc2nc3n(c2c1)CCCNC3=O		CHEMBL3673582	=	IC50	nM	290.0	CHEMBL2345	Homo sapiens	IC50	nM	290.0
311894	17692160	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1cc(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)no1		CHEMBL3673583	=	IC50	nM	1550.0	CHEMBL2345	Homo sapiens	IC50	nM	1550.0
311895	17692161	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)(C)c1cc(NC(=O)c2ccc3nc4n(c3c2)CCCNC4=O)no1		CHEMBL3673584	=	IC50	nM	2000.0	CHEMBL2345	Homo sapiens	IC50	nM	2000.0
311896	17692162	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cccc(-c2c[nH]cn2)c1)c1ccc2nc3n(c2c1)CCCNC3=O		CHEMBL3673585	=	IC50	nM	1700.0	CHEMBL2345	Homo sapiens	IC50	nM	1700.0
311897	17692163	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cnc2ccccc2c1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673586	=	IC50	nM	9.2	CHEMBL2345	Homo sapiens	IC50	nM	9.2
311898	17692164	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1nc(-c2cccc(NC(=O)c3ccc4cc5n(c4n3)CCCNC5=O)c2)cs1		CHEMBL3673587	=	IC50	nM	56.0	CHEMBL2345	Homo sapiens	IC50	nM	56.0
311899	17692165	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cccc(F)c1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673588	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	nM	20.0
311900	17692166	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	NC(=O)c1ccccc1NC(=O)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673589	=	IC50	nM	2.3	CHEMBL2345	Homo sapiens	IC50	nM	2.3
311901	17692167	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cccnc1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673590	=	IC50	nM	37.0	CHEMBL2345	Homo sapiens	IC50	nM	37.0
311902	17692168	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCOC(=O)c1nc(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)cn1C		CHEMBL3673591	=	IC50	nM	90.0	CHEMBL2345	Homo sapiens	IC50	nM	90.0
311903	17692169	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1ncc2cc(NC(=O)c3ccc4cc5n(c4n3)C(C)CCNC5=O)cnc21		CHEMBL3673592	=	IC50	nM	2.1	CHEMBL2345	Homo sapiens	IC50	nM	2.1
311904	17692170	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1ncc2cc(NC(=O)c3ccc4cc5n(c4n3)CCCNC5=O)cnc21		CHEMBL3673593	=	IC50	nM	25.0	CHEMBL2345	Homo sapiens	IC50	nM	25.0
311905	17692171	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1ncc2cc(NC(=O)c3ccc4cc5n(c4n3)CC(C)(C)CNC5=O)cnc21		CHEMBL3673594	=	IC50	nM	105.0	CHEMBL2345	Homo sapiens	IC50	nM	105.0
311906	17692172	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cnc5c(cnn5C5CCOCC5)c4)nc3n21		CHEMBL3673595	=	IC50	nM	2.3	CHEMBL2345	Homo sapiens	IC50	nM	2.3
311907	17692173	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cnc2c(cnn2C2CCOCC2)c1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673596	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	nM	20.0
311908	17692174	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cnc5c(cnn5C5CCOCC5)c4)nc3n2C1		CHEMBL3673597	=	IC50	nM	62.0	CHEMBL2345	Homo sapiens	IC50	nM	62.0
311909	17692175	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cnc5c(cnn5CC5CCOC5)c4)nc3n21		CHEMBL3673598	=	IC50	nM	1.6	CHEMBL2345	Homo sapiens	IC50	nM	1.6
311910	17692176	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cnc2c(cnn2CC2CCOC2)c1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673599	=	IC50	nM	13.0	CHEMBL2345	Homo sapiens	IC50	nM	13.0
311911	17692177	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cnc5c(cnn5CC5CCOC5)c4)nc3n2C1		CHEMBL3673600	=	IC50	nM	25.0	CHEMBL2345	Homo sapiens	IC50	nM	25.0
311912	17692178	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1ccnc(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)c1		CHEMBL3673601	=	IC50	nM	3.8	CHEMBL2345	Homo sapiens	IC50	nM	3.8
311913	17692179	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cnc5ccccc5c4)nc3n2C1		CHEMBL3673602	=	IC50	nM	91.0	CHEMBL2345	Homo sapiens	IC50	nM	91.0
311914	17692180	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cnn(C)c4)nc3n21		CHEMBL3673603	=	IC50	nM	0.78	CHEMBL2345	Homo sapiens	IC50	nM	0.78
311915	17692181	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1cc(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)cn1		CHEMBL3673604	=	IC50	nM	4.8	CHEMBL2345	Homo sapiens	IC50	nM	4.8
311916	17692182	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1cc(NC(=O)c2ccc3cc4n(c3n2)CC(C)(C)CNC4=O)cn1		CHEMBL3673605	=	IC50	nM	72.0	CHEMBL2345	Homo sapiens	IC50	nM	72.0
311917	17692183	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cnn(C(C)(C)C)c4)nc3n21		CHEMBL3673606	=	IC50	nM	1.1	CHEMBL2345	Homo sapiens	IC50	nM	1.1
311918	17692184	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)(C)n1cc(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)cn1		CHEMBL3673607	=	IC50	nM	9.7	CHEMBL2345	Homo sapiens	IC50	nM	9.7
311919	17692185	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cnn(C(C)(C)C)c4)nc3n2C1		CHEMBL3673608	=	IC50	nM	50.0	CHEMBL2345	Homo sapiens	IC50	nM	50.0
311920	17692186	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cnn(Cc5ccccc5)c4)nc3n21		CHEMBL3673609	=	IC50	nM	0.39	CHEMBL2345	Homo sapiens	IC50	nM	0.39
311921	17692187	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cnn(Cc2ccccc2)c1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673610	=	IC50	nM	3.8	CHEMBL2345	Homo sapiens	IC50	nM	3.8
311922	17692188	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cnn(Cc5ccccc5)c4)nc3n2C1		CHEMBL3673611	=	IC50	nM	12.0	CHEMBL2345	Homo sapiens	IC50	nM	12.0
311923	17692189	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1nc2cc(Cl)cc(CN3CCOCC3)c2[nH]1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673612	=	IC50	nM	6.7	CHEMBL2345	Homo sapiens	IC50	nM	6.7
311924	17692190	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4nc5cc(Cl)ccc5[nH]4)nc3n2C1		CHEMBL3673613	=	IC50	nM	55.0	CHEMBL2345	Homo sapiens	IC50	nM	55.0
311925	17692191	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1c(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)nc2ccccc21		CHEMBL3673614	=	IC50	nM	365.0	CHEMBL2345	Homo sapiens	IC50	nM	365.0
311926	17692192	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1c(NC(=O)c2ccc3cc4n(c3n2)CC(C)(C)CNC4=O)nc2ccccc21		CHEMBL3673615	=	IC50	nM	2500.0	CHEMBL2345	Homo sapiens	IC50	nM	2500.0
311927	17692193	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1c(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)nc2ccccc21		CHEMBL3673616	=	IC50	nM	630.0	CHEMBL2345	Homo sapiens	IC50	nM	630.0
311928	17692194	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1c(NC(=O)c2ccc3cc4n(c3n2)CC(C)(C)CNC4=O)nc2ccccc21		CHEMBL3673617	=	IC50	nM	1300.0	CHEMBL2345	Homo sapiens	IC50	nM	1300.0
311929	17692195	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)nc2ccccc21		CHEMBL3673618	=	IC50	nM	140.0	CHEMBL2345	Homo sapiens	IC50	nM	140.0
311930	17692196	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3cc4n(c3n2)CC(C)(C)CNC4=O)nc2ccccc21		CHEMBL3673619	=	IC50	nM	195.0	CHEMBL2345	Homo sapiens	IC50	nM	195.0
311931	17692197	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)nc2ccccc21		CHEMBL3673620	=	IC50	nM	245.0	CHEMBL2345	Homo sapiens	IC50	nM	245.0
311932	17692198	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3n2)CC(C)(C)CNC4=O)nc2ccccc21		CHEMBL3673621	=	IC50	nM	2300.0	CHEMBL2345	Homo sapiens	IC50	nM	2300.0
311933	17692199	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@@H]1CNC(=O)c2cc3ccc(C(=O)Nc4cnn(Cc5ccccc5)c4)nc3n21		CHEMBL3673622	=	IC50	nM	0.2	CHEMBL2345	Homo sapiens	IC50	nM	0.2
311934	17692200	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@H]1CNC(=O)c2cc3ccc(C(=O)Nc4cnn(Cc5ccccc5)c4)nc3n21		CHEMBL3673623	=	IC50	nM	12.0	CHEMBL2345	Homo sapiens	IC50	nM	12.0
311935	17692201	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@H]1[C@@H](C)NC(=O)c2cc3ccc(C(=O)Nc4cnn(Cc5ccccc5)c4)nc3n21		CHEMBL3673624	=	IC50	nM	0.34	CHEMBL2345	Homo sapiens	IC50	nM	0.34
311936	17692202	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@@H]1NC(=O)c2cc3ccc(C(=O)Nc4cnn(Cc5ccccc5)c4)nc3n2[C@H]1C		CHEMBL3673625	=	IC50	nM	3.0	CHEMBL2345	Homo sapiens	IC50	nM	3.0
311937	17692203	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1ncc2cc(NC(=O)c3ccc4cc5n(c4n3)[C@@H](C)CNC5=O)cnc21		CHEMBL3673626	=	IC50	nM	84.0	CHEMBL2345	Homo sapiens	IC50	nM	84.0
311938	17692204	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@@H]1CNC(=O)c2cc3ccc(C(=O)Nc4cnc5ccccc5c4)nc3n21		CHEMBL3673627	=	IC50	nM	3.0	CHEMBL2345	Homo sapiens	IC50	nM	3.0
311939	17692205	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@H]1CNC(=O)c2cc3ccc(C(=O)Nc4cnc5ccccc5c4)nc3n21		CHEMBL3673628	=	IC50	nM	34.0	CHEMBL2345	Homo sapiens	IC50	nM	34.0
311940	17692206	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)n1ncc2cc(NC(=O)c3ccc4cc5n(c4n3)[C@H](C)CNC5=O)cnc21		CHEMBL3673629	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	nM	4.0
311941	17692207	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1nc2cc(Cl)ccc2[nH]1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673630	=	IC50	nM	6.1	CHEMBL2345	Homo sapiens	IC50	nM	6.1
311942	17692208	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cnn(Cc5ccncc5)c4)nc3n21		CHEMBL3673631	=	IC50	nM	0.27	CHEMBL2345	Homo sapiens	IC50	nM	0.27
311943	17692209	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3cc4n(c3n2)C(C)CCNC4=O)nc2ccccc21		CHEMBL3673632	=	IC50	nM	15.0	CHEMBL2345	Homo sapiens	IC50	nM	15.0
311944	17692210	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)nc3n21		CHEMBL3673633	=	IC50	nM	27.0	CHEMBL2345	Homo sapiens	IC50	nM	27.0
311945	17692211	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3cc4n(c3n2)[C@@H](C)CNC4=O)nc2ccccc21		CHEMBL3673634	=	IC50	nM	54.5	CHEMBL2345	Homo sapiens	IC50	nM	54.5
311946	17692212	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3cc4n(c3n2)[C@H](C)CNC4=O)nc2ccccc21		CHEMBL3673635	=	IC50	nM	26.5	CHEMBL2345	Homo sapiens	IC50	nM	26.5
311947	17692213	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3cc4n(c3n2)[C@@H](C)[C@@H](C)NC4=O)nc2ccccc21		CHEMBL3673636	=	IC50	nM	11.6	CHEMBL2345	Homo sapiens	IC50	nM	11.6
311948	17692214	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCn1c(NC(=O)c2ccc3cc4n(c3n2)[C@@H](C)[C@H](C)NC4=O)nc2ccccc21		CHEMBL3673637	=	IC50	nM	1111.0	CHEMBL2345	Homo sapiens	IC50	nM	1111.0
311949	17692215	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@H]1CNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)nc3n21		CHEMBL3673638	=	IC50	nM	265.0	CHEMBL2345	Homo sapiens	IC50	nM	265.0
311950	17692216	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@@H]1CNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)nc3n21		CHEMBL3673639	=	IC50	nM	54.0	CHEMBL2345	Homo sapiens	IC50	nM	54.0
311951	17692217	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@H]1[C@@H](C)NC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)nc3n21		CHEMBL3673640	=	IC50	nM	29.0	CHEMBL2345	Homo sapiens	IC50	nM	29.0
311952	17692218	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@@H]1NC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)nc3n2[C@H]1C		CHEMBL3673641	=	IC50	nM	205.0	CHEMBL2345	Homo sapiens	IC50	nM	205.0
311953	17692219	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)(C)c1cc(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)no1		CHEMBL3673642	=	IC50	nM	19.0	CHEMBL2345	Homo sapiens	IC50	nM	19.0
311954	17692220	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1cc(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)no1		CHEMBL3673643	=	IC50	nM	19.0	CHEMBL2345	Homo sapiens	IC50	nM	19.0
311955	17692221	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cc(-c2ccccc2)no1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673644	=	IC50	nM	4.3	CHEMBL2345	Homo sapiens	IC50	nM	4.3
311956	17692222	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1cc(NC(=O)c2ccc3cc4n(c3n2)C(C)CCNC4=O)no1		CHEMBL3673645	=	IC50	nM	5.2	CHEMBL2345	Homo sapiens	IC50	nM	5.2
311957	17692223	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1cc(NC(=O)c2ccc3cc4n(c3n2)[C@@H](C)CNC4=O)no1		CHEMBL3673646	=	IC50	nM	380.0	CHEMBL2345	Homo sapiens	IC50	nM	380.0
311958	17692224	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1cc(NC(=O)c2ccc3cc4n(c3n2)[C@H](C)CNC4=O)no1		CHEMBL3673647	=	IC50	nM	6.6	CHEMBL2345	Homo sapiens	IC50	nM	6.6
311959	17692225	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1cc(NC(=O)c2ccc3cc4n(c3n2)[C@@H](C)[C@@H](C)NC4=O)no1		CHEMBL3673648	=	IC50	nM	2.6	CHEMBL2345	Homo sapiens	IC50	nM	2.6
311960	17692226	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1cc(NC(=O)c2ccc3cc4n(c3n2)[C@@H](C)[C@H](C)NC4=O)no1		CHEMBL3673649	=	IC50	nM	110.0	CHEMBL2345	Homo sapiens	IC50	nM	110.0
311961	17692227	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cc(C(C)(C)C)on4)nc3n2C1		CHEMBL3673650	=	IC50	nM	175.0	CHEMBL2345	Homo sapiens	IC50	nM	175.0
311962	17692228	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CCc1cc(NC(=O)c2ccc3cc4n(c3n2)CC(C)(C)CNC4=O)no1		CHEMBL3673651	=	IC50	nM	109.0	CHEMBL2345	Homo sapiens	IC50	nM	109.0
311963	17692229	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC(C)c1cc(NC(=O)c2ccc3cc4n(c3n2)CC(C)(C)CNC4=O)no1		CHEMBL3673652	=	IC50	nM	125.0	CHEMBL2345	Homo sapiens	IC50	nM	125.0
311964	17692230	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cc(C5CC5)on4)nc3n2C1		CHEMBL3673653	=	IC50	nM	43.0	CHEMBL2345	Homo sapiens	IC50	nM	43.0
311965	17692231	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cc1cc(NC(=O)c2ccc3cc4n(c3n2)CC(C)(C)CNC4=O)no1		CHEMBL3673654	=	IC50	nM	395.0	CHEMBL2345	Homo sapiens	IC50	nM	395.0
311966	17692232	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cc(-c5ccccc5)on4)nc3n2C1		CHEMBL3673655	=	IC50	nM	502.0	CHEMBL2345	Homo sapiens	IC50	nM	502.0
311967	17692233	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1(C)CNC(=O)c2cc3ccc(C(=O)Nc4cc(Cc5ccccc5)on4)nc3n2C1		CHEMBL3673656	=	IC50	nM	360.0	CHEMBL2345	Homo sapiens	IC50	nM	360.0
311968	17692234	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cc(Cc5ccccc5)on4)nc3n21		CHEMBL3673657	=	IC50	nM	3.3	CHEMBL2345	Homo sapiens	IC50	nM	3.3
311969	17692235	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cc(Cc2ccccc2)no1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673658	=	IC50	nM	3.6	CHEMBL2345	Homo sapiens	IC50	nM	3.6
311970	17692236	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CCNC(=O)c2cc3ccc(C(=O)Nc4cc(Cc5ccccc5)no4)nc3n21		CHEMBL3673659	=	IC50	nM	13.0	CHEMBL2345	Homo sapiens	IC50	nM	13.0
311971	17692237	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@H]1CNC(=O)c2cc3ccc(C(=O)Nc4cc(Cc5ccccc5)on4)nc3n21		CHEMBL3673660	=	IC50	nM	490.0	CHEMBL2345	Homo sapiens	IC50	nM	490.0
311972	17692238	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@@H]1CNC(=O)c2cc3ccc(C(=O)Nc4cc(Cc5ccccc5)on4)nc3n21		CHEMBL3673661	=	IC50	nM	3.9	CHEMBL2345	Homo sapiens	IC50	nM	3.9
311973	17692239	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@H]1[C@@H](C)NC(=O)c2cc3ccc(C(=O)Nc4cc(Cc5ccccc5)on4)nc3n21		CHEMBL3673662	=	IC50	nM	5.1	CHEMBL2345	Homo sapiens	IC50	nM	5.1
311974	17692240	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	C[C@@H]1NC(=O)c2cc3ccc(C(=O)Nc4cc(Cc5ccccc5)on4)nc3n2[C@H]1C		CHEMBL3673663	=	IC50	nM	57.0	CHEMBL2345	Homo sapiens	IC50	nM	57.0
311975	17692241	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4cccnc4)nc3n21		CHEMBL3673664	=	IC50	nM	120.0	CHEMBL2345	Homo sapiens	IC50	nM	120.0
311976	17692242	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CNC(=O)c1csc(NC(=O)c2ccc3cc4n(c3n2)C(C)CNC4=O)n1		CHEMBL3673665	=	IC50	nM	130.0	CHEMBL2345	Homo sapiens	IC50	nM	130.0
311977	17692243	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	CC1CNC(=O)c2cc3ccc(C(=O)Nc4nccs4)nc3n21		CHEMBL3673666	=	IC50	nM	330.0	CHEMBL2345	Homo sapiens	IC50	nM	330.0
311978	17692244	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	Cn1cc(NC(=O)c2ccc3cc4n(c3n2)CCCNC4=O)nc1C(=O)NC1CCCC1		CHEMBL3639725	=	IC50	nM	1.6	CHEMBL2345	Homo sapiens	IC50	nM	1.6
311979	17692245	CHEMBL3706312	Kinase Glo Assay: Human RSK2 protein, purchased from Invitrogen, is used to measure kinase activity utilizing Kinase Glo Plus (Promega) a homogeneous assay technology, which uses a luciferin-luciferase based ATP detection reagent to quantify residual ATP. The assay is performed using 0.75 nM His-RSK2, 0.75 uM ATP and 1.0 uM S6 Kinase/RSK Substrate Peptide 1 (Upstate, catalog #12-124), in assay buffer consisting of 25 mM HEPES, pH 7.5, 10 mM MgCl2, 5 mM MnCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 uM Na3VO4, 0.5 mM DTT, and 1% DMSO. Solutions of test compounds at various concentrations are prepared by 1:3 fold serial dilution of a 1 mM solution of compound in DMSO. The DMSO solutions are further diluted with assay buffer to a final concentration of DMSO of 5%.The assay is performed in a 384 well, white, non-binding plate (Corning, catalogue #3574). Solutions of test compounds (10 uL) are transferred to a dry assay plate, followed by addition of 20 uL kinase.	B	O=C(Nc1cccc(-c2c[nH]cn2)c1)c1ccc2cc3n(c2n1)CCCNC3=O		CHEMBL3673667	=	IC50	nM	17.0	CHEMBL2345	Homo sapiens	IC50	nM	17.0
412047	17776762	CHEMBL3888690	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
Inactive	17936467	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936468	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936469	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936470	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936471	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936472	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936473	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936474	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936475	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936476	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936477	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936478	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936479	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936480	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936481	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936482	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936483	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936484	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	100.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	100.0
Active	17936485	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	2990.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	2990.0
Inactive	17936486	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936487	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936488	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936489	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936490	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936491	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936492	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936493	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936494	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936495	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936496	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936497	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936498	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936499	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936500	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936501	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936502	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936503	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936504	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936505	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936506	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936507	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936508	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936509	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936510	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936511	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936512	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936513	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936514	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936515	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936516	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	5997.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	5997.0
Inactive	17936517	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936518	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936519	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936520	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936521	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936522	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936523	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936524	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936525	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936526	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936527	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936528	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936529	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1392.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	1392.0
Inactive	17936530	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936531	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936532	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936533	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936534	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936535	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936536	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936537	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936538	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936539	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1696.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	1696.0
Inactive	17936540	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936541	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936542	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936543	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936544	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936545	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936546	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936547	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936548	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936549	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936550	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936551	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936552	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936553	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936554	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936555	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936556	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936557	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	3497.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	3497.0
Active	17936558	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	4973.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	4973.0
Inactive	17936559	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936560	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936561	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936562	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936563	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936564	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936565	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936566	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936567	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936568	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936569	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936570	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936571	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936572	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936573	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936574	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936575	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936576	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936577	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936578	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936579	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936580	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936581	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936582	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936583	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936584	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936585	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936586	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936587	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936588	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936589	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936590	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936591	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936592	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936593	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936594	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936595	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936596	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936597	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936598	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936599	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936600	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936601	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936602	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936603	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936604	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936605	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936606	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936607	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936608	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936609	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936610	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936611	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936612	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	108.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	108.0
Inactive	17936613	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936614	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936615	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936616	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936617	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936618	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936619	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936620	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936621	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936622	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936623	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936624	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936625	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936626	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936627	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936628	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936629	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936630	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936631	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936632	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936633	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936634	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936635	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936636	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936637	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936638	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936639	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936640	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936641	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936642	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936643	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936644	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936645	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936646	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936647	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936648	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936649	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936650	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936651	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936652	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936653	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936654	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936655	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936656	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936657	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936658	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936659	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936660	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936661	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	37605.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	37605.0
Inactive	17936662	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936663	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936664	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936665	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936666	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936667	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936668	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936669	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936670	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2022.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	2022.0
Inactive	17936671	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936672	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936673	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936674	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936675	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936676	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936677	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936678	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936679	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936680	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936681	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936682	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936683	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936684	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936685	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936686	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	2661.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	2661.0
Active	17936687	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	734.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	734.0
Inactive	17936688	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936689	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936690	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936691	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	166.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	166.0
Active	17936692	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	5305.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	5305.0
Inactive	17936693	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936694	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936695	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Active	17936696	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	5891.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	5891.0
Inactive	17936697	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936698	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936699	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936700	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936701	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936702	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936703	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936704	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936705	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936706	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936707	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936708	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936709	CHEMBL3991873	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2345	Homo sapiens	Kd apparent	nM	30000.0
	18031861	CHEMBL4007744	Inhibition of RSK2 (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	83.0	CHEMBL2345	Homo sapiens	IC50	uM	0.083
	18031862	CHEMBL4007744	Inhibition of RSK2 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
	18031863	CHEMBL4007744	Inhibition of RSK2 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	=	IC50	nM	9810.0	CHEMBL2345	Homo sapiens	IC50	uM	9.81
	18031864	CHEMBL4007744	Inhibition of RSK2 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
	18113835	CHEMBL4024864	Inhibition of RSK2 in human MDA-MB-231 cells after 2 hrs	B	Cc1ccc(-c2c(/C=C(\C#N)C(=O)NC(C)C)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL4089765	=	IC50	nM	5.0	CHEMBL2345	Homo sapiens	IC50	uM	0.005
	18113836	CHEMBL4024864	Inhibition of RSK2 in human MDA-MB-231 cells after 2 hrs	B	Cc1ccc(-c2c(/C=C(\C#N)C(=O)OC(C)(C)C)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL4061650	=	IC50	nM	7.0	CHEMBL2345	Homo sapiens	IC50	uM	0.007
	18113837	CHEMBL4024864	Inhibition of RSK2 in human MDA-MB-231 cells after 2 hrs	B	Cc1ccc(-c2c(/C=C/C#N)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL4069201	=	IC50	nM	750.0	CHEMBL2345	Homo sapiens	IC50	uM	0.75
	18113838	CHEMBL4024864	Inhibition of RSK2 in human MDA-MB-231 cells after 2 hrs	B	COC(=O)/C=C/c1c(-c2ccc(C)cc2)c2c(N)ncnc2n1CCCO		CHEMBL4065469	=	IC50	nM	250.0	CHEMBL2345	Homo sapiens	IC50	uM	0.25
	18114844	CHEMBL4025374	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	18114845	CHEMBL4025375	Inhibition of wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	96.0	CHEMBL2345	Homo sapiens	Activity	%	96.0
	18153005	CHEMBL4034545	Inhibition of RSK2 domain 1 (unknown origin) labeling at conserved lysine2 at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	9.5	CHEMBL2345	Homo sapiens	INH	%	9.5
	18153034	CHEMBL4034484	Inhibition of RSK2 domain 2 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	8.4	CHEMBL2345	Homo sapiens	INH	%	8.4
	18153193	CHEMBL4034544	Inhibition of RSK2 domain 1 (unknown origin) labeling at activation loop at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	5.9	CHEMBL2345	Homo sapiens	INH	%	5.9
	18153226	CHEMBL4034483	Inhibition of RSK2 domain 1 ATP binding site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	3.2	CHEMBL2345	Homo sapiens	INH	%	3.2
	18203900	CHEMBL4044187	Inhibition of wild-type human partial length N-terminal RSK3 kinase domain 1 (M1 to Q385 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	97.0	CHEMBL2345	Homo sapiens	Activity	%	97.0
	18203901	CHEMBL4044188	Inhibition of wild-type human partial length C-terminal RSK3 kinase domain 2 (V403 to K700 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	88.0	CHEMBL2345	Homo sapiens	Activity	%	88.0
	18211726	CHEMBL4045822	Inhibition of RSK2 conserved Lys2 (DLKPENILLDEEGHIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	10.2	CHEMBL2345	Homo sapiens	INH	%	10.2
	18211728	CHEMBL4045824	Inhibition of RSK2 domain1 activation Loop (LTDFGLSKESIDHEKK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	22.0	CHEMBL2345	Homo sapiens	INH	%	22.0
	18211729	CHEMBL4045825	Inhibition of RSK2 domain1 ATP binding site (VLGQGSFGKVFLVK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	23.2	CHEMBL2345	Homo sapiens	INH	%	23.2
	18211730	CHEMBL4045826	Inhibition of RSK2 domain1 conserved Lys2 (DLKPENILLDEEGHIKLTDFGLSKESIDHEK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	18.1	CHEMBL2345	Homo sapiens	INH	%	18.1
	18211731	CHEMBL4045827	Inhibition of RSK2 domain2 conserved Lys2 (DLKPSNILYVDESGNPESIR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-6.6	CHEMBL2345	Homo sapiens	INH	%	-6.6
	18211967	CHEMBL4046063	Inhibition of RSK2 conserved Lys2 (DLKPENILLDEEGHIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	11.8	CHEMBL2345	Homo sapiens	INH	%	11.8
	18211969	CHEMBL4046065	Inhibition of RSK2 domain1 activation Loop (LTDFGLSKESIDHEKK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	7.7	CHEMBL2345	Homo sapiens	INH	%	7.7
	18211970	CHEMBL4046066	Inhibition of RSK2 domain1 ATP binding site (VLGQGSFGKVFLVK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	3.1	CHEMBL2345	Homo sapiens	INH	%	3.1
	18211971	CHEMBL4046067	Inhibition of RSK2 domain1 conserved Lys2 (DLKPENILLDEEGHIKLTDFGLSKESIDHEK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	8.8	CHEMBL2345	Homo sapiens	INH	%	8.8
	18211972	CHEMBL4046068	Inhibition of RSK2 domain2 conserved Lys2 (DLKPSNILYVDESGNPESIR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-0.7	CHEMBL2345	Homo sapiens	INH	%	-0.7
	18232191	CHEMBL4050315	Inhibition of human RSK2 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	62.0	CHEMBL2345	Homo sapiens	Activity	%	62.0
	18253295	CHEMBL4054931	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	47.0	CHEMBL2345	Homo sapiens	Activity	%	47.0
	18253296	CHEMBL4054931	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	74.0	CHEMBL2345	Homo sapiens	Activity	%	74.0
	18253441	CHEMBL4055004	Inhibition of wild-type human partial length N-terminal RSK3 kinase domain 1 (M1 to Q385 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	77.0	CHEMBL2345	Homo sapiens	Activity	%	77.0
	18253442	CHEMBL4055004	Inhibition of wild-type human partial length N-terminal RSK3 kinase domain 1 (M1 to Q385 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	87.0	CHEMBL2345	Homo sapiens	Activity	%	87.0
	18253519	CHEMBL4055043	Inhibition of wild-type human partial length C-terminal RSK3 kinase domain 2 (V403 to K700 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	85.0	CHEMBL2345	Homo sapiens	Activity	%	85.0
	18253520	CHEMBL4055043	Inhibition of wild-type human partial length C-terminal RSK3 kinase domain 2 (V403 to K700 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	93.0	CHEMBL2345	Homo sapiens	Activity	%	93.0
	18265798	CHEMBL4057248	Inhibition of RSK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	36.0	CHEMBL2345	Homo sapiens	INH	%	36.0
	18265996	CHEMBL4057446	Inhibition of RSK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-2.0	CHEMBL2345	Homo sapiens	INH	%	-2.0
	18275265	CHEMBL4118467	Inhibition of RSK2 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENILLDEEGHIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	42.5	CHEMBL2345	Homo sapiens	INH	%	42.5
	18275266	CHEMBL4118467	Inhibition of RSK2 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENILLDEEGHIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	13.0	CHEMBL2345	Homo sapiens	INH	%	13.0
	18275267	CHEMBL4118467	Inhibition of RSK2 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENILLDEEGHIK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	65.4	CHEMBL2345	Homo sapiens	INH	%	65.4
	18275274	CHEMBL4118470	Inhibition of RSK2 domain2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNILYVDESGNPESIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-39.8	CHEMBL2345	Homo sapiens	INH	%	-39.8
	18275275	CHEMBL4118470	Inhibition of RSK2 domain2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNILYVDESGNPESIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-9.3	CHEMBL2345	Homo sapiens	INH	%	-9.3
	18275276	CHEMBL4118470	Inhibition of RSK2 domain2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNILYVDESGNPESIR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-25.7	CHEMBL2345	Homo sapiens	INH	%	-25.7
Active	18275784	CHEMBL4118744	Binding affinity to RPS6KA3 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2345	Homo sapiens	Activity		
Active	18275935	CHEMBL4118895	Binding affinity to RPS6KA3 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2345	Homo sapiens	Activity		
	18282200	CHEMBL4120155	Inhibition of recombinant full length His-tagged human RSK2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	2.8	CHEMBL2345	Homo sapiens	INH	%	2.8
	18282519	CHEMBL4120155	Inhibition of recombinant full length His-tagged human RSK2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	2.0	CHEMBL2345	Homo sapiens	INH	%	2.0
	18282692	CHEMBL4120277	Inhibition of RSK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	36.0	CHEMBL2345	Homo sapiens	INH	%	36.0
	18282913	CHEMBL4120498	Inhibition of RSK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-5.7	CHEMBL2345	Homo sapiens	INH	%	-5.7
	18283133	CHEMBL4120718	Inhibition of RSK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	1.7	CHEMBL2345	Homo sapiens	INH	%	1.7
	18415122	CHEMBL4152886	Binding affinity to RPS6KA3 (unknown origin)	B	CN(C1COC1)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21		CHEMBL3702836	=	Kd	nM	0.54	CHEMBL2345	Homo sapiens	Kd	pM	540.0
	18431082	CHEMBL4155763	Inhibition of recombinant full length His-tagged human RSK2 expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	98.0	CHEMBL2345	Homo sapiens	INH	%	98.0
	18440442	CHEMBL4157266	Binding affinity to wild-type human partial length N-termianl RSK3 kinase domain 1 (M1 to Q385 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	82.0	CHEMBL2345	Homo sapiens	Activity	%	82.0
	18440443	CHEMBL4157267	Binding affinity to wild-type human partial length C-terminal RSK3 kinase domain 2 (V403 to K700 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	76.0	CHEMBL2345	Homo sapiens	Activity	%	76.0
	18449893	CHEMBL4178127	Inhibition of human RSK2 assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	18463804	CHEMBL4181220	Inhibition of recombinant human full length N-terminal His6-tagged Rsk2 expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	4.0	CHEMBL2345	Homo sapiens	INH	%	4.0
	18484398	CHEMBL4186045	Binding affinity to wild-type human partial length N-terminal RSK3 kinase domain 1 (M1 to Q385 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	89.0	CHEMBL2345	Homo sapiens	Activity	%	89.0
	18484399	CHEMBL4186046	Binding affinity to wild-type human partial length C-terminal RSK3 kinase domain 2 (V403 to K700 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	18484882	CHEMBL4186045	Binding affinity to wild-type human partial length N-terminal RSK3 kinase domain 1 (M1 to Q385 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	85.0	CHEMBL2345	Homo sapiens	Activity	%	85.0
	18484883	CHEMBL4186046	Binding affinity to wild-type human partial length C-terminal RSK3 kinase domain 2 (V403 to K700 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	85.0	CHEMBL2345	Homo sapiens	Activity	%	85.0
	18489563	CHEMBL4187304	Inhibition of wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	75.0	CHEMBL2345	Homo sapiens	Activity	%	75.0
	18507615	CHEMBL4191177	Inhibition of recombinant human Rsk2 (2 to end residues) at 1 uM using KKKNRTLSVA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-5.0	CHEMBL2345	Homo sapiens	INH	%	-5.0
	18578780	CHEMBL4222450	Inhibition of RSK2 (unknown origin)	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	=	IC50	nM	180.0	CHEMBL2345	Homo sapiens	IC50	nM	180.0
	18578781	CHEMBL4222450	Inhibition of RSK2 (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	=	IC50	nM	260.0	CHEMBL2345	Homo sapiens	IC50	nM	260.0
	18653377	CHEMBL4230217	Inhibition of RSK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	18653378	CHEMBL4230217	Inhibition of RSK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	18655291	CHEMBL4230944	Binding affinity to wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	18655292	CHEMBL4230943	Binding affinity to wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	18663959	CHEMBL4232943	Inhibition of human N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	91.0	CHEMBL2345	Homo sapiens	Activity	%	91.0
	18664056	CHEMBL4233040	Binding affinity to human N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2345	Homo sapiens	Kd	uM	5.0
	18665528	CHEMBL4233404	Inhibition of RSK2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL2345	Homo sapiens	IC50	nM	1000.0
	18674889	CHEMBL4235432	Inhibition of RSK2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2345	Homo sapiens	Ki	nM	2000.0
	18674890	CHEMBL4235432	Inhibition of RSK2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2345	Homo sapiens	Ki	nM	2000.0
Not Determined	18674891	CHEMBL4235432	Inhibition of RSK2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL2345	Homo sapiens	Ki		
	18751231	CHEMBL4263940	Inhibition of RSK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	11.0	CHEMBL2345	Homo sapiens	INH	%	11.0
	18752195	CHEMBL4264532	Binding affinity to wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	18752196	CHEMBL4264533	Binding affinity to wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	98.0	CHEMBL2345	Homo sapiens	Activity	%	98.0
	18763725	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	CN1CCN(c2ccc(-c3c(-c4cn[nH]c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4280695	=	IC50	nM	2400.0	CHEMBL2345	Homo sapiens	IC50	uM	2.4
	18763726	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	CN1CCN(c2ccc(-c3c(-c4ccc(N)nc4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4288604	=	IC50	nM	7200.0	CHEMBL2345	Homo sapiens	IC50	uM	7.2
	18763727	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	CN1CCN(c2ccc(-c3c(-c4ccc(C(F)F)cc4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4277304	=	IC50	nM	18100.0	CHEMBL2345	Homo sapiens	IC50	uM	18.1
	18763728	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	CN1CCN(c2ccc(-c3c(-c4ccc(F)cc4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4285259	>	IC50	nM	20000.0	CHEMBL2345	Homo sapiens	IC50	uM	20.0
	18763729	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	CN1CCN(c2ccc(-c3c(-c4ccnc(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4287512	>	IC50	nM	20000.0	CHEMBL2345	Homo sapiens	IC50	uM	20.0
	18763730	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	COc1c(F)cc(-c2cnc3[nH]ccc3c2-c2ccc(N3CCN(C)CC3)cc2)cc1F		CHEMBL4276872	>	IC50	nM	20000.0	CHEMBL2345	Homo sapiens	IC50	uM	20.0
	18763731	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	CN1CCN(c2ccc(-c3c(-c4cc(F)cc(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4284142	=	IC50	nM	6000.0	CHEMBL2345	Homo sapiens	IC50	uM	6.0
	18763732	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	CN1CCN(c2ccc(-c3c(-c4cc(F)c(O)c(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4292020	=	IC50	nM	54.0	CHEMBL2345	Homo sapiens	IC50	uM	0.054
	18763733	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	Oc1c(F)cc(-c2cnc3[nH]ccc3c2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL4278817	=	IC50	nM	50.0	CHEMBL2345	Homo sapiens	IC50	uM	0.05
	18763734	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	Cc1ccc(-c2c(-c3cc(F)c(O)c(F)c3)cnc3[nH]ccc23)cc1		CHEMBL4289492	=	IC50	nM	232.0	CHEMBL2345	Homo sapiens	IC50	uM	0.232
	18763735	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	IC50	nM	210.0	CHEMBL2345	Homo sapiens	IC50	uM	0.21
	18763736	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		CHEMBL3604793	=	IC50	nM	340.0	CHEMBL2345	Homo sapiens	IC50	uM	0.34
	18763737	CHEMBL4266991	Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylation	B	Oc1ccc(-c2cn[nH]c2-c2ccc(O)cc2)cc1		CHEMBL3604771	=	IC50	nM	2800.0	CHEMBL2345	Homo sapiens	IC50	uM	2.8
	18763738	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4cn[nH]c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4280695	=	IC50	nM	240.0	CHEMBL2345	Homo sapiens	IC50	uM	0.24
	18763739	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4ccc(N)nc4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4288604	=	IC50	nM	810.0	CHEMBL2345	Homo sapiens	IC50	uM	0.81
	18763740	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4ccc(C(F)F)cc4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4277304	=	IC50	nM	800.0	CHEMBL2345	Homo sapiens	IC50	uM	0.8
	18763741	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4ccc(F)cc4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4285259	=	IC50	nM	1900.0	CHEMBL2345	Homo sapiens	IC50	uM	1.9
	18763742	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4ccnc(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4287512	=	IC50	nM	1100.0	CHEMBL2345	Homo sapiens	IC50	uM	1.1
	18763743	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	COc1c(F)cc(-c2cnc3[nH]ccc3c2-c2ccc(N3CCN(C)CC3)cc2)cc1F		CHEMBL4276872	=	IC50	nM	500.0	CHEMBL2345	Homo sapiens	IC50	uM	0.5
	18763744	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4cc(F)cc(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4284142	=	IC50	nM	38.0	CHEMBL2345	Homo sapiens	IC50	uM	0.038
	18763745	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4cc(F)c(O)c(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4292020	=	IC50	nM	0.3	CHEMBL2345	Homo sapiens	IC50	uM	0.0003
	18763746	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	Oc1c(F)cc(-c2cnc3[nH]ccc3c2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL4278817	=	IC50	nM	2.0	CHEMBL2345	Homo sapiens	IC50	uM	0.002
	18763747	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	Cc1ccc(-c2c(-c3cc(F)c(O)c(F)c3)cnc3[nH]ccc23)cc1		CHEMBL4289492	=	IC50	nM	2.0	CHEMBL2345	Homo sapiens	IC50	uM	0.002
	18763748	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	uM	0.004
	18763749	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		CHEMBL3604793	=	IC50	nM	5.0	CHEMBL2345	Homo sapiens	IC50	uM	0.005
	18763750	CHEMBL4266990	Inhibition of RSK2 (unknown origin)	B	Oc1ccc(-c2cn[nH]c2-c2ccc(O)cc2)cc1		CHEMBL3604771	=	IC50	nM	20.0	CHEMBL2345	Homo sapiens	IC50	uM	0.02
	18764403	CHEMBL4267053	Inhibition of human RSK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL2345	Homo sapiens	INH	%	70.0
	18764404	CHEMBL4267053	Inhibition of human RSK2 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL2345	Homo sapiens	INH	%	70.0
	18764405	CHEMBL4267053	Inhibition of human RSK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL2345	Homo sapiens	INH	%	70.0
Not Active	18847268	CHEMBL4304952	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	18858195	CHEMBL4308041	Binding affinity to wild-type human partial length N- terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	92.0	CHEMBL2345	Homo sapiens	Activity	%	92.0
	18858196	CHEMBL4308042	Binding affinity to wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	87.0	CHEMBL2345	Homo sapiens	Activity	%	87.0
	18892706	CHEMBL4314543	Inhibition of human Rsk2 (2 to end residues) using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	18919557	CHEMBL4322913	Binding affinity to recombinant human full length N-terminal GST-tagged RPS6KA3 expressed in baculovirus expression system using S6K peptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	4.0	CHEMBL2345	Homo sapiens	Kd	nM	4.0
	18919745	CHEMBL4322913	Binding affinity to recombinant human full length N-terminal GST-tagged RPS6KA3 expressed in baculovirus expression system using S6K peptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	2.0	CHEMBL2345	Homo sapiens	Kd	nM	2.0
	18938283	CHEMBL4327868	Inhibition of human RSK2 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	103.95	CHEMBL2345	Homo sapiens	Activity	%	103.95
	18938284	CHEMBL4327868	Inhibition of human RSK2 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	103.64	CHEMBL2345	Homo sapiens	Activity	%	103.64
	18938713	CHEMBL4328232	Inhibition of human RSK2 assessed as residual activity at 100 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2345	Homo sapiens	Activity	%	65.0
	18939099	CHEMBL4328596	Inhibition of human RSK2 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.124	CHEMBL2345	Homo sapiens	IC50	10'-10M	1.24
	18953727	CHEMBL4331956	Inhibition of RSK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	38.0	CHEMBL2345	Homo sapiens	INH	%	38.0
	18953791	CHEMBL4331956	Inhibition of RSK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	51.0	CHEMBL2345	Homo sapiens	INH	%	51.0
	18953870	CHEMBL4331956	Inhibition of RSK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	73.0	CHEMBL2345	Homo sapiens	INH	%	73.0
	18953962	CHEMBL4332015	Inhibition of RSK2 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	58.0	CHEMBL2345	Homo sapiens	INH	%	58.0
	18954026	CHEMBL4332015	Inhibition of RSK2 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	18954093	CHEMBL4331956	Inhibition of RSK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	73.0	CHEMBL2345	Homo sapiens	INH	%	73.0
	18958565	CHEMBL4333626	Binding affinity to wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	99.0	CHEMBL2345	Homo sapiens	Activity	%	99.0
	18964668	CHEMBL4335275	Inhibition of recombinant human Rsk2 (2 to end residues) assessed as residual activity at 1 uM using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	85.0	CHEMBL2345	Homo sapiens	Activity	%	85.0
	18964669	CHEMBL4335275	Inhibition of recombinant human Rsk2 (2 to end residues) assessed as residual activity at 1 uM using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	112.0	CHEMBL2345	Homo sapiens	Activity	%	112.0
	18972090	CHEMBL4337100	Inhibition of recombinant human Rsk2 (2 to end residues) assessed as residual activity at 10 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	53.0	CHEMBL2345	Homo sapiens	Activity	%	53.0
Not Active	19040148	CHEMBL4352049	Inhibition of human Rsk2 (2 to end residues) using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	19041274	CHEMBL4352535	Inhibition of human RSK2 at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	19059820	CHEMBL4358121	Binding affinity to wild-type human partial length N- terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	75.0	CHEMBL2345	Homo sapiens	Activity	%	75.0
	19059821	CHEMBL4358122	Binding affinity to wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	19090384	CHEMBL4365958	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	77.0	CHEMBL2345	Homo sapiens	Activity	%	77.0
	19090385	CHEMBL4365959	Inhibition of wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	19092107	CHEMBL4366581	Inhibition of human RSK2 at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	19.61	CHEMBL2345	Homo sapiens	INH	%	19.61
	19144836	CHEMBL4377852	Inhibition of recombinant full-length human Rsk3 at 1 uM using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	12.0	CHEMBL2345	Homo sapiens	INH	%	12.0
	19146970	CHEMBL4378822	Inhibition of full length recombinant human Rsk2 (2 to end residues) at 10 uM using KKKNRTLSVA as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-3.0	CHEMBL2345	Homo sapiens	INH	%	-3.0
	19148028	CHEMBL4379424	Inhibition of recombinant human Rsk2 (2 to end residues) using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
	19159648	CHEMBL4382752	Binding affinity to wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	1.7	CHEMBL2345	Homo sapiens	Activity	%	1.7
	19159649	CHEMBL4382753	Binding affinity to wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	75.0	CHEMBL2345	Homo sapiens	Activity	%	75.0
	19181135	CHEMBL4387346	Inhibition of recombinant full length human His-tagged RSK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	10.5	CHEMBL2345	Homo sapiens	INH	%	10.5
	19181360	CHEMBL4387346	Inhibition of recombinant full length human His-tagged RSK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	53.0	CHEMBL2345	Homo sapiens	INH	%	53.0
	19191358	CHEMBL4389472	Inhibition of wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL2345	Homo sapiens	INH	%	100.0
	19191359	CHEMBL4389471	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	57.0	CHEMBL2345	Homo sapiens	INH	%	57.0
	19192134	CHEMBL4389948	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	94.0	CHEMBL2345	Homo sapiens	INH	%	94.0
	19192135	CHEMBL4389949	Inhibition of wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL2345	Homo sapiens	INH	%	100.0
	19200390	CHEMBL4391574	Binding affinity to wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	1.7	CHEMBL2345	Homo sapiens	Activity	%	1.7
	19200391	CHEMBL4391575	Binding affinity to wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL2345	Homo sapiens	Activity	%	100.0
	19266603	CHEMBL4405553	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	19266604	CHEMBL4405554	Inhibition of wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	19276120	CHEMBL4408123	Inhibition of recombinant human RSK2 (2 to end residues) at 1 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	19.0	CHEMBL2345	Homo sapiens	INH	%	19.0
	19317089	CHEMBL4417283	Inhibition of RPS6KA3 (unknown origin) at 1000 nM relative to control	B	Cc1c(C(=O)Nc2ccc3ccccc3n2)cnn1-c1ccccc1Br		CHEMBL4555217	=	Inhibition	%	39.0	CHEMBL2345	Homo sapiens	INH	%	39.0
	19476628	CHEMBL4479776	Inhibition of full-length recombinant human His-tagged RPS6KA3 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	260.0	CHEMBL2345	Homo sapiens	IC50	nM	260.0
	19476728	CHEMBL4479776	Inhibition of full-length recombinant human His-tagged RPS6KA3 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	380.0	CHEMBL2345	Homo sapiens	IC50	nM	380.0
	19476828	CHEMBL4479776	Inhibition of full-length recombinant human His-tagged RPS6KA3 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	<	IC50	nM	1.0	CHEMBL2345	Homo sapiens	IC50	nM	1.0
	19476928	CHEMBL4479776	Inhibition of full-length recombinant human His-tagged RPS6KA3 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	47.0	CHEMBL2345	Homo sapiens	IC50	nM	47.0
	20600441	CHEMBL4603308	Inhibition of recombinant full length human His-tagged RSK2 expressed in baculovirus expression system using serine/threonine-6 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	29080.0	CHEMBL2345	Homo sapiens	IC50	uM	29.08
	20604089	CHEMBL4604474	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system at 10 uM after 1 hr by by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	Inhibition	%	95.0	CHEMBL2345	Homo sapiens	INH	%	95.0
	20604090	CHEMBL4604474	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system at 10 uM after 1 hr by by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	Inhibition	%	96.0	CHEMBL2345	Homo sapiens	INH	%	96.0
	20604091	CHEMBL4604474	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system at 10 uM after 1 hr by by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	Inhibition	%	96.0	CHEMBL2345	Homo sapiens	INH	%	96.0
	20604102	CHEMBL4604474	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system at 10 uM after 1 hr by by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	Inhibition	%	93.0	CHEMBL2345	Homo sapiens	INH	%	93.0
	20604103	CHEMBL4604474	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system at 10 uM after 1 hr by by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	Inhibition	%	94.0	CHEMBL2345	Homo sapiens	INH	%	94.0
	20604104	CHEMBL4604474	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system at 10 uM after 1 hr by by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	Inhibition	%	102.0	CHEMBL2345	Homo sapiens	INH	%	102.0
	20604119	CHEMBL4604477	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system after 1 hr by by Z'-LYTE assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	IC50	nM	800.0	CHEMBL2345	Homo sapiens	IC50	uM	0.8
	20604120	CHEMBL4604477	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system after 1 hr by by Z'-LYTE assay	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	IC50	nM	230.0	CHEMBL2345	Homo sapiens	IC50	uM	0.23
	20604121	CHEMBL4604477	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system after 1 hr by by Z'-LYTE assay	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	IC50	nM	660.0	CHEMBL2345	Homo sapiens	IC50	uM	0.66
	20604122	CHEMBL4604477	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system after 1 hr by by Z'-LYTE assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	IC50	nM	970.0	CHEMBL2345	Homo sapiens	IC50	uM	0.97
	20604123	CHEMBL4604477	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system after 1 hr by by Z'-LYTE assay	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	IC50	nM	640.0	CHEMBL2345	Homo sapiens	IC50	uM	0.64
	20604124	CHEMBL4604477	Inhibition of His-tagged recombinant human RSK2 expressed in baculovirus expression system after 1 hr by by Z'-LYTE assay	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	IC50	nM	680.0	CHEMBL2345	Homo sapiens	IC50	uM	0.68
	20680637	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	23300.0	CHEMBL2345	Homo sapiens	IC50	uM	23.3
	20680638	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3ccc(CO)cc3)ncc2N(C)C(=O)C1C	Outside typical range	CHEMBL4645183	=	IC50	nM	739000.0	CHEMBL2345	Homo sapiens	IC50	uM	739.0
	20680639	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3ccc(O)cc3)ncc2N(C)C(=O)C1C		CHEMBL4643216	=	IC50	nM	54800.0	CHEMBL2345	Homo sapiens	IC50	uM	54.8
	20680640	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3ccc(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL4645589	=	IC50	nM	25400.0	CHEMBL2345	Homo sapiens	IC50	uM	25.4
	20680641	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3ccc(O)c(Cl)c3)ncc2N(C)C(=O)C1C		CHEMBL4641669	=	IC50	nM	71500.0	CHEMBL2345	Homo sapiens	IC50	uM	71.5
	20680642	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3ccc(O)c(Br)c3)ncc2N(C)C(=O)C1C	Outside typical range	CHEMBL4641310	=	IC50	nM	141000.0	CHEMBL2345	Homo sapiens	IC50	uM	141.0
	20680643	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2NC(=O)C1C		CHEMBL4643363	=	IC50	nM	18200.0	CHEMBL2345	Homo sapiens	IC50	uM	18.2
	20680644	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1CC(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4648201	=	IC50	nM	17600.0	CHEMBL2345	Homo sapiens	IC50	uM	17.6
	20680645	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1CC(=O)Nc2cnc(Nc3ccc(O)c(F)c3)nc21		CHEMBL4647466	=	IC50	nM	38300.0	CHEMBL2345	Homo sapiens	IC50	uM	38.3
	20680646	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1CC(=O)Nc2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4644875	=	IC50	nM	23400.0	CHEMBL2345	Homo sapiens	IC50	uM	23.4
	20680647	CHEMBL4623004	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1CC(=O)N(C)c2cnc(Nc3ccc(O)c(F)c3)nc21		CHEMBL4643631	=	IC50	nM	24700.0	CHEMBL2345	Homo sapiens	IC50	uM	24.7
Active	20680669	CHEMBL4623008	Inhibition of RSK2 in HEK293 cells at 1.25uM to 40uM using Nano-Glo as substrate measured after 2 hrs by nanoBRET assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Not Active	20680670	CHEMBL4623008	Inhibition of RSK2 in HEK293 cells at 1.25uM to 40uM using Nano-Glo as substrate measured after 2 hrs by nanoBRET assay	B	CC(C)CCN1c2nc(Nc3ccc(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL4645589		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	20680671	CHEMBL4623008	Inhibition of RSK2 in HEK293 cells at 1.25uM to 40uM using Nano-Glo as substrate measured after 2 hrs by nanoBRET assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2NC(=O)C1C		CHEMBL4643363		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	20680672	CHEMBL4623008	Inhibition of RSK2 in HEK293 cells at 1.25uM to 40uM using Nano-Glo as substrate measured after 2 hrs by nanoBRET assay	B	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		CHEMBL3604793		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	20680673	CHEMBL4623008	Inhibition of RSK2 in HEK293 cells at 1.25uM to 40uM using Nano-Glo as substrate measured after 2 hrs by nanoBRET assay	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	20680677	CHEMBL4623015	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3cc(F)cc(F)c3)ncc2N(C)C(=O)C1C		CHEMBL4639061	=	Inhibition	%	71.0	CHEMBL2345	Homo sapiens	INH	%	71.0
	20680678	CHEMBL4623015	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	COc1c(F)cc(Nc2ncc3c(n2)N(CCC(C)C)C(C)C(=O)N3C)cc1F		CHEMBL4641184	=	Inhibition	%	43.0	CHEMBL2345	Homo sapiens	INH	%	43.0
	20680679	CHEMBL4623015	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3cc(Cl)c(O)c(Cl)c3)ncc2N(C)C(=O)C1C		CHEMBL4634617	=	Inhibition	%	83.0	CHEMBL2345	Homo sapiens	INH	%	83.0
	20680680	CHEMBL4623015	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3cc(Br)c(O)c(Br)c3)ncc2N(C)C(=O)C1C		CHEMBL4634594	=	Inhibition	%	78.0	CHEMBL2345	Homo sapiens	INH	%	78.0
	20680681	CHEMBL4623015	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncccn2)cc1F		CHEMBL4642760	=	Inhibition	%	45.0	CHEMBL2345	Homo sapiens	INH	%	45.0
	20680682	CHEMBL4623015	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	CC1Nc2nc(Nc3cc(F)c(O)c(F)c3)ncc2NC1=O		CHEMBL4640954	=	Inhibition	%	83.0	CHEMBL2345	Homo sapiens	INH	%	83.0
	20680683	CHEMBL4623015	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	Nc1nc(Nc2cc(F)c(O)c(F)c2)ncc1[N+](=O)[O-]		CHEMBL4642315	=	Inhibition	%	72.0	CHEMBL2345	Homo sapiens	INH	%	72.0
	20680684	CHEMBL4623015	Inhibition of full length human GST-tagged RSK2 using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	Nc1cnc(Nc2cc(F)c(O)c(F)c2)nc1N		CHEMBL4637827	=	Inhibition	%	38.0	CHEMBL2345	Homo sapiens	INH	%	38.0
	20680692	CHEMBL4623009	Inhibition of RSK2 (unknown origin) using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK a substrate by [32P] gammaATP assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	24.0	CHEMBL2345	Homo sapiens	IC50	nM	24.0
	20680697	CHEMBL4622999	Inhibition of RSK2 (unknown origin)	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	nM	4.0
	20680698	CHEMBL4622999	Inhibition of RSK2 (unknown origin)	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	IC50	nM	5.0	CHEMBL2345	Homo sapiens	IC50	nM	5.0
	22392156	CHEMBL4667251	Inhibition of recombinant human His-tagged full length RSK2 expressed in baculovirus expression system using Ser/Thr 06 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	2.0	CHEMBL2345	Homo sapiens	INH	%	2.0
	22423261	CHEMBL4674206	Inhibition of human RSK2 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	93.02	CHEMBL2345	Homo sapiens	Activity	%	93.02
	22423262	CHEMBL4674206	Inhibition of human RSK2 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	59.56	CHEMBL2345	Homo sapiens	Activity	%	59.56
	22479243	CHEMBL4686933	Inhibition of human recombinant RSK2 (2 to end residues) assessed as residual activity using KKKNRTLSVA as substrate at 1 uM incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925	=	Activity	%	22.0	CHEMBL2345	Homo sapiens	Activity	%	22.0
	22751204	CHEMBL4699846	Inhibition of RSK2 (unknown origin) using FRET-peptide as substrate incubated for 1 hr by Z-lyte assay	B	Nc1cccc2cc[nH]c(=O)c12		CHEMBL4784866	=	IC50	nM	16500.0	CHEMBL2345	Homo sapiens	IC50	uM	16.5
	22770395	CHEMBL4704292	Inhibition of RSK2 (unknown origin) at 1 uM relative to control	B	Cc1cn([C@@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12		CHEMBL4778578	=	Inhibition	%	84.0	CHEMBL2345	Homo sapiens	INH	%	84.0
	22804207	CHEMBL4712068	Inhibition of RSK2 (unknown origin) at 100 uM pre-incubated for 20 mins followed by 33P-gamma-ATP addition and measured after 120 mins by filter-binding method relative to control	B	COc1ccc(-n2cc(-c3ccc4nonc4c3)c3cc(-c4ccc(C(=O)O)cc4)cnc32)cc1		CHEMBL4747136	=	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	22804208	CHEMBL4712068	Inhibition of RSK2 (unknown origin) at 100 uM pre-incubated for 20 mins followed by 33P-gamma-ATP addition and measured after 120 mins by filter-binding method relative to control	B	O=C(O)c1ccc(-c2cnc3[nH]cc(-c4ccc5nonc5c4)c3c2)cc1		CHEMBL4752578	=	Inhibition	%	95.0	CHEMBL2345	Homo sapiens	INH	%	95.0
	22843210	CHEMBL4720237	Inhibition of recombinant human RSK2 using Histone H3 full length as substrate incubate for 10 mins by LANCE assay	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	nM	10000.0
	22843576	CHEMBL4720562	Inhibition of human RSK2 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.0795	CHEMBL2345	Homo sapiens	IC50	10^-11M	7.95
	22843920	CHEMBL4720906	Inhibition of human RSK2 assessed as residual activity using KKLNRTLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	110.9	CHEMBL2345	Homo sapiens	Activity	%	110.9
	22844858	CHEMBL4721533	Inhibition of wild-type human partial length N-terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	65.09	CHEMBL2345	Homo sapiens	Activity	%	65.09
	22883479	CHEMBL4727564	Inhibition of recombinant human full-length His-tagged RSK2 expressed in baculovirus expression system	B	CC(C)n1cnnc1-c1cccc(NC(=O)[C@H]2CN(c3ccc(C4CC4)nc3)CCO2)n1		CHEMBL4744428	<=	IC50	nM	500.0	CHEMBL2345	Homo sapiens	IC50	nM	500.0
	22886562	CHEMBL4728266	Binding affinity to RSK1B (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	4.0	CHEMBL2345	Homo sapiens	deltaTm	degrees C	4.0
Not Active	22889560	CHEMBL4729079	Inhibition of wild-type human partial length N- terminal RSK2 kinase domain 1 (M1 to D394 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	22950620	CHEMBL4766187	Inhibition of human recombinant RSK2 (2 to end residues) using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	>	IC50	nM	10000.0	CHEMBL2345	Homo sapiens	IC50	uM	10.0
	22952989	CHEMBL4766926	Inhibition of recombinant human Rsk2 (2 to end residues) assessed as residual activity at 10 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	52.0	CHEMBL2345	Homo sapiens	Activity	%	52.0
	23121004	CHEMBL4804487	Inhibition of RSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	3300.0	CHEMBL2345	Homo sapiens	IC50	uM	3.3
	23121005	CHEMBL4804487	Inhibition of RSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	13300.0	CHEMBL2345	Homo sapiens	IC50	uM	13.3
	23121006	CHEMBL4804487	Inhibition of RSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	15800.0	CHEMBL2345	Homo sapiens	IC50	uM	15.8
	23121007	CHEMBL4804487	Inhibition of RSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	25800.0	CHEMBL2345	Homo sapiens	IC50	uM	25.8
	23121008	CHEMBL4804487	Inhibition of RSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	68400.0	CHEMBL2345	Homo sapiens	IC50	uM	68.4
	23121009	CHEMBL4804487	Inhibition of RSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	58700.0	CHEMBL2345	Homo sapiens	IC50	uM	58.7
	23121022	CHEMBL4804490	Inhibition of RSK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	3800.0	CHEMBL2345	Homo sapiens	IC50	uM	3.8
	23121023	CHEMBL4804490	Inhibition of RSK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-20000.0	CHEMBL2345	Homo sapiens	IC50	uM	-20.0
	23121024	CHEMBL4804490	Inhibition of RSK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	3200.0	CHEMBL2345	Homo sapiens	IC50	uM	3.2
	23121025	CHEMBL4804490	Inhibition of RSK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	9000.0	CHEMBL2345	Homo sapiens	IC50	uM	9.0
	23121026	CHEMBL4804490	Inhibition of RSK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	7200.0	CHEMBL2345	Homo sapiens	IC50	uM	7.2
	23121027	CHEMBL4804490	Inhibition of RSK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-23200.0	CHEMBL2345	Homo sapiens	IC50	uM	-23.2
	23122043	CHEMBL4804669	Inhibition of RSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	23122044	CHEMBL4804669	Inhibition of RSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	23122045	CHEMBL4804669	Inhibition of RSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	23122046	CHEMBL4804669	Inhibition of RSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	35.0	CHEMBL2345	Homo sapiens	INH	%	35.0
	23122047	CHEMBL4804669	Inhibition of RSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	23122048	CHEMBL4804669	Inhibition of RSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	50.0	CHEMBL2345	Homo sapiens	INH	%	50.0
	23122061	CHEMBL4804672	Inhibition of RSK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	23122062	CHEMBL4804672	Inhibition of RSK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	23122063	CHEMBL4804672	Inhibition of RSK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	23122064	CHEMBL4804672	Inhibition of RSK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	23122065	CHEMBL4804672	Inhibition of RSK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	75.0	CHEMBL2345	Homo sapiens	INH	%	75.0
	23122066	CHEMBL4804672	Inhibition of RSK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL2345	Homo sapiens	INH	%	0.0
	23122805	CHEMBL4805156	Inhibition of human N-terminal RSK2 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	62.0	CHEMBL2345	Homo sapiens	Activity	%	62.0
	23122806	CHEMBL4805157	Inhibition of human C-terminal RSK2 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	65.0	CHEMBL2345	Homo sapiens	Activity	%	65.0
	23123500	CHEMBL4805744	Inhibition of human N-terminal RSK2 kinase domain 1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	67.0	CHEMBL2345	Homo sapiens	Activity	%	67.0
	23123501	CHEMBL4805745	Inhibition of human C-terminal RSK2 kinase domain 2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	53.0	CHEMBL2345	Homo sapiens	Activity	%	53.0
	23123955	CHEMBL4806199	Inhibition of DNA-tagged human N-terminal RSK2 kinase domain 1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	94.0	CHEMBL2345	Homo sapiens	Activity	%	94.0
	23125090	CHEMBL4806761	Inhibition of human N-terminal RSK2 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	90.0	CHEMBL2345	Homo sapiens	Activity	%	90.0
	23125091	CHEMBL4806761	Inhibition of human N-terminal RSK2 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	64.0	CHEMBL2345	Homo sapiens	Activity	%	64.0
	23125092	CHEMBL4806762	Inhibition of human C-terminal RSK2 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	94.0	CHEMBL2345	Homo sapiens	Activity	%	94.0
	23125093	CHEMBL4806762	Inhibition of human C-terminal RSK2 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL2345	Homo sapiens	Activity	%	92.0
	23128548	CHEMBL4807991	Inhibition of RPS6KA3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2345	Homo sapiens	Activity	%	75.0
	23128549	CHEMBL4807991	Inhibition of RPS6KA3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2345	Homo sapiens	Activity	%	75.0
	23128550	CHEMBL4807991	Inhibition of RPS6KA3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2345	Homo sapiens	Activity	%	75.0
	23165277	CHEMBL4813086	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3nc[nH]c3n2)cc1F		CHEMBL4878386	=	Inhibition	%	67.0	CHEMBL2345	Homo sapiens	INH	%	67.0
	23165278	CHEMBL4813086	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(-c5ccccc5)cc4)c3n2)cc1F		CHEMBL4848761	=	Inhibition	%	49.0	CHEMBL2345	Homo sapiens	INH	%	49.0
	23165279	CHEMBL4813086	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4cccc(OCc5ccccc5)c4)c3n2)cc1F		CHEMBL4871264	=	Inhibition	%	63.0	CHEMBL2345	Homo sapiens	INH	%	63.0
	23165280	CHEMBL4813086	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(OCc5ccccc5)cc4)c3n2)cc1F		CHEMBL4879022	=	Inhibition	%	42.0	CHEMBL2345	Homo sapiens	INH	%	42.0
	23165281	CHEMBL4813086	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate at 10 uM incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3cc[nH]c3n2)cc1F		CHEMBL4855811	=	Inhibition	%	77.0	CHEMBL2345	Homo sapiens	INH	%	77.0
	23165282	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	22.6	CHEMBL2345	Homo sapiens	IC50	nM	22.6
	23165283	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCn1cnc2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4858257	=	IC50	nM	55.5	CHEMBL2345	Homo sapiens	IC50	nM	55.5
	23165284	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(N5CCOCC5)cc4)c3n2)cc1F		CHEMBL4858455	=	IC50	nM	24.6	CHEMBL2345	Homo sapiens	IC50	nM	24.6
	23165285	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(CCN5CCOCC5)cc4)c3n2)cc1F		CHEMBL4849660	=	IC50	nM	18.4	CHEMBL2345	Homo sapiens	IC50	nM	18.4
	23165286	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4cccc(Oc5ccccc5)c4)c3n2)cc1F		CHEMBL4845736	=	IC50	nM	329.0	CHEMBL2345	Homo sapiens	IC50	nM	329.0
	23165287	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(Oc5ccccc5)cc4)c3n2)cc1F		CHEMBL4860957	=	IC50	nM	148.0	CHEMBL2345	Homo sapiens	IC50	nM	148.0
	23165288	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1cccc(-n2cnc3cnc(Nc4cc(F)c(O)c(F)c4)nc32)c1		CHEMBL4861235	=	IC50	nM	79.8	CHEMBL2345	Homo sapiens	IC50	nM	79.8
	23165289	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1ccc(-n2cnc3cnc(Nc4cc(F)c(O)c(F)c4)nc32)cc1		CHEMBL4865383	=	IC50	nM	81.8	CHEMBL2345	Homo sapiens	IC50	nM	81.8
	23165290	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	COC(=O)CCc1ccc(-n2cnc3cnc(Nc4cc(F)c(O)c(F)c4)nc32)cc1		CHEMBL4878141	=	IC50	nM	15.7	CHEMBL2345	Homo sapiens	IC50	nM	15.7
	23165291	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	COC(=O)CCCc1ccc(-n2cnc3cnc(Nc4cc(F)c(O)c(F)c4)nc32)cc1		CHEMBL4851452	=	IC50	nM	17.8	CHEMBL2345	Homo sapiens	IC50	nM	17.8
	23165292	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CC(C)CCn1ccc2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4873445	=	IC50	nM	95.8	CHEMBL2345	Homo sapiens	IC50	nM	95.8
	23165293	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	Oc1c(F)cc(Nc2ncc3ccn(-c4ccc(N5CCOCC5)cc4)c3n2)cc1F		CHEMBL4857399	=	IC50	nM	25.7	CHEMBL2345	Homo sapiens	IC50	nM	25.7
	23165294	CHEMBL4813087	Inhibition of RSK2 (unknown origin) using Ulight-rpS6 as substrate incubated for 1 hr in presence of ATP by TR FRET assay	B	CN1CCN(c2ccc(-n3ccc4cnc(Nc5cc(F)c(O)c(F)c5)nc43)cc2)CC1		CHEMBL4864190	=	IC50	nM	34.7	CHEMBL2345	Homo sapiens	IC50	nM	34.7
Active	23165295	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	23165296	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	CC(C)CCn1cnc2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4858257		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	23165297	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(N5CCOCC5)cc4)c3n2)cc1F		CHEMBL4858455		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	23165298	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(CCN5CCOCC5)cc4)c3n2)cc1F		CHEMBL4849660		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Not Active	23165299	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	COC(=O)CCc1ccc(-n2cnc3cnc(Nc4cc(F)c(O)c(F)c4)nc32)cc1		CHEMBL4878141		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	23165300	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	COC(=O)CCCc1ccc(-n2cnc3cnc(Nc4cc(F)c(O)c(F)c4)nc32)cc1		CHEMBL4851452		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	23165301	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	CC(C)CCn1ccc2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4873445		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	23165302	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	Oc1c(F)cc(Nc2ncc3ccn(-c4ccc(N5CCOCC5)cc4)c3n2)cc1F		CHEMBL4857399		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Active	23165303	CHEMBL4813088	Inhibition of RSK2 (unknown origin) expressed in HEK293 cells at 3 uM to 100 uM after 2 hrs using Nano-Glo as substrate measured by nanoBRET assay	B	CN1CCN(c2ccc(-n3ccc4cnc(Nc5cc(F)c(O)c(F)c5)nc43)cc2)CC1		CHEMBL4864190		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	23165304	CHEMBL4813089	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability measured after 72 hrs by MTS assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	EC50	nM	2600.0	CHEMBL2345	Homo sapiens	EC50	uM	2.6
	23165305	CHEMBL4813089	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability measured after 72 hrs by MTS assay	B	CC(C)CCn1cnc2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4858257	=	EC50	nM	970.0	CHEMBL2345	Homo sapiens	EC50	uM	0.97
	23165306	CHEMBL4813089	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability measured after 72 hrs by MTS assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(CCN5CCOCC5)cc4)c3n2)cc1F		CHEMBL4849660	=	EC50	nM	1900.0	CHEMBL2345	Homo sapiens	EC50	uM	1.9
	23165307	CHEMBL4813089	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability measured after 72 hrs by MTS assay	B	COC(=O)CCCc1ccc(-n2cnc3cnc(Nc4cc(F)c(O)c(F)c4)nc32)cc1		CHEMBL4851452	=	EC50	nM	13900.0	CHEMBL2345	Homo sapiens	EC50	uM	13.9
	23165308	CHEMBL4813089	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability measured after 72 hrs by MTS assay	B	CC(C)CCn1ccc2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4873445	=	EC50	nM	1300.0	CHEMBL2345	Homo sapiens	EC50	uM	1.3
	23165309	CHEMBL4813089	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability measured after 72 hrs by MTS assay	B	Oc1c(F)cc(Nc2ncc3ccn(-c4ccc(N5CCOCC5)cc4)c3n2)cc1F		CHEMBL4857399	=	EC50	nM	230.0	CHEMBL2345	Homo sapiens	EC50	uM	0.23
	23165310	CHEMBL4813089	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability measured after 72 hrs by MTS assay	B	CN1CCN(c2ccc(-n3ccc4cnc(Nc5cc(F)c(O)c(F)c5)nc43)cc2)CC1		CHEMBL4864190	=	EC50	nM	70.0	CHEMBL2345	Homo sapiens	EC50	uM	0.07
	23165311	CHEMBL4813090	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability at 60 uM measured after 72 hrs by MTS assay	B	Oc1c(F)cc(Nc2ncc3ncn(-c4ccc(N5CCOCC5)cc4)c3n2)cc1F		CHEMBL4858455	=	Inhibition	%	53.0	CHEMBL2345	Homo sapiens	INH	%	53.0
	23165312	CHEMBL4813090	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability at 60 uM measured after 72 hrs by MTS assay	B	COC(=O)CCc1ccc(-n2cnc3cnc(Nc4cc(F)c(O)c(F)c4)nc32)cc1		CHEMBL4878141	=	Inhibition	%	5.0	CHEMBL2345	Homo sapiens	INH	%	5.0
	23165313	CHEMBL4813090	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability at 60 uM measured after 72 hrs by MTS assay	B	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		CHEMBL3604793	=	Inhibition	%	96.0	CHEMBL2345	Homo sapiens	INH	%	96.0
	23165314	CHEMBL4813090	Inhibition of RSK2 in human MOLM-13 assessed as reduction in cell viability at 60 uM measured after 72 hrs by MTS assay	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	Inhibition	%	87.0	CHEMBL2345	Homo sapiens	INH	%	87.0
	23213443	CHEMBL4822977	Inhibition of human recombinant RSK2 in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	11.0	CHEMBL2345	Homo sapiens	INH	%	11.0
	23239300	CHEMBL4828825	Inhibition of ADP(ATP)-biotin probe binding to RSK2 domain 1 in human Kelly cells at 1 uM incubated for 6 hrs by KiNativ profiling analysis	B	CN(C)C/C=C/C(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1		CHEMBL4754873	=	Inhibition	%	46.0	CHEMBL2345	Homo sapiens	INH	%	46.0
	23239314	CHEMBL4828839	Inhibition of ADP(ATP)-biotin probe binding to RSK2 domain 1 in human Kelly cells incubated for 6 hrs by KiNativ profiling analysis	B	CN(C)C/C=C/C(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1		CHEMBL4754873	=	IC50	nM	4500.0	CHEMBL2345	Homo sapiens	IC50	nM	4500.0
	23252620	CHEMBL4831409	Inhibition of wild type human RSK2 expressed in mammalian expression system assessed as protein activity at 0.5 uM relative to control	B	CC(C)(N)CCNc1nc(Nc2ccc(C#N)nc2)ncc1C(F)(F)F		CHEMBL4861256	=	Activity	%	13.0	CHEMBL2345	Homo sapiens	Activity	%	13.0
	23297877	CHEMBL4841335	Inhibition of His6-tagged human RSK2 using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK-peptide as substrate in presence of [gamma-32P]ATP	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	24.0	CHEMBL2345	Homo sapiens	IC50	nM	24.0
	23297882	CHEMBL4841339	Inhibition of full length recombinant His-tagged human RSK2 expressed in baculovirus expression system using biotin-labelled AGAGRSRHSSYPAGT-OH as substrate in presence of ATP	B	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		CHEMBL3604793	=	IC50	nM	4.0	CHEMBL2345	Homo sapiens	IC50	nM	4.0
	23297883	CHEMBL4841339	Inhibition of full length recombinant His-tagged human RSK2 expressed in baculovirus expression system using biotin-labelled AGAGRSRHSSYPAGT-OH as substrate in presence of ATP	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	IC50	nM	6.0	CHEMBL2345	Homo sapiens	IC50	nM	6.0
	23297886	CHEMBL4841341	Inhibition of RSK2 (unknown origin)	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	IC50	nM	15.0	CHEMBL2345	Homo sapiens	IC50	nM	15.0
Not Active	23297917	CHEMBL4841349	Inhibition of RSK2 in human TE-10 cells assessed as suppression of creb-phosphorylation at 1 to 10 uM measured after 24 hrs by Western blot analysis	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Not Active	23297918	CHEMBL4841350	Inhibition of RSK2 in human TE-10 cells assessed as suppression of HSP27 at residue 32 phosphorylation at 1 to 10 uM measured after 24 hrs by Western blot analysis	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
Not Active	23297919	CHEMBL4841351	Inhibition of RSK2 in human TE-10 cells assessed as suppression of HSP27 at residue 33 phosphorylation at 1 to 10 uM measured after 24 hrs by Western blot analysis	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762		Inhibition	%		CHEMBL2345	Homo sapiens	INH		
	23297924	CHEMBL4841356	Inhibition of RSK2 (unknown origin) at 100 nM relative to control	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762	>	Inhibition	%	90.0	CHEMBL2345	Homo sapiens	INH	%	90.0
Not Active	23317641	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	81.0	CHEMBL2345	Homo sapiens	% Control	%	81.0
Not Active	23317642	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23318109	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23318110	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23318775	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23318776	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	87.0	CHEMBL2345	Homo sapiens	% Control	%	87.0
Not Active	23319259	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	98.0	CHEMBL2345	Homo sapiens	% Control	%	98.0
Not Active	23319260	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	72.0	CHEMBL2345	Homo sapiens	% Control	%	72.0
Not Active	23319896	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23319897	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	54.9	CHEMBL2345	Homo sapiens	% Control	%	54.9
Not Active	23320371	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	99.2	CHEMBL2345	Homo sapiens	% Control	%	99.2
Not Active	23320372	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	85.4	CHEMBL2345	Homo sapiens	% Control	%	85.4
Not Active	23321049	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23321050	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23321517	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	83.0	CHEMBL2345	Homo sapiens	% Control	%	83.0
Not Active	23321518	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	77.0	CHEMBL2345	Homo sapiens	% Control	%	77.0
Not Active	23322147	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	72.0	CHEMBL2345	Homo sapiens	% Control	%	72.0
Not Active	23322148	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	73.0	CHEMBL2345	Homo sapiens	% Control	%	73.0
Not Active	23322615	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	95.0	CHEMBL2345	Homo sapiens	% Control	%	95.0
Not Active	23322616	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	76.0	CHEMBL2345	Homo sapiens	% Control	%	76.0
Not Active	23323304	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	81.0	CHEMBL2345	Homo sapiens	% Control	%	81.0
Not Active	23323305	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23323772	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	74.0	CHEMBL2345	Homo sapiens	% Control	%	74.0
Not Active	23323773	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	93.0	CHEMBL2345	Homo sapiens	% Control	%	93.0
Not Active	23324126	CHEMBL4880745	Rsk2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	46.0	CHEMBL2345	Homo sapiens	% inhibition	%	46.0
	23324127	CHEMBL4880745	Rsk2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Non standard unit for type	CHEMBL4593677		IC50	M	0.9	CHEMBL2345	Homo sapiens	IC50	M	0.9
Not Active	23324626	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	78.1	CHEMBL2345	Homo sapiens	% Control	%	78.1
Not Active	23324627	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	86.2	CHEMBL2345	Homo sapiens	% Control	%	86.2
Not Active	23325261	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	81.0	CHEMBL2345	Homo sapiens	% Control	%	81.0
Not Active	23325262	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	83.0	CHEMBL2345	Homo sapiens	% Control	%	83.0
Not Active	23325729	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23325730	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	85.0	CHEMBL2345	Homo sapiens	% Control	%	85.0
Not Active	23326376	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	72.0	CHEMBL2345	Homo sapiens	% Control	%	72.0
Not Active	23326377	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	98.0	CHEMBL2345	Homo sapiens	% Control	%	98.0
Not Active	23326844	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	92.0	CHEMBL2345	Homo sapiens	% Control	%	92.0
Not Active	23326845	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	92.0	CHEMBL2345	Homo sapiens	% Control	%	92.0
Not Active	23327544	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	70.0	CHEMBL2345	Homo sapiens	% Control	%	70.0
Not Active	23327545	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23328012	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	57.0	CHEMBL2345	Homo sapiens	% Control	%	57.0
Not Active	23328013	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	82.0	CHEMBL2345	Homo sapiens	% Control	%	82.0
Not Active	23328599	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	82.0	CHEMBL2345	Homo sapiens	% Control	%	82.0
Not Active	23328600	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	87.0	CHEMBL2345	Homo sapiens	% Control	%	87.0
Not Active	23329067	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23329068	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23329516	CHEMBL4881223	Rsk2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	109.0	CHEMBL2345	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23330013	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	85.0	CHEMBL2345	Homo sapiens	% Control	%	85.0
Not Active	23330014	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	80.0	CHEMBL2345	Homo sapiens	% Control	%	80.0
Not Active	23330481	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23330482	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	82.0	CHEMBL2345	Homo sapiens	% Control	%	82.0
Not Active	23331237	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23331238	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23331705	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23331706	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23332292	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	84.4	CHEMBL2345	Homo sapiens	% Control	%	84.4
Not Active	23332293	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	65.1	CHEMBL2345	Homo sapiens	% Control	%	65.1
Not Active	23332758	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	66.6	CHEMBL2345	Homo sapiens	% Control	%	66.6
Not Active	23332759	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	89.0	CHEMBL2345	Homo sapiens	% Control	%	89.0
Not Active	23333476	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23333477	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	99.2	CHEMBL2345	Homo sapiens	% Control	%	99.2
Not Active	23334115	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	80.0	CHEMBL2345	Homo sapiens	% Control	%	80.0
Not Active	23334116	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	76.0	CHEMBL2345	Homo sapiens	% Control	%	76.0
Not Active	23334583	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23334584	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	78.0	CHEMBL2345	Homo sapiens	% Control	%	78.0
Not Active	23334960	CHEMBL4881580	Rsk2 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	61.0	CHEMBL2345	Homo sapiens	% inhibition	%	61.0
Not Active	23335562	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	79.0	CHEMBL2345	Homo sapiens	% Control	%	79.0
Not Active	23335563	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	73.0	CHEMBL2345	Homo sapiens	% Control	%	73.0
Not Active	23336030	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	71.0	CHEMBL2345	Homo sapiens	% Control	%	71.0
Not Active	23336031	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	79.0	CHEMBL2345	Homo sapiens	% Control	%	79.0
Not Active	23336657	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	94.0	CHEMBL2345	Homo sapiens	% Control	%	94.0
Not Active	23336658	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	89.0	CHEMBL2345	Homo sapiens	% Control	%	89.0
Not Active	23337125	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23337126	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	86.0	CHEMBL2345	Homo sapiens	% Control	%	86.0
Not Active	23337764	CHEMBL4882135	RPS6KA3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	105.0	CHEMBL2345	Homo sapiens	% Ctrl	%	105.0
Not Active	23338206	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	83.0	CHEMBL2345	Homo sapiens	% Control	%	83.0
Not Active	23338207	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23338674	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	92.0	CHEMBL2345	Homo sapiens	% Control	%	92.0
Not Active	23338675	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	85.0	CHEMBL2345	Homo sapiens	% Control	%	85.0
Not Active	23339286	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23339287	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	93.0	CHEMBL2345	Homo sapiens	% Control	%	93.0
Not Active	23339754	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23339755	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23340391	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	99.0	CHEMBL2345	Homo sapiens	% Control	%	99.0
Not Active	23340392	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23340859	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23340860	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	98.0	CHEMBL2345	Homo sapiens	% Control	%	98.0
Not Active	23341516	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	95.0	CHEMBL2345	Homo sapiens	% Control	%	95.0
Not Active	23341517	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23341984	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23341985	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	99.0	CHEMBL2345	Homo sapiens	% Control	%	99.0
Not Active	23342600	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	88.0	CHEMBL2345	Homo sapiens	% Control	%	88.0
Not Active	23342601	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	87.0	CHEMBL2345	Homo sapiens	% Control	%	87.0
Not Active	23343068	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	91.0	CHEMBL2345	Homo sapiens	% Control	%	91.0
Not Active	23343069	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	91.0	CHEMBL2345	Homo sapiens	% Control	%	91.0
Active	23343287	CHEMBL4882472	RPS6KA3 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	5.0	CHEMBL2345	Homo sapiens	% Ctrl	%	5.0
Not Active	23343698	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23343699	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	80.0	CHEMBL2345	Homo sapiens	% Control	%	80.0
Not Active	23344166	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	78.0	CHEMBL2345	Homo sapiens	% Control	%	78.0
Not Active	23344167	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	70.0	CHEMBL2345	Homo sapiens	% Control	%	70.0
Not Active	23344804	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	84.0	CHEMBL2345	Homo sapiens	% Control	%	84.0
Not Active	23344805	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	87.0	CHEMBL2345	Homo sapiens	% Control	%	87.0
Not Active	23345377	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23345378	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	82.0	CHEMBL2345	Homo sapiens	% Control	%	82.0
Not Active	23345845	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23345846	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	89.0	CHEMBL2345	Homo sapiens	% Control	%	89.0
Not Active	23346422	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	87.6	CHEMBL2345	Homo sapiens	% Control	%	87.6
Not Active	23346423	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	83.4	CHEMBL2345	Homo sapiens	% Control	%	83.4
Not Active	23346890	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	93.0	CHEMBL2345	Homo sapiens	% Control	%	93.0
Not Active	23346891	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	73.8	CHEMBL2345	Homo sapiens	% Control	%	73.8
Not Active	23347490	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	85.4	CHEMBL2345	Homo sapiens	% Control	%	85.4
Not Active	23347491	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	70.0	CHEMBL2345	Homo sapiens	% Control	%	70.0
Not Active	23347982	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	79.5	CHEMBL2345	Homo sapiens	% Control	%	79.5
Not Active	23347983	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	80.7	CHEMBL2345	Homo sapiens	% Control	%	80.7
Not Active	23348561	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	90.0	CHEMBL2345	Homo sapiens	% Control	%	90.0
Not Active	23348562	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	99.0	CHEMBL2345	Homo sapiens	% Control	%	99.0
Not Active	23349029	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	75.0	CHEMBL2345	Homo sapiens	% Control	%	75.0
Not Active	23349030	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23349616	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	96.0	CHEMBL2345	Homo sapiens	% Control	%	96.0
Not Active	23349617	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	83.0	CHEMBL2345	Homo sapiens	% Control	%	83.0
Not Active	23350234	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23350235	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23350702	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	97.0	CHEMBL2345	Homo sapiens	% Control	%	97.0
Not Active	23350703	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23351307	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23351308	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	86.0	CHEMBL2345	Homo sapiens	% Control	%	86.0
Not Active	23351775	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	80.0	CHEMBL2345	Homo sapiens	% Control	%	80.0
Not Active	23351776	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	81.0	CHEMBL2345	Homo sapiens	% Control	%	81.0
Not Active	23352216	CHEMBL4882905	RPS6KA3 (RSK2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.911	CHEMBL2345	Homo sapiens	% Inhibition	%	3.9109
Not Active	23352799	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	73.0	CHEMBL2345	Homo sapiens	% Control	%	73.0
Not Active	23352800	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	85.0	CHEMBL2345	Homo sapiens	% Control	%	85.0
Not Active	23353267	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	82.0	CHEMBL2345	Homo sapiens	% Control	%	82.0
Not Active	23353268	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	91.0	CHEMBL2345	Homo sapiens	% Control	%	91.0
Not Active	23354149	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23354150	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	80.0	CHEMBL2345	Homo sapiens	% Control	%	80.0
Not Active	23354617	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23354618	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	80.0	CHEMBL2345	Homo sapiens	% Control	%	80.0
Not Active	23355349	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23355350	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	82.0	CHEMBL2345	Homo sapiens	% Control	%	82.0
Not Active	23355817	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	94.0	CHEMBL2345	Homo sapiens	% Control	%	94.0
Not Active	23355818	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	67.0	CHEMBL2345	Homo sapiens	% Control	%	67.0
Not Active	23356453	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23356454	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	69.0	CHEMBL2345	Homo sapiens	% Control	%	69.0
Not Active	23356921	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	89.0	CHEMBL2345	Homo sapiens	% Control	%	89.0
Not Active	23356922	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	71.0	CHEMBL2345	Homo sapiens	% Control	%	71.0
Not Active	23357530	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23357531	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	89.0	CHEMBL2345	Homo sapiens	% Control	%	89.0
Not Active	23358177	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23358178	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23358645	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	73.0	CHEMBL2345	Homo sapiens	% Control	%	73.0
Not Active	23358646	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	89.0	CHEMBL2345	Homo sapiens	% Control	%	89.0
Not Active	23359231	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23359232	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	56.5	CHEMBL2345	Homo sapiens	% Control	%	56.5
Not Active	23359829	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	95.0	CHEMBL2345	Homo sapiens	% Control	%	95.0
Not Active	23359830	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	80.0	CHEMBL2345	Homo sapiens	% Control	%	80.0
Not Active	23360297	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	94.0	CHEMBL2345	Homo sapiens	% Control	%	94.0
Not Active	23360298	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	86.0	CHEMBL2345	Homo sapiens	% Control	%	86.0
Not Active	23360882	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	99.0	CHEMBL2345	Homo sapiens	% Control	%	99.0
Not Active	23360883	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23361350	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23361351	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	84.0	CHEMBL2345	Homo sapiens	% Control	%	84.0
Slightly Active	23361923	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	48.0	CHEMBL2345	Homo sapiens	% Control	%	48.0
Not Active	23361924	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	58.0	CHEMBL2345	Homo sapiens	% Control	%	58.0
Not Active	23362459	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	95.0	CHEMBL2345	Homo sapiens	% Control	%	95.0
Not Active	23362460	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23362927	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23362928	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	99.0	CHEMBL2345	Homo sapiens	% Control	%	99.0
Not Active	23364569	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	71.0	CHEMBL2345	Homo sapiens	% Control	%	71.0
Not Active	23364570	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23365037	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23365038	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23365776	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	97.0	CHEMBL2345	Homo sapiens	% Control	%	97.0
Not Active	23365777	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23366319	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23366320	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	99.0	CHEMBL2345	Homo sapiens	% Control	%	99.0
Not Active	23366909	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23366910	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	92.0	CHEMBL2345	Homo sapiens	% Control	%	92.0
Not Active	23367377	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23367378	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23367735	CHEMBL4884088	RPS6KA3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	89.0	CHEMBL2345	Homo sapiens	% Residual activity with Skepinone-L	%	89.0
Not Active	23368255	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	97.0	CHEMBL2345	Homo sapiens	% Control	%	97.0
Not Active	23368256	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	91.0	CHEMBL2345	Homo sapiens	% Control	%	91.0
Not Active	23368723	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	84.0	CHEMBL2345	Homo sapiens	% Control	%	84.0
Not Active	23368724	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	97.0	CHEMBL2345	Homo sapiens	% Control	%	97.0
Not Active	23369322	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23369323	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23369790	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	81.0	CHEMBL2345	Homo sapiens	% Control	%	81.0
Not Active	23369791	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	87.0	CHEMBL2345	Homo sapiens	% Control	%	87.0
Not Active	23370231	CHEMBL4884472	Rsk2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	0.0	CHEMBL2345	Homo sapiens	% residual kinase activity	%	0.0
	23370232	CHEMBL4884472	Rsk2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	52.0	CHEMBL2345	Homo sapiens	IC50	nM	52.0
Active	23370758	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	0.3	CHEMBL2345	Homo sapiens	% Control	%	0.3
Not Active	23370759	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23371226	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	86.0	CHEMBL2345	Homo sapiens	% Control	%	86.0
Not Active	23371227	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	94.0	CHEMBL2345	Homo sapiens	% Control	%	94.0
Not Active	23372035	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23372036	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23372503	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23372504	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
	23373741	CHEMBL4885518	RSK2(R6A3CGE1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2345	Homo sapiens	pIC50		6.0
Not Active	23375092	CHEMBL4886080	RSK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	15.0	CHEMBL2345	Homo sapiens	% Inhibition	%	15.0
Not Active	23375371	CHEMBL4886353	ribosomal protein S6 kinase, 90kDa, polypeptide 3  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1	Outside typical range	CHEMBL2180408		Inhibition	%	-20.0	CHEMBL2345	Homo sapiens	% inhibition	%	-20.0
Not Active	23375930	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23375931	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23376398	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23376399	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	87.0	CHEMBL2345	Homo sapiens	% Control	%	87.0
Not Active	23376975	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	71.0	CHEMBL2345	Homo sapiens	% Control	%	71.0
Not Active	23376976	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	88.0	CHEMBL2345	Homo sapiens	% Control	%	88.0
Not Active	23377443	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	72.0	CHEMBL2345	Homo sapiens	% Control	%	72.0
Not Active	23377444	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	78.0	CHEMBL2345	Homo sapiens	% Control	%	78.0
Not Active	23378303	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL2345	Homo sapiens	% Control	%	88.0
Not Active	23378304	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	87.0	CHEMBL2345	Homo sapiens	% Control	%	87.0
Not Active	23378771	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	75.0	CHEMBL2345	Homo sapiens	% Control	%	75.0
Not Active	23378772	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	84.0	CHEMBL2345	Homo sapiens	% Control	%	84.0
Not Active	23379938	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	81.0	CHEMBL2345	Homo sapiens	% Control	%	81.0
Not Active	23379939	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23380406	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	60.0	CHEMBL2345	Homo sapiens	% Control	%	60.0
Not Active	23380407	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23381100	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23381101	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	85.0	CHEMBL2345	Homo sapiens	% Control	%	85.0
Not Active	23381748	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23381749	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23382216	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23382217	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23382840	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	82.0	CHEMBL2345	Homo sapiens	% Control	%	82.0
Not Active	23382841	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Slightly Active	23383308	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	25.0	CHEMBL2345	Homo sapiens	% Control	%	25.0
Not Active	23383309	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	85.0	CHEMBL2345	Homo sapiens	% Control	%	85.0
Not Active	23383977	CHEMBL4887581	RPS6KA3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	94.0	CHEMBL2345	Homo sapiens	% Ctrl	%	94.0
Not Active	23383978	CHEMBL4887581	RPS6KA3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	95.0	CHEMBL2345	Homo sapiens	% Ctrl	%	95.0
Not Active	23384043	CHEMBL4887641	MAPKAP-K1B DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	78.2	CHEMBL2345	Homo sapiens	% Ctrl	%	78.2
Not Active	23384453	CHEMBL4888048	Rsk2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	1.78	CHEMBL2345	Homo sapiens	% inhibition	%	1.78
Not Active	23384710	CHEMBL4888236	RPS6KA3 (RSK2) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	21.0	CHEMBL2345	Homo sapiens	% Inhibition	%	21.0
Not Active	23385223	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23385224	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	87.0	CHEMBL2345	Homo sapiens	% Control	%	87.0
Not Active	23385690	CHEMBL4879947	KinomeScan assay: inhibition of RSK2(Kin.Dom.1-N-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
Not Active	23385691	CHEMBL4879948	KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL2345	Homo sapiens	% Control	%	100.0
